<SEC-DOCUMENT>0001553350-22-000798.txt : 20220928 <SEC-HEADER>0001553350-22-000798.hdr.sgml : 20220928 <ACCEPTANCE-DATETIME>20220928172816 ACCESSION NUMBER: 0001553350-22-000798 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GHST World Inc. CENTRAL INDEX KEY: 0001121795 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 912007477 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-31705 FILM NUMBER: 221277109 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: (212) 634-6860 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Ghost Technology Inc. DATE OF NAME CHANGE: 20080922 FORMER COMPANY: FORMER CONFORMED NAME: I A EUROPE GROUP INC DATE OF NAME CHANGE: 20021209 FORMER COMPANY: FORMER CONFORMED NAME: GENERAL TELEPHONY COM INC DATE OF NAME CHANGE: 20000810 </SEC-HEADER> <DOCUMENT> <TYPE>10-K <SEQUENCE>1 <FILENAME>ghst_10k.htm <DESCRIPTION>FORM 10-K <TEXT> <XBRL> <?xml version="1.0" encoding="utf-8"?> <html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:GHST="http://ghstworld.com/20220630"> <head> <title></title> <meta http-equiv="Content-Type" content="text/html" /> </head> <!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 --> <!-- Field: Set; Name: xdx; ID: xdx_036_GHST_ghstworld.com_20220630 --> <!-- Field: Set; Name: xdx; ID: xdx_04F_20210701_20220630 --> <!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001121795 --> <!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false --> <!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 --> <!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY --> <!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD --> <!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure --> <body style="font: 10pt Times New Roman, Times, Serif"> <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityCentralIndexKey">0001121795</ix:nonNumeric> <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric> <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric> <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric> <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0149" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0150" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0165" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0168" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0171" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0174" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_custom_PreferredStockSeriesAMember" id="xdx2ixbrl0228" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_custom_PreferredStockSeriesBMember" id="xdx2ixbrl0229" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0231" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30_custom_PreferredStockSeriesAMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30_custom_PreferredStockSeriesBMember" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0269" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0313" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction> </ix:hidden> <ix:references> <link:schemaRef xlink:href="ghst-20220630.xsd" xlink:type="simple" /> </ix:references> <ix:resources> <xbrli:context id="From2021-07-01to2022-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-09-22"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-22</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-07-012021-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-30_custom_PreferredStockSeriesAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-30_custom_PreferredStockSeriesBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_custom_PreferredStockSeriesAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_custom_PreferredStockSeriesBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-07-012021-06-30_custom_PreferredStockSeriesAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-07-012021-06-30_custom_PreferredStockSeriesBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-01</xbrli:startDate> <xbrli:endDate>2021-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-07-012022-06-30_custom_PreferredStockSeriesAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-07-012022-06-30_custom_PreferredStockSeriesBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_custom_PreferredStockSeriesAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_custom_PreferredStockSeriesBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-09-022021-09-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-09-02</xbrli:startDate> <xbrli:endDate>2021-09-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-07-012022-06-30_us-gaap_InvestorMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">us-gaap:InvestorMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-06-30_us-gaap_InvestorMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">us-gaap:InvestorMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2018-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-08-07"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-07</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-08-012022-08-18_us-gaap_SubsequentEventMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121795</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-01</xbrli:startDate> <xbrli:endDate>2022-08-18</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> <xbrli:unit id="USDPShares"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit> <xbrli:unit id="Pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> </ix:resources> </ix:header> </div> <p style="margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20210701__20220630_zKvGJvgEXOZd"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif"><b><span id="xdx_905_edei--DocumentAnnualReport_c20210701__20220630_zmS2a1LuNRlg"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleantrue" name="dei:DocumentAnnualReport">☒</ix:nonNumeric></span></b></span><b> ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the fiscal year ended <b><span id="xdx_900_edei--DocumentPeriodEndDate_c20210701__20220630_z9gy9F9sXDh8"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_903_edei--CurrentFiscalYearEndDate_c20210701__20220630_zmvs0SYjO4W3"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, 2022</ix:nonNumeric></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Or</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif"><b><span id="xdx_905_edei--DocumentTransitionReport_c20210701__20220630_zNHlsWm5qKTk"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">☐</ix:nonNumeric></span></b></span><b> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the transition period from ___________ to ___________</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Commission file number: <b><span id="xdx_900_edei--EntityFileNumber_c20210701__20220630_ze68oKvhJweh"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityFileNumber">000-31705</ix:nonNumeric></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><b><span id="xdx_90D_edei--EntityRegistrantName_c20210701__20220630_zcsLSLOQ3x46"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityRegistrantName">GHST World Inc.</ix:nonNumeric></span></b></td></tr> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><i>(Exact name of registrant as specified in charter)</i></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: black 1pt solid; vertical-align: top; width: 51%; text-align: center"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20210701__20220630_zPazZFyrI2f"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="border-bottom: black 1pt solid; vertical-align: top; width: 48%; text-align: center"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20210701__20220630_zOUwDhpDCxOk"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityTaxIdentificationNumber">91-2007477</ix:nonNumeric></span></b></td></tr> <tr> <td style="vertical-align: top; text-align: center"><i>(State or other jurisdiction of<br /> incorporation or organization)</i></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><i>(I.R.S. Employer<br /> Identification No.)</i></td></tr> <tr> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td></tr> <tr> <td style="border-bottom: black 1pt solid; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20210701__20220630" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressAddressLine1">667 Madison Avenue</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressAddressLine2_c20210701__20220630" title="Entity Address, Address Line Two"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressAddressLine2">5th Floor</ix:nonNumeric></span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20210701__20220630_zTjQOl86RySc"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20210701__20220630_zMEdCHMd8AM9"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></b></p></td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20210701__20220630_zo5l0F6y4WJk"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressPostalZipCode">10065</ix:nonNumeric></span></b></td></tr> <tr> <td style="vertical-align: top; text-align: center"><i>(Address of principal executive offices)</i></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><i>(Zip Code)</i></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: black 1pt solid; width: 100%; text-align: center"><span><b>+1 (<span id="xdx_90C_edei--CityAreaCode_c20210701__20220630" title="City Area Code"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:CityAreaCode">212</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20210701__20220630" title="Local Phone Number"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:LocalPhoneNumber">634-6860</ix:nonNumeric></span></b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><i>(Registrant’s telephone number, including area code)</i></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities registered pursuant to Section 12(b) of the Act: None</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities registered pursuant to Section 12(g) of the Act: Common stock, par value $0.001 per share</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-family: Segoe UI Symbol,sans-serif">☐</span> <span id="xdx_90B_edei--EntityWellKnownSeasonedIssuer_c20210701__20220630_z7AIcgtYSUJ"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">☒</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes <span style="font-family: Segoe UI Symbol,sans-serif">☐<span style="font-family: Segoe UI Symbol,sans-serif"></span> <span id="xdx_908_edei--EntityVoluntaryFilers_c20210701__20220630_zN9aoLQ6pRQb"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">☒</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_90F_edei--EntityCurrentReportingStatus_c20210701__20220630_zhmYkwG4lWDi"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">☒</span> No <span style="font-family: Segoe UI Symbol,sans-serif">☐</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_909_edei--EntityInteractiveDataCurrent_c20210701__20220630_zZKU0topesBl"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">☒</span> No <span style="font-family: Segoe UI Symbol,sans-serif">☐</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 5%"> </td> <td style="width: 37%">Large accelerated filer</td> <td style="vertical-align: top; width: 5%; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif">☐</span></td> <td style="vertical-align: top; width: 48%">Accelerated filer</td> <td style="vertical-align: top; width: 5%; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif">☐</span></td></tr> <tr> <td> </td> <td><span id="xdx_908_edei--EntityFilerCategory_c20210701__20220630_z4Trdasf4G6k"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></td> <td style="vertical-align: top"><span style="font-family: Segoe UI Symbol,sans-serif">☒</span></td> <td style="vertical-align: top">Smaller reporting company</td> <td style="vertical-align: top"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_905_edei--EntitySmallBusiness_c20210701__20220630_zcmOZsi6yTb8"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">☒</ix:nonNumeric></span></span></td></tr> <tr> <td> </td> <td> </td> <td style="vertical-align: top; text-align: justify"> </td> <td>Emerging growth company</td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20210701__20220630_zYw20GdbgtXd"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">☒</ix:nonNumeric></span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standard provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_900_edei--EntityExTransitionPeriod_c20210701__20220630_zpoqXyvqVzz9"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleantrue" name="dei:EntityExTransitionPeriod">☒</ix:nonNumeric></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span style="font-family: Segoe UI Symbol,sans-serif">☐</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes <span style="font-family: Segoe UI Symbol,sans-serif">☐</span> <span id="xdx_900_edei--EntityShellCompany_c20210701__20220630_zNN5r23sxzEe"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">☒</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, as of December 31, 2021, the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $<span id="xdx_90C_edei--EntityPublicFloat_iI_c20211231_zPWXlqOpwi89"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">911,327</ix:nonFraction></span> based upon the last sales price of the common stock as of such date. Solely for purposes of this disclosure, shares of common stock held by executive officers, directors and beneficial holders of 10% or more of the outstanding common stock of the registrant as of such date have been excluded because such persons may be deemed to be affiliates. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 22, 2022, the issuer had <span id="xdx_90D_edei--EntityCommonStockSharesOutstanding_iI_c20220922_zPrIxXnCGFf5" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-09-22" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">124,430,534</ix:nonFraction></span> shares of its common stock, $0.001 par value per share, outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>TABLE OF CONTENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 11%"> </td> <td style="vertical-align: bottom; width: 82%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; text-align: center"><b>PAGE</b></td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><b>PART I</b></td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 1</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item1">Business</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">1</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 1A</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#RiskFactors">Risk Factors</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">6</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 1B</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item1b">Unresolved Staff Comments</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">19</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 2</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item2">Properties</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">19</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 3</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item3">Legal Proceedings</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">19</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 4</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item4">Mine Safety Disclosures</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">19</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><b>PART II</b></td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 5</td> <td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12pt; text-indent: -12pt"><a href="#Item5">Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></p></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">20</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 6</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item6and7">[Reserved]</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">22</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 7</td> <td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12pt; text-indent: -12pt"><a href="#Item6and7">Management’s Discussion and Analysis of Financial Condition and Results of Operations</a></p></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 7A</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item7a">Quantitative and Qualitative Disclosures About Market Risk</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 8</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item8">Financial Statements and Supplementary Data</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 9</td> <td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12pt; text-indent: -12pt"><a href="#Item9">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></p></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 9A</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item9a">Controls and Procedures</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 9B</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item9a">Other Information</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 9C</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#item9c">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">25</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><b>PART III</b></td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 10</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item10">Directors, Executive Officers and Corporate Governance</a></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">26</td></tr> <tr> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Item 11</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item11">Executive Compensation</a></td> <td> </td> <td style="text-align: right">25</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Item 12</td> <td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12pt; text-indent: -12pt"><a href="#Item12">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></p></td> <td> </td> <td style="text-align: right">27</td></tr> <tr> <td style="vertical-align: top">Item 13</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item13">Certain Relationships and Related Transactions, and Director Independence</a></td> <td> </td> <td style="text-align: right">29</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Item 14</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item14">Principal Accounting Fees and Services</a></td> <td> </td> <td style="text-align: right">29</td></tr> <tr> <td style="vertical-align: top"><b>PART IV</b></td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Item 15</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Exhibits">Exhibits, Financial Statement Schedules</a></td> <td> </td> <td style="text-align: right">30</td></tr> <tr> <td style="vertical-align: top">Item 16</td> <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><a href="#Item16">Form 10-K Summary</a></td> <td> </td> <td style="text-align: right">31</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 2; Options: NewSection --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><span style="font-size: 9pt">i</span></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item1"></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>PART I</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.75in"><b>ITEM 1.</b></td><td><b>BUSINESS.</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cautionary Note Regarding Forward Looking Statements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This annual report on Form 10-K (this “Report”) contains forward-looking statements including statements regarding the Company’s patents and patent applications, the development, marketing and sale of its products including its Smart Shin Guard, the implementation of its business plan and expected timelines for meeting its objectives, the continued effect of the COVID-19 pandemic on our business and prospective customers and the economy, the need for capital to fund and grow its operations, and liquidity. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements are summarized in the “Summary of Risk Factors” below and are more particularly described in Item 1A. – Risk Factors. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>History</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GHST World Inc. (“Ghost” or the “Company”) was organized on November 12, 1999 as a Nevada corporation. On December 2, 2002, the Company merged with and into I.A. Europe, leaving I.A. Europe as the surviving corporation and on April 8, 2008, the Company amended its certificate of incorporation to change its name. From 2002, Ghost was a shell corporation with no assets, revenues or operations until January 2008 when it acquired rights to an advertisement filtration system for televisions. It subsequently abandoned that business and became a shell corporation again until 2020 when it entered the sports technology industry when it obtained the rights to a patent for Smart Shin Guard technology.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 10, 2009, our registration statement was revoked for failure to file reports required under the Securities Exchange Act of 1934, (the “Exchange Act”). On September 7, 2010, we re-registered our common stock, and on September 6, 2013 we terminated our registration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 21, 2017 we changed our name to “GHST World, Inc.” On March 9, 2021 we filed a registration statement on Form 10 (File No. 000-31705), as amended on April 4, 2021 and May 7, 2021 (the “Form 10”) to register our common stock pursuant to Section 12(g) of the Exchange Act. The Form 10 as amended became effective on May 8, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Current Status</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2019 we formed GHST Sport Inc. (“Ghost Sport”) as a wholly-owned subsidiary of the Company and shifted our business focus to the marketing and sale of technologically-enhanced sports equipment and the acquisition and development of related intellectual property. To that end, on June 30, 2020 we obtained a U.S. patent for our Smart Shin Guard. We also have patent applications pending in Canada, Australia, Hong Kong, and 36 countries in Europe.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 29, 2019, the Company acquired all of the capital stock of GHST ART WORLD Inc., a Florida corporation (“Ghost Art”), whose principal assets consisted of 119 art paintings and reproductions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have minimal assets other than our patented technology and are relying on the ability to raise the necessary capital to exploit the patent we acquired to the Smart Shin Guard for the United States, and the pending applications in other jurisdictions. We plan to market and sell this product to athletes, sports teams, organizations and leagues, with an initial focus on professional and amateur soccer (football) teams and leagues, both within the U.S. and abroad.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <!-- Field: Page; Sequence: 3; Options: NewSection --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have not yet generated initial revenue from any of our current products, and have relied upon issuances of shares of our common stock and related party loans to fund our operations. We continue to develop our Smart Shin Guard and related technology, including a smart phone application, as more particularly described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management and directors are based in Italy and other European countries. We have no employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Acquisition of Intellectual Property Rights to the Smart Shin Guard</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2018, the Company acquired the rights to the 2015 Italian patent and underlying concept for the Smart Shin Guard in exchange for 2,000,000 shares of common stock. The Company has since been issued a U.S. patent (Patent No. US 10,695,651 B2; “Protection Device for Carrying Out Sports Activities Usable in Data Analysis and Monitoring System, and Relative System and Method for Processing and Calculating the Sent Data”) for the Smart Shin Guard and has patent applications pending in Canada, Australia, Hong Kong and the European Union (36 countries) as well as for an international patent. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The patent and patent applications contemplate potential application of the invention within other forms of athletic equipment outside of shin guards used in soccer or similar sports. We may consider expanding our technology to other applications of the invention in the sporting world depending on the results our efforts to market and sell the Smart Shin Guard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>The Smart Shin Guard</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Smart Shin Guard is a shin guard, which is a form of protective equipment placed on the front portion of the lower leg while playing soccer and similar sports, combined with our data collection and analysis technology that monitors players’ individual and collective physical and performance-based metrics and transmits this information to a separate module in real-time. Examples of the information the Smart Shin Guard can collect and analyze for users is covered distance, acceleration, kicking force, collision impact, positioning, directional movement, and performance alerts. This information will vary depending on the version of the product that is used, which will depend on the customers and their particular purposes for using the Smart Shin Guard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The product is designed for use by teams and individuals to enhance their ability to track player performance, stamina, and conditioning at matches, practices or any other circumstance in which they desire to play the sport. We believe the Smart Shin Guard will provide valuable insight to players, coaches and organizations seeking to gain a competitive advantage over their opponents be assisting with in-game monitoring and pre- and post-game assessment and strategy using our technology. Our goal is to empower coaches, players and teams to make faster and potentially in-game decisions regarding their players, team and strategies in reaction to the data provided and obtain an advantage therefrom that helps them achieve their objectives, both individually and in the leagues in which they compete. Additionally, we believe this product has attractive features for more casual players seeking to track their individual performances for educational, informational, or health-related purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Product Development</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has completed the Beta testing of the functionality of the Smart Shin Guard is now in the industrial development phase which involves a focus on further development of the electronic component (including miniaturization and a proper arrangement), having the software for data collection and transmission and adding artificial intelligence to assist with precision and repeatability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are continuing to collect data on the functionality of our Smart Shin Guards. We expect to complete the development phase of the Smart Shin Guard in approximately four or five months, whereupon we intend to begin the manufacturing process through a third party and then the sales process, which will initially be focused on non-professional players (teams and individuals).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with our development efforts for the Smart Shin Guard, in calendar year 2021 we entered into two agreements with independent contractors which provide for the development, testing and improvement of prototype software, which are summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 4 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2021, we entered into an agreement with a third party electronic device development and manufacturing firm providing for the development of an artificial intelligence software component for our Smart Shin Guard. The independent contractor had previously assisted with the development and production of a prototype for the hardware component for the Smart Shin Guard, specifically a pair of shin guards which contain sensors for data collection and accompanying Bluetooth transmission technology. The artificial intelligence software component contemplated by the agreement is intended to allow for more accurate and reliable data collection, analysis and transmission. The agreement contemplates the production of machine learning models aimed at enhancing the product’s data analysis functionality, with data collection and basic analysis using sensors to occur in-game, and more advanced analysis to occur post-game. Under the agreement, this phase of the development process is projected to last two months. The development agreement contemplates that the deliverables under the agreement will allow for future in-house operation by the Company. Further testing, analysis and development under this agreement remains ongoing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2021, we entered into an agreement with another independent contractor for the development of mobile and website applications to be used in conjunction with the Smart Shin Guard and the information and analysis it provides. The agreement contemplates the development of necessary features for these applications, including data transmission and display, user interfacing and notifications. We recently received the initial deliverables under this agreement with respect to the mobile phone application and are in the process of further testing and preparing for consumer use, pending completion of other aspects of the Smart Shin Guard development process described elsewhere in this Report. For more information on these features, see “Applications and Uses.” <span style="background-color: lime"><b>.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Applications and Uses</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We plan to sell two versions of the Smart Shin Guard which will vary in terms of sophistication of features offered and target demographics of users:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Consumer Kit</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard version which collects data and provides analysis on basic physical and performance metrics, including covered distance, instantaneous and average speed, movement and direction, acceleration and deceleration, kicking power, shot, pass, tackle, and header identification, and performance alerts. The consumer kit is designed for athletes at all levels ranging from casual players to amateur and professional athletes. The remote access to the information and analysis provided can be accessed by coaches, teammates, friends and family. We expect for the development of the consumer kit, including the corresponding smart phone application, to be completed before the more advanced professional kit described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Professional Kit</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An advanced version which will be more sophisticated in terms of the types of data collected and the level of analysis and computation. In addition to the statistics available with the consumer kit, the professional kit allows users to collect information on calorie consumption, metabolic power, elevation distance, directional changes and angles, heart rate, positioning map, and team barycenter, which is the center of gravity of a game. The professional kit is designed for and will be marketed primarily toward professional athletes and teams. The development of the professional kit will be a longer process than the consumer kit due to factors including increased sophistication and technical complexity of the data collection and analysis capabilities, contractual terms and limitations in our human and capital resources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Smart Phone Application</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is in the process of developing a smart phone application (“phone app”) for use by customers using the Smart Shin Guard. The phone app will function by receiving and displaying data collected and processed by the Smart Shin Guard. When developed, the phone app will be essential for use in connection with the consumer kit, to the extent such consumers intend to review and use the data provided in real time while training or playing in games. We have developed a prototype of the phone app for the consumer kit, and development for the professional kit, as well as additional continued efforts to improve the application generally, remain ongoing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <!-- Field: Page; Sequence: 5 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Other Subsidiaries</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other than Ghost Sport, we have two other subsidiaries which we expect to play a less central role to our business plan and future operations, at least in the short term. These subsidiaries are still in the early developmental stages and we do not expect either to materially contribute to our business plan and operations as described elsewhere in this report. If we find investors or strategic partners interested in either of these subsidiaries, we may enter into agreements or arrangements with such parties pursuant to which we will issue equity or debt interests in the Company or one of our subsidiaries. Below is a brief description of each subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Ghost Art World Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ghost Art is our wholly-owned subsidiary which we acquired on June 29, 2019 together with its portfolio of 119 art paintings and reproductions as its principal assets. We have not sold any of these assets. We are also developing a virtual artist “incubator” and art trading platform and network to assist emerging artists increase their visibility and locate and procure sales of their artwork to consumers. This concept is still in the early development stage and we do not expect to bring it to market or generate revenue therefrom in the short term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">IoTT World, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IoTT World Inc. (“IoTT”), which is an acronym for “Internet of Things Tech,” is our wholly-owned subsidiary which focuses on the research and development of technology and products designed to connect common household and other electronic devices using the Internet. This concept is still in the early development stage and we do not expect to bring it to market or generate revenue from it in the short term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Meanwhile, for IoTT we plan to insert a database sector in which all the data collected per user of those who buy and wear our SSGs will converge, so that they can be consulted, for a fee, by insiders such as coaches, athletic trainers, technical sports directors, and others involved with the player/team, or by the players themselves, thus creating a large sports database with the hopes that over time the system will be used for all sports.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Competition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With respect to Ghost Sport, we will compete directly with sports equipment and apparel developers, wholesalers and retailers, as well as other businesses offering player and team tracking technology, some of which sell similar products to ours, and many of which have significantly greater capital and human resources than we do. For example, we face competition from other businesses which provide smart data tracking and collection technology in the form of wearable sporting equipment, including Soccerment and TibTop, each of which offers wearable shin guards, and Catapult Sports, which offers similar wearable devices, with some level of data collection, analysis and transmission functionalities. Although we believe our Smart Shin Guard technology to be unique in terms of its patented features and processes and the depth of information it can collect, analyze and transmit, there can be no guarantee that our competitors have not or will not develop and sell technology that is similar or superior to ours and/or that will hinder or limit our ability to access the market. Further, with respect to the phone app for the Smart Shin Guard, there is at least one other similar application called Goalon which allows users to track certain performance metrics directly on their cellular device, and there may be others currently in the market or that are being or may be developed that we will compete with. Additionally, some sporting equipment companies and service providers offer technology or services using different means, such as cameras that collect and transmit team and player data in a manner similar to ours, could be seen as competitors. Offerings of similar equipment and technology to our Smart Shin Guard by any of these competitors will likely create a barrier to market entry for our product and/or render it difficult to develop or grow a customer base, particularly to the extent our potential customers and users have already integrated competitor products and services. Further, while we are not aware of similar wearable devices that are approved by soccer leagues for in-play usage, we have also not obtained such approval for the Smart Shin Guard ourselves, and there can be no assurance that such approval will be obtained.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With respect to Ghost Art, we expect to face competition from niche art platforms and galleries as well as larger platforms on which artists can display their works, such as Instagram and Facebook. Among our more direct competitors in the artist accelerator and marketing platform businesses are Looklateral, Koones, Lean Artist, Mecenate.online, Rise Art and Saatchi Art. Many of our competitors in this field have access to greater financial resources and business networks and more experience in the industry, which will pose challenges to any future operations and barriers to market entry and growth.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 6 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With respect to IoTT, a variety of technology research and development companies have already made headway on connecting various devices and otherwise making life easier for consumers using the internet and artificial intelligence. The market is currently saturated with such products, and with companies seeking to develop and evolve such products and underlying concepts as to enhance their functionality. In light of these market conditions and the intense competitive environment in this area, competition will be intense, as will risks inherent therewith including the reality that many competitors have more capital, experience and progress with respect to their offerings than we do and that we may face difficulty in obtaining or protecting intellectual property rights or avoiding the infringement of others in our operations of IoTT.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Employees</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have no employees. Our officers provide services on a part-time basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Status as an Emerging Growth Company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because we have no revenues and have never had a registration statement become effective, we are an emerging growth company. An emerging growth company is defined as a company which had annual gross revenues were less than $1.07 billion during its most recently completed fiscal year and had not sold common equity securities under a registration statement as of December 8, 2011. We will continue to be an emerging growth company until the earlier of: (i) the last day of the fiscal year of the Company during which we had total annual gross revenues of $1.07 billion or more; (ii) the last day of the fiscal year of the Company following the fifth anniversary of the date of the Company’s first sale of common equity securities of pursuant to an effective registration statement under the Securities Act; (iii) the date on which the Company has, during the previous three-year period, issued more than $1 billion in non-convertible debt; or (iv) the date on which the Company is deemed to be a “large accelerated filer” as that term is defined in Rule 12b-2 promulgated under the Exchange Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The federal securities laws and regulations provide certain exemptions for emerging growth companies with respect to financial information and disclosure requirements in registration statements and periodic reports and certain activities in connection with initial public offerings. The exemptions available to us as a result of our status as an emerging growth company are summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Symbol">·</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify">Unlike other reporting companies, we are not required to hold periodic shareholder voting on executive compensation, the frequency of shareholder voting of executive compensation, and golden parachute compensation.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We are permitted to include less extensive narrative disclosure in our reports filed with the Securities and Exchange Commission (the “SEC”) than is required of other reporting companies, particularly in the description of executive compensation.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We are not required to include a report of our independent registered public accounting firm on the Company’s internal control over financial reporting in our SEC filings.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We would not be required to comply with new or revised financial accounting standards until private companies (e.g., those that have not had a Securities Act registration statement declared effective and do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We would be exempt from any requirement adopted by the Public Company Accounting Oversight Board in the future providing for a mandatory rotation of companies’ accounting firms.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We are permitted to submit a registration statement under the Securities Act to the SEC on a confidential basis if the registration statement and all amendments are publicly filed at least 21 days before we were to conduct any road show with respect to such offering.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 7 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We may communicate with prospective investors that are qualified institutional buyers or institutions that are accredited investors to determine interest in a contemplated offering either prior to or after filing a registration statement under the Securities Act.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Some of the above-described exemptions are also available to smaller reporting companies, and therefore a termination of our status as an emerging growth company would not necessarily result in a requirement that we comply with the default disclosure requirements applicable to reporting companies generally.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have elected not to use the extended transition period for complying with any new or revised accounting standards under Section 102(b)(1) of the Exchange Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="RiskFactors"></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.75in"><b>ITEM 1A.</b></td><td><b>RISK FACTORS.</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investing in our common stock involves a high degree of risk. You should carefully consider the following risk factors before deciding whether to invest in the common stock. If any of the events discussed in the risk factors below occur, our business, financial condition, results of operations or prospects could be materially and adversely affected. In such case, the value and marketability of the common stock could decline, and you might lose all or part of your investment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Summary of Risk Factors</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business is subject to numerous risks and uncertainties that you should consider before investing in our common stock. Some of the principal risk factors that make an investment in the Company speculative or risky are summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Symbol">·</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify">We have generated no material revenue during the last two fiscal years or current fiscal year and in order to continue as a going concern we require additional capital either through a debt or equity financing.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We are still in the process of developing our Smart Shin Guard, which is our principal product, and there can be no assurance we will be successful in completing such development or that we can successfully market this product once developed.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We have a limited operating history and our likelihood of success is contingent upon the problems, expenses, and complications frequently encountered by development stage companies.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We may have or discover in the future material weaknesses in our internal controls and may face difficulties remediating any such weaknesses;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">In order to generate material revenue, we will need to successfully develop and market our products and services, including the Smart Shin Guard which is our principal product and is still under development;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%">•</td> <td style="width: 94%; text-align: justify">Our business is dependent upon our intellectual property which we may be unable to obtain or protect without incurring significant expenses or at all.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We may become involved in litigation to defend our intellectual property or to defend against infringement claims from third parties, which would be expensive and time consuming and could materially adversely affect our business.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We are highly dependent on a small number of key personnel, the loss of whom would materially adversely affect our business.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">The industry in which we principally operate is highlight competitive, and most of our competitors have greater financial and other resources and capital raising abilities than we do, which will render our efforts to establish a market for our brand and products, including our Smart Shin Guard, particularly challenging.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Because we will be reliant on a single product, if we are unable to establish a market for our product and generate material revenue, this lack of diversification will be difficult to overcome and investors could lose some or all of their investment.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 8 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">There is currently no active market for our securities, there can be no assurance that such a market will ever develop, and the future prices and liquidity of our securities could be unpredictable and volatile.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">The COVID-19 pandemic has caused and may continue to cause disruptions in our business and industry, which may hinder our progress and growth prospects.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Risks Relating to the Company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Our ability to continue as a going concern is in doubt absent obtaining adequate new debt or equity financing.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have limited capital and have accumulated losses of over $9.2 million since inception. Because we do not have sufficient working capital and cash flows for continued operations for at least the next 12 months, our auditors have issued a qualified opinion. Our continued existence is dependent upon us or obtaining the necessary capital to meet our expenditures. We cannot assure you that we will be able to raise adequate capital to meet our future working capital needs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because we expect to need additional capital to fund our growing operations, we may not be able to obtain sufficient capital and may be forced to limit the scope of our operations.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently need substantial working capital. The slowdown in the global economy or any subsequent or further financial hardship caused by the COVID-19 pandemic may adversely affect our ability to raise capital. If adequate additional debt and/or equity financing is not available on reasonable terms or at all, we may not be able to remain in business, and we will have to cease operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Even if we secure the necessary working capital, we may not be able to negotiate terms and conditions for receiving the additional capital that are acceptable to us. Any future equity capital investments will dilute existing shareholders. In addition, new equity or convertible debt securities issued by us to obtain financing could have rights, preferences and privileges senior to our common stock. We cannot give you any assurance that any additional financing will be available to us, or if available, will be on terms favorable to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>If we are not successful, you may lose your entire investment.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prospective investors should be aware that if we are not successful in our new business, their entire investment in the Company could become worthless. Even if the Company is successful, we can provide no assurances that investors will derive a profit from their investment. Even if we can raise sufficient capital or generate revenue, we cannot guarantee any resulting proceeds to us will be sufficient for us to grow our operations and become profitable. If we are not successful, you may lose your entire investment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because we have a limited operating history to evaluate our company, the likelihood of our success must be considered in light of the problems, expenses, difficulties, complications and delay frequently encountered by a new company.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since we have a limited operating history under our current business model, it is difficult for investors to evaluate our business and prospects. You must consider our prospects in light of the risks, expenses and difficulties we face as an early stage company with a limited operating history. Investors should evaluate an investment in our company in light of the uncertainties encountered by start-up companies in a highly competitive industry such as ours, which contains significant barriers to market entry. There can be no assurance that our efforts will be successful or that we will be able to attain profitability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because Ghost’s business plan is unproven it may not result in the generation of any revenue, material revenue or profitability.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ghost is relying upon its U.S. patented sports equipment technology which we intend to market and sell in the U.S. and foreign athletic markets to individual players, teams and organizations interested in the Smart Shin Guard’s data collecting capabilities. We have not sold our products, and do not presently have inventory available for sale. We cannot assure you that assuming we obtain sufficient financing, we will be able to successfully market our product in any of the target countries, derive any material revenue or attain profitability. If we are not successful in marketing the Smart Shin Guard, it is likely that you will lose your entire investment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <!-- Field: Page; Sequence: 9 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because our business model is new, our growth strategy may not be achievable and may not result in profitability.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may not be able to implement our growth strategy reflected in our business plan rapidly enough as to achieve profitability. Our growth strategy is dependent on a number of factors, including market acceptance of the Smart Shin Guard. We cannot assure you that consumers and others will purchase the Smart Shin Guard or that a sufficient market demand for our product will develop for us to generate revenue or become profitable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Among other things, implementation of our growth strategy would be adversely affected by the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; text-align: justify; line-height: 115%"> </td> <td style="width: 3%; line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="width: 94%; text-align: justify; line-height: 115%"><span style="line-height: 115%">we may not be able to attract sufficient customers/subscribers for our product(s);</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">our research and development, manufacturing and marketing costs may be materially more than we anticipate which will affect our future gross profit margins;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">a decline in general market conditions may prevent us from successfully establishing a customer base or raising capital as required; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">we may face significant litigation from competitors with intellectual property rights for products that are similar to ours, the occurrence of which would not only divert our management’s time and attention, but involve prohibitive legal and other defense costs.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Our business will depend, to a large extent, upon our intellectual property.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We rely on our U.S. patent and have applied for patents in other jurisdictions to protect our Smart Shin Guard technology. This patent and any future patents we can obtain will be critical to our ability to market our product in applicable jurisdictions without the risk of reverse engineering of our technology. In the event that we are unable to secure such patents, the marketability and viability of our product could be adversely affected, including by being vulnerable to reverse engineering in any jurisdiction where the patent did not issue. While we received the U.S. patent, there can be no assurance that the other patents will be secured. In the event these patents do not issue, the value of our intellectual property and our ability to generate revenue therefrom could be materially adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>If we cannot obtain or protect intellectual property rights related to our current or future products, we may not be able to compete effectively in our markets.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We rely upon a combination of patents, trade secret protection and confidentiality agreements to protect the intellectual property related to our current or future products. The strength of our patent in the sports logistics and technology field involves complex legal questions and can be uncertain. Our international patent applications may fail to result in patents with claims that cover the products in the countries in which we desire to market and sell our products. There is no assurance that all of the potentially relevant prior art relating to our patent and patent applications has been found; such prior art can invalidate a patent or prevent a patent from issuing based on a pending patent application. Even if patents do successfully issue, third parties may challenge their validity, enforceability or scope, which may cause such patents to be narrowed or invalidated. Even if unchallenged, our patents and patent applications may not adequately protect our intellectual property or prevent others from designing around our claims.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the patent applications we hold fail to issue or if their breadth or strength of protection is threatened, it could threaten our ability to commercialize our products. Patents may not issue and issued patents may be found invalid and unenforceable or challenged by third parties. Since patent applications in the United States and most other countries are confidential for a period after filing, and some remain so until issued, we cannot be certain that we were the first to invent a patent application related to a product. Patents have a limited lifespan. In the United States, the natural expiration of a patent is 20 years after it is filed, although various extensions may be available. The life of a patent, and the protection it affords, is limited. When the patent life has expired for a product, we will become vulnerable to competition from similar products or generic versions attempting to replicate our Smart Shin Guard or other products we may develop or acquire in the future. Further, if we encounter delays in regulatory or league approvals, the time during which we will be able to market and commercialize a product candidate under patent protection could be reduced.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 10 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to patent protection, we rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is not patentable, processes for which patents are difficult to enforce and any other elements of our product development processes that involve proprietary know-how, information or technology not covered by patents. As a general practice, our employees, consultants, advisors and any third parties who have access to our proprietary know-how, information or technology enter into confidentiality agreements. Nonetheless, our trade secrets and other confidential proprietary information may be disclosed and competitors may otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. We may encounter significant problems in protecting and defending our intellectual property both in the United States and abroad, particularly given our present business plan to primarily focus our marketing and sales efforts on countries located outside of the United States. If we are unable to prevent material disclosure of the non-patented intellectual property related to our technologies to third parties, and there is no guarantee we will have any such enforceable trade secret protection, we may not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, results of operations and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b><span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Third-party intellectual property infringement claims may prevent or delay our development and commercialization efforts.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our commercial success depends in part on our avoiding infringement on the patents and proprietary rights of third parties. There is substantial technology litigation, both within and outside the United States, involving patent and other intellectual property rights, including patent infringement lawsuits, interferences, oppositions, and reexaminations and other post-grant proceedings before the U.S. Patent and Trademark Office, and corresponding foreign patent offices. U.S. and foreign issued patents and pending patent applications, which are owned by third parties, may exist in the fields in which we are pursuing patents for our product. As the sports logistics and technology industries expand and more patents are issued, the risk increases that our products may be subject to claims of infringement of the patent rights of third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, concepts, or methods of manufacture related to the use or manufacture of our products. Because patent applications can take many years to issue, there may be patent applications currently pending that may later result in patents that our products may infringe. Third parties may obtain patents in the future and claim that use of our technologies infringes on these patents. If any third-party patents were to be held by a court of competent jurisdiction to cover the manufacturing process of our products, the holders of any such patents may be able to block our ability to commercialize such products unless we obtained a license under the applicable patents, or until such patents expire. Similarly, if any third-party patents were to be held by a court of competent jurisdiction to cover aspects of our concepts, processes for manufacture or methods of use, the holders of any such patents may be able to block our ability to develop and commercialize the applicable product unless we obtained a license or until such patent expires. In either case, such a license may not be available on commercially reasonable terms or at all.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties making intellectual property claims against us may obtain injunctive or other equitable relief, which could block our ability to further develop and commercialize our products. Defense of these claims, regardless of their merit, involves substantial litigation expense and would involve a substantial diversion of our management’s attention from our business. Because of the costs involved in defending patent litigation, we currently lack and may in the future lack the capital to defend our intellectual property rights. If a claim of infringement against us succeeds, we may have to pay substantial damages, possibly including treble damages and attorneys’ fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 11 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because, we may need to obtain licenses to intellectual property rights from third parties, we may be unable to obtain licenses on reasonable terms or at all.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may need to obtain licenses from third parties to allow commercialization of our products. We may fail to obtain these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize those products, which could harm our business significantly. We cannot provide any assurances that third-party patents do not exist that might be enforced against our products, resulting in either an injunction prohibiting our sales, or, with respect to our sales and other activities, an obligation on our part to pay royalties and/or other forms of compensation to third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We may be involved in lawsuits to protect or enforce our patents or other intellectual property rights, which could be expensive, time-consuming and unsuccessful.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We rely on a patent on the Smart Shin Guard to protect our intellectual property rights. In the United States, we have a patent and also have patent applications pending in international jurisdictions. If an international patent does not issue, we may be subject to significant competition. Competitors may infringe our patents or interfere with our patent applications or otherwise take action against our intellectual property rights. To counter such infringement, interference or similar adverse occurrence, we may be required to file infringement or similar claims, or we may be required to defend the validity or enforceability of our intellectual property rights, including our patents or patent applications, which can be expensive and time-consuming and may force us to divert our limited resources. In an infringement proceeding, a court may decide that either one or more of our patents is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue because our patents do not cover that technology. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing. Additionally, we may face challenges, including from competitors’ technologies, in our ability to obtain a patent in jurisdictions in which we have patent applications pending. Any difficulties or inability to obtain a patent in a jurisdiction in which we have applied or may apply for patent protection would materially adversely harm our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interference proceedings provoked by third parties or brought by us may be necessary to determine the priority of inventions regarding our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all. Our defense of litigation or interference proceedings may fail and, even if successful, may cause us to incur substantial costs and distract the attention of our management and other employees. We may not be able to prevent misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because of the substantial amount of discovery required in intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If investors perceive these results to be negative, it could have a material adverse effect on the price of our securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may be subject to claims asserting that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of our employees’ former employers or other third parties. We may also be subject to claims that former employers or other third parties have an ownership interest in our patents. Litigation may be necessary to defend against these claims. There is no guarantee of success in defending these claims, and if we succeed, litigation could cause substantial cost and be a distraction to our management and other employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>If we cannot manage our growth effectively, we may not become profitable.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Businesses, including development stage companies such as ours which often grow rapidly, tend to have difficulty managing their growth. If we are able to successfully market our product(s), we will likely need to expand our management team and other key personnel by recruiting and employing experienced executives and key employees and/or consultants capable of providing the necessary support.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 12 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We cannot assure you that our management will be able to manage our growth effectively or successfully. Our failure to meet these challenges could cause us to lose money, and your investment could be lost. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>It may be difficult to predict our financial performance because our quarterly operating results may fluctuate.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our revenue and operating results may vary significantly from quarter-to-quarter due to a variety of factors, many of which are beyond our control. You should not rely on period-to-period comparisons of our results of operations as an indication of our future performance. Our results of operations may fall below the expectations of market analysts and our own forecasts. If this happens, the market price of our common stock may fall significantly. The factors that may affect our quarterly operating results include the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; line-height: 115%"> </td> <td style="width: 3%; line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="width: 94%; text-align: justify; line-height: 115%"><span style="line-height: 115%">the rate at which we are able to distribute our product;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">the usage by subscribers of our interactive technology;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">seasonal patterns in the athletic and sporting goods industry</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">worsening economic conditions such as those caused by the COVID-19 pandemic which cause customers to reduce spending and purchases such as our product which they may deem to be unnecessary;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">changes in the regulatory environment, including regulation of advertising, that may negatively impact our marketing practices;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">the adoption of new accounting pronouncements, or new interpretations of existing accounting pronouncements, that impact the manner in which we account for, measure or disclose our results of operations, financial position or other financial measures; and</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">costs related to acquisitions of technologies or businesses.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expenditures by customers also tend to be cyclical, reflecting overall economic conditions as well as budgeting and buying patterns of athletes, teams, leagues and the general public. Any decline in the economy may alter teams’ and players’ current or prospective spending abilities or priorities and limit our sales, or may delay sales with such prospective customers, and could materially and adversely affect our business, results of operations and financial condition. For example, leagues operate on a seasonal basis, and may reduce or suspend their periods of activity due to factors beyond our control, as has taken place during calendar years 2020 and 2021 due to COVID-19.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>If we fail to retain our key personnel, we may not be able to achieve our anticipated level of growth and our business could suffer.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our future depends, in part, on our ability to attract and retain key personnel and the continued contributions of our executive officers, each of whom may be difficult to replace. In particular, Mr. Esterino Castellazzi, our President and Chairman of our Board of Directors, plays an important role in moving our business ahead and obtaining financing. None of our key personnel have any agreements to continue serving us. The loss of the services of Mr. Castellazzi or other key personnel and the process to replace any key personnel would involve significant time and expense and may significantly delay or prevent the achievement of our business objectives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We expect to rely on outside consultants and employees who may be difficult to control and may expose to liability and/or limit our ability to grow our operations as desired or at all.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Due to our limited capital, we will rely on the outside consultants and employees to develop and market our product. In the event that one or more of these consultants or employees terminates their services to with the Company, fails to follow management’s instructions or becomes unavailable, we may see adverse effects to our business and face difficulty locating and retaining suitable replacements. Further, because we will operate in multiple countries, language barriers and complications with respect to monitoring our personnel is more likely than a more localized approach. There can no assurance that our employees or consultants will stay with us or can be adequately controlled, or that we will be able to retain replacements on favorable terms or at all, in which case our business could be harmed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 13 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We will rely on third parties to sell our products, and if any of these third parties alter, restrict access to or discontinue their relationships with us, or experience technical difficulties, our ability to market our product(s) would be diminished and our business, revenue and financial results could be harmed. </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We will rely on a combination of direct sales, licensing agreements, and the use of our website to sell our Smart Shin Guard and any other products we have or may develop or acquire. If our website or one or more of these third parties experiences a security breach or outage, or any third party through which we sell or to whom we license our product terminates or adversely modifies the terms of their engagement with us, our ability to develop and grow a customer base decline and our ability to reach potential customers would be negatively affected, causing our revenues and financial results to be harmed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because of the current uncertainties, the COVID-19 pandemic could materially adversely affect our financial condition, future plans and results of operations.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The COVID-19 pandemic has and is continuing to spread throughout the world, including the United States and Western Europe. This pandemic has had a significant adverse effect on the economy throughout the world, including the live sports industry on which are business plan partially depends. The COVID-19 pandemic, including the recent resurgence in the summer of 2021, has delayed our business plan, particularly by causing disruptions in league play throughout Europe. The Company is not able to predict the ultimate impact that COVID -19 will have on its business; however, if the pandemic and government action in response thereto result in a prolonged economic recession or depression, or otherwise hinders our operations or those of the teams and leagues we intend to target a consumers of our product, the Company’s development and implementation of its business plan and our ability to commence and grow our operations, as well as our ability to generate material revenue therefrom, will continue to be hindered, which would have a material negative impact on the Company’s financial condition and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because of COVID-19, we may encounter delays or difficulties in obtaining inventory which may have a material adverse effect our future results of operations.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We will be required to obtain our inventory from third parties for our Smart Shin Guards. As a result of COVID-19 as well as due to our small size, we may be delayed in acquiring inventory. COVID-19 has had an impact on the supply chain with many products as some companies have had to either suspend or limit operations. If we experience any such delays, it may have a material adverse effect on our future results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>If we are unable to meet competitive challenges, we may not successfully market our patented product.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">There are several companies that have developed products and technology that collect, analyze and transmit physical and performance-based information about players and teams. While we believe our product is unique in that it is both wearable while playing and collects and quickly transmits a greater depth of information and analysis than most comparable devices currently in the market, there can be no assurance that this feature will be adequate to attract new customers or convince players and teams using similar or related technology from switching to the Smart Shin Guard. Further, we will be competing for a limited number of prospective customers in the area of professional and amateur soccer, many of whom may not be willing or able to purchase our products at the prices we desire or at all. Our competitors will include major sports apparel firms with greater name recognition and/or existing relationships with prospective customers, such as Nike, Adidas and Puma. We will also compete with lesser known brands who have had a significant head start offering data collection devices, technology or services to customers, including Soccerment, TibTop and Catapult Sport, each of which offer wearable devices that are similar to ours. While we believe the Smart Shin Guard to have unique attributes that will render it attractive to customers, we cannot guarantee this alone will enable us to effectively compete for the limited number of consumers in the soccer world.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Specifically, most of our competitors have longer operating histories and greater resources than us, and could focus their substantial financial resources to develop or sustain a competing business model and develop products or services that are more attractive to potential customers than what we offer. Our competitors may also offer similar products and services at prices below cost and/or devote significant sales forces to competing with us for customers, endorsements, or key personnel, any of which could improve their competitive positions. Any of these competitive factors could make it more difficult for us to attract and retain customers or personnel or force us to lower our prices in order to compete, which would in turn reduce our market share and revenue. We can provide no assurance our management will be successful in navigating this complex competitive landscape, in which case our financial condition would be adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 14 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because we will be reliant primarily on a single product to be sold to a limited number of prospective customers, we will face significant risks associated with a lack of diversification.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We anticipate that the majority of our operations will be focused on the marketing and sale of our Smart Shin Guard, a product with relatively limited application and a narrow group of potential customers, namely soccer teams and players. Any unexpected developments with respect to these prospective customers or the leagues in which they play would therefore materially harm our ability to establish, maintain or grow a significant market position. Demand for our product may fluctuate in response to new products that emerge or changes to the way the game is played, officiated or regulated, or due to unexpected natural or uncontrollable events. For example, the COVID-19 pandemic has forced worldwide shutdowns of sports leagues, and some leagues have delayed or suspended play for indeterminate periods of time. Similarly, those leagues that have resumed play in the wake of the pandemic have seen drastic declines in fan attendance, due to government shutdowns, safety protocols and general public concern. Any of these or related events could result in a decline in the demand for our product or the price point at which prospective customers will be willing to purchase it, and in such event we will not have material alternative products or services to offset such negative effects to our business. If we fail to generate material sales of our Smart Shin Guard for any of the foregoing reasons, your investment in us would be materially harmed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Because our success will depend to a large extent on our ability to develop and grow a market for our Smart Shin Guard, you may lose your investment.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In order to be successful, we will need to establish a market for our product. There can be no assurance that anyone will purchase our product at the prices we need to generate material revenue or at all. Further, even if we do attract some customers, there can be no assurance that enough customers will purchase our products or that they will continue to purchase our products in sufficient volumes to produce the cash flow needed to sustain our operations, in which case your entire investment could be lost.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We may encounter difficulty obtaining approval for our product for in-game use by soccer leagues, which could hinder or eliminate any competitive advantage with respect to our Smart Shin Guard.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A material aspect of the Smart Shin Guard’s potential attractive features for consumers, particularly professional and amateur soccer players and teams, is its relatively small size and integration into a shin guard, which is already used in games and therefore does not add additional bulk or weight to a player’s normal in-game apparel. However, many soccer leagues impose restrictions and policies on the apparel and equipment that players may wear during games. As such, we will likely need to obtain approval for the Smart Shin Guard’s use by the soccer leagues of teams we market the product to in order for those teams to use the product in-game. There can be no assurance we will obtain such approval in any or a sufficient number of leagues. Leagues may be hesitant to allow our product to be used in games for a variety of reasons, including potential safety concerns, concerns that such use would confer on certain teams an unfair advantage at the expense of others, or simply reluctance to change. If we are unable to obtain approval for in-game use in leagues, soccer teams and players in those leagues may be unable to use our product in-game or in real-time, which would reduce the usefulness of our product to them and limit our ability to sell our product or generate material revenue therefrom. If we are unable to convince soccer leagues to allow players’ and teams’ in-game use of our product, it could materially harm our business and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>The failure to obtain endorsements from athletes or teams could significantly impair our ability to market our products.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">A key component of our business plan and marketing strategy currently contemplates obtaining endorsements from prominent athletes or teams to market our products. As of the date of this filing, we have not obtained any such endorsements. Our ability to obtain any such endorsements will likely be dependent on future funding. Because of our limited capital, there can be no assurance that we can procure any endorsements, in which case our business could be adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 15 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We may be exposed to liabilities under the Foreign Corrupt Practices Act, and any determination that we violated the Foreign Corrupt Practices Act could have a material adverse effect on our business</b>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because we intend to operate in foreign markets, we will be subject to the Foreign Corrupt Practice Act (the “FCPA”), and other laws that prohibit improper payments or offers of payments to foreign governments (as well as similar laws in the United States). We expect to have operations and distribution channels in jurisdictions creating the potential for corrupt practices by our employees, consultants or agents. We may employ sales personnel or independent contractors who may be viewed as our agents or otherwise expose us to liability under the FCPA. While we intend to comply fully with the FCPA and similar anti-bribery laws in conducting our business abroad, we cannot guarantee that we will be able to control the conduct of our employees and contractors to prevent corrupt practices. The potential penalties for violating the FCPA include anti-bribery laws and criminal or civil sanctions, including a fine of up to $2 million per violation. If we were to be found in violation of the FCPA or local anti-bribery laws, the resultant penalties and collateral consequences could negatively affect our business, operating results and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We plan to conduct a substantial portion of our business in foreign markets, which will expose us to the risks of trade or foreign exchange restrictions, increased tariffs, foreign currency fluctuations, disruptions or conflicts with our third-party importers and similar risks associated with foreign operations.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our current business plan includes expansion into multiple foreign markets exposing our Company to risks associated with foreign operations. For example, a foreign government may impose trade or foreign exchange restrictions or increased tariffs, or otherwise limit or restrict our ability to import products into a country, any of which could negatively impact our operations. We are also exposed to risks associated with foreign currency fluctuations by selling our products to consumers in foreign markets. Accordingly, strengthening of the Euro which is our primary currency versus a foreign currency could have a negative impact on us. Additionally, we may be negatively impacted by conflicts with or disruptions caused or faced by third-party importers, as well as conflicts between such importers and local governments or regulating agencies. Our operations in some markets also may be adversely affected by political, economic and social instability in foreign countries, as well as economic tensions between governments, the implementation of new or increased tariffs and other changes in international trade policies. Finally, since we plan to operate in the European Union, the impact of the United Kingdom exiting the European Union, commonly referred to as “Brexit,” may adversely affect our operations in the European Union.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Another risk associated with our international operations is the possibility that a foreign government may impose foreign currency remittance restrictions. Due to the possibility of government restrictions on transfers of cash out of the country and control of exchange rates, we may not be able to immediately repatriate cash at the official exchange rate. If this should occur, or if the official exchange rate devalues, it may have a material adverse effect on our business, assets, financial condition, liquidity, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>If we do not comply with transfer pricing, customs duties, value added taxes, and similar regulations, then we may be subjected to additional taxes, duties, interest and penalties in material amounts, which could harm our operating results and financial condition.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">By operating in many countries outside of the United States, we will be subject to transfer pricing and other tax regulations designed to ensure that our intercompany transactions are consummated at prices that have not been manipulated to produce a desired tax result, that appropriate levels of income are reported as earned by our United States or local entities, and that we are taxed appropriately on such transactions. In addition, our operations will be subject to regulations designed to ensure that appropriate levels of customs duties are assessed on the importation of our products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The imposition of new taxes, even pass-through taxes such as value added taxes, could have an impact on our perceived product pricing and will likely require that we increase prices in certain jurisdictions, and therefore could have a potential negative impact on our business and results of operations. If they arise, the ultimate resolution of these matters may take several years, and the outcome is uncertain. If the Internal Revenue Service or any foreign taxing authorities were to successfully challenge our transfer pricing practices or our positions regarding the payment of income taxes, customs duties, value added taxes, withholding taxes, sales and use taxes, and other taxes, we could become subject to higher taxes, we may determine it is necessary to raise prices in certain jurisdictions accordingly, and our revenue and earnings and our results of operations could be adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 16 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>If we fail to comply with U.S. and foreign laws related to privacy, data security, and data protection, it could adversely affect our operating results and financial condition.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are or may become subject to a variety of laws and regulations including the European Union’s General Data Protection Regulation (the “GDPR”) regarding privacy, data protection, and data security. These laws and regulations are continuously evolving and developing. The scope and interpretation of the laws that are or may be applicable to us are often uncertain and may be conflicting, particularly with respect to foreign laws.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In particular, there are numerous U.S. federal, state, and local laws and regulations and foreign laws and regulations regarding privacy and the collection, sharing, use, processing, disclosure, and protection of personal data. Such laws and regulations often vary in scope, may be subject to differing interpretations, and may be inconsistent among different jurisdictions. For example, the GDPR includes operational requirements for companies that receive or process personal data of residents of the European Union that are broader and more stringent than those previously in place in the European Union and in most other jurisdictions around the world. The GDPR includes significant penalties for non-compliance, including fines of up to €20 million or 4% of total worldwide revenue. Additionally, in June 2018, California enacted the California Consumer Privacy Act (the “CCPA”). The CCPA requires covered companies to provide California consumers with new disclosures and will expand the rights afforded consumers regarding their data. Fines for noncompliance may be up to $7,500 per violation. Since the CCPA was enacted, Nevada, Maine, Colorado and Virginia have enacted similar legislation designed to protect the personal information of consumers and penalize companies that fail to comply, and other states have proposed similar legislation. The costs of compliance with, and other burdens imposed by, the GDPR, CCPA, and similar laws may limit the use and adoption of our products and services and/or require us to incur substantial compliance costs, which could have an adverse impact on our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We intend to strive to comply with all applicable laws, policies, legal obligations, and industry codes of conduct relating to privacy, data security, and data protection. Our limited resources may adversely affect our compliance effort. Given that the scope, interpretation, and application of these laws and regulations are often uncertain and may be in conflict across jurisdictions, it is possible that these obligations may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with other rules or our practices. Any failure or perceived failure by us or third party service providers to comply with our privacy or security policies or privacy-related legal obligations, or any compromise of security that results in the unauthorized release or transfer of personal data, may result in governmental enforcement actions, litigation, or negative publicity, and could have an adverse effect on our operating results and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Governments are continuing to focus on privacy and data security, and it is possible that new privacy or data security laws will be passed or existing laws will be amended in a way that is material to our business. Any significant change to applicable laws, regulations, or industry practices regarding the personal data of our employees, agents or customers could require us to modify our practices and may limit our ability to expand or sustain our salesforce or bring our products to market. Changes to applicable laws and regulations in this area could subject us to additional regulation and oversight, any of which could significantly increase our operating costs and materially affect our operating results and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Risks Related to Our Common Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Our registration under the Securities Exchange Act of 1934 could be revoked by the Securities and Exchange Commission if we fail to file required reports. </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following the registration of our common stock with the SEC on May 8, 2021 pursuant to the registration statement on Form 10, if we fail to file reports as required under the Exchange Act, we may lose our registration. While we intend to comply with the Exchange Act’s reporting requirements moving forward, and we may be unable to comply in the future as we did in the past. For example, in June 2009, the SEC revoked our registration under the Act for failure to file required reports.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following that action, the Company expended resources to again become a reporting company with the SEC in 2010; however, it was never able to file an annual report on Form 10-K and ultimately withdrew its registration in 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 17 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If we are unable to comply with the SEC reporting provisions in the future, such failure will affect the liquidity of our common stock and act as a depressant to the price. We cannot assure you we will not become delinquent again.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because of our limited working capital, we lack required internal controls and unless we remediate them, we may be hampered in a number of ways, which could materially and adversely affect us.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management and directors are based in Italy and other European countries. Although our accounting and legal professionals, as well as our auditors, are based in the United States, our lack of familiarity with United States federal and Delaware law has adversely affected us and may continue to adversely affect us as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Due to our limited size, we do not segregate our accounting functions which creates a material weakness;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">The lack of controls may ultimately cause errors in our financial statements;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">As we expand our business, we may fail to comply with local laws that could result in fines and the inability to do business; and</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Once our common stock publicly trades, investors may react to our lack of internal controls by selling our stock and depressing the price.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a public company in the United States, we are required to maintain internal control over financial reporting and disclosure controls and procedures. These controls and other procedures are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is disclosed accurately and is recorded, processed, summarized and reported within the time periods specified in SEC rules.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ensuring that we have adequate controls and procedures in place to help produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be evaluated frequently. We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies relating to internal controls, which could materially adversely affect our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Once we raise sufficient capital, we plan to take steps to remediate our material weaknesses, including hiring a principal financial officer with knowledge of generally accepted accounting principles as well as reporting and disclosure obligations. As our business expands we intend to retain additional consultants as required. If we fail to maintain proper and effective internal controls in future periods, we could become subject to potential review by the SEC or other regulatory authorities, which could require additional financial and management resources, could compromise our ability to run our business effectively and could cause investors to lose confidence in our financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recently the SEC sued four public companies alleging in part that they had violated Section 13(b) of the Exchange Act resulting from their failure to remediate material weaknesses in their internal control over financial reporting over an extensive period of time. Three of these companies had remediated their material weaknesses at the time the lawsuits were filed. If the SEC Staff investigates us and following that investigation a lawsuit is filed alleging that we have and/or have not remediated our material weaknesses, we will face the following risks:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">It will divert our management’s attention from our core business of developing, marketing and selling the Smart Shin Guard;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify; text-indent: -1.5pc"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">We will incur substantial legal fees in connection with both the investigation and the lawsuit if it is filed;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -1.5pc"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">If we are sued, we may be required to pay a civil monetary penalty in addition to other remedies the SEC or a court may impose;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -1.5pc"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Any public disclosure may cause investors to sell our stock which may result in a material decline in our stock price that will cause investors to lose money; and</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-indent: -1.5pc"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Our existing stockholders will experience more dilution as we are required to raise capital at a lower price per share.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <!-- Field: Page; Sequence: 18 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because all of our officers and directors reside outside of the United States, it will be difficult for investors to sue them personally in the United States and may be difficult to enforce any judgment against their assets, which are located outside of the United States. </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our officers and directors reside in and are based in Italy and other European countries. In the event that investors sue them in the United States alleging that any registration statement, report or proxy filed with the SEC or other disclosure in connection with the purchase or sale of our common stock violates the United States federal and/or state securities laws, they may claim that they are not subject to suit individually in the United States. If a Court later determines that these individuals may be sued in the United States and there is an adverse judgment against all or some of these directors, it may be difficult to enforce a United States judgment in the home countries of the defendants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Currently there is no active public market for our common stock, and we cannot predict the future prices or the amount of liquidity</b>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Currently, there is no active public market for our common stock and one may never develop. Our common stock trades sporadically on the Pink Open Market under the symbol GHST. We do not know if an active market will develop even if we begin filing required reports with the SEC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The OTC Pink Open Market generally is not an active market. Further, our common stock has only traded sporadically. In order to move to a higher market, such as the OTCQB, we are required to pay $10,000 per year. Even if our common stock begins trading on the OTCQB, investors should be aware that the OTCQB is not as liquid as major national securities exchanges.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These stock market and industry factors may adversely affect the market price of our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Due to recent changes to Rule 15c2-11 under the Exchange Act, our common stock may become subject to limitations or reductions on stock price, liquidity or volume.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 16, 2020, the SEC adopted amendments to Rule 15c2-11 under the Exchange Act. This Rule applies to broker-dealers who quote securities listed on over-the-counter markets such as our common stock. The Rule as amended prohibits broker-dealers from publishing quotations on OTC markets for an issuer’s securities unless they are based on current publicly available information about the issuer. The amended Rule became effective on September 28, 2021; the amended Rule will also limit the Rule’s “piggyback” exception, which allows broker-dealers to publish quotations for a security in reliance on the quotations of a broker-dealer that initially performed the information review required by the Rule, to issuers with current publicly available information or issuers that are up-to-date in their Exchange Act reports. As of this date, we are uncertain as what actual effect the Rule may have on us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Rule changes could harm the liquidity and/or market price of our common stock by either preventing our shares from being quoted or driving up our costs of compliance. We became subject to filing reports under the Exchange Act following the effectiveness of our Form 10 in May 2021. If we cannot or do not provide or maintain current public information about our Company our stockholders may face difficulties in selling their shares of our common stock at desired prices, quantities or times, or at all, as a result of the amendments to the Rule.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We are subject to the “penny stock” rules which will adversely affect the liquidity of our common stock.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The SEC has adopted regulations which generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share, subject to specific exemptions. The market price of our common stock on the OTC Pink Open Market is presently less than $5.00 per share and therefore we are considered a “penny stock” company according to SEC rules. Further, we do not expect our stock price to rise above $5.00 in the foreseeable future. The “penny stock” designation requires any broker-dealer selling our securities to disclose certain information concerning the transaction, obtain a written agreement from the purchaser and determine that the purchaser is reasonably suitable to purchase the securities. These rules limit the ability of broker-dealers to solicit purchases of our common stock and therefore reduce the liquidity of the public market for our shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 19 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Broker-dealers are increasingly reluctant to permit investors to buy or sell speculative unlisted stock and often impose costs which make it uneconomical for small shareholders to do so. Moreover, as a result of apparent regulatory pressure from the SEC and the Financial Industry Regulatory Authority (“FINRA”), a growing number of broker-dealers decline to permit investors to purchase and sell or otherwise make it difficult to sell shares of penny stocks. The “penny stock” designation may have a depressive effect upon our common stock price. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Our stock price may be volatile because of factors beyond our control</b>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any of the following factors could affect the market price of our common stock:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; line-height: 115%"> </td> <td style="width: 3%; line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="width: 94%; text-align: justify; line-height: 115%"><span style="line-height: 115%">our failure to generate revenue;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">our failure to achieve and maintain profitability;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">actual or anticipated variations in our quarterly results of operations;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">announcement by us of the commencement of or the progress of any litigation;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">our failure to meet anticipated results with respect to distribution of the Smart Shin Guard to consumers and others;</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">the failure of the Smart Shin Guard to operate as expected; </span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">complaints received from consumers and other users; and</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"><span style="font-family: Symbol; line-height: 115%">·</span></td> <td style="text-align: justify; line-height: 115%"><span style="line-height: 115%">our failure to remain current with our Exchange Act filing requirements.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been instituted. A securities class action suit against us could result in substantial costs and divert our management’s time and attention, which would otherwise be used to benefit our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Because of FINRA sales practice requirements which affect broker-dealers, the market price for our common stock will be adversely affected.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy shares of our common stock, which may limit your ability to buy and sell our common stock and have an adverse effect on the market for our shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>We have in the past and may in the future face difficulty in effecting certain corporate actions we deem necessary or appropriate to raise capital due to FINRA or SEC rules and processes.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2019, FINRA declined to process a 1-for-100 reverse stock split of our outstanding common stock because we did not maintain current public information. This action was taken by FINRA based on perceived deficiencies under FINRA Rule 6490, which is based on SEC Rule 10b-17 and is designed to prevent fraudulent and deceptive practices in connection with certain corporate actions including a reverse stock split. A primary reason for our filing the Form 10 is to comply with these rules and effect the reverse stock split, as well as having the ability to take such other action in the future as may be needed and to have access to the U.S. capital markets. There can be no assurance that the Form 10 will be sufficient for FINRA to process a reverse stock split or allow us to take other action in the future, including such actions as may be necessary to conduct a financing on favorable terms or at all. If this were to occur with respect to actions currently contemplated or that we may in the future determine to undertake, it could have a material adverse effect on our Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>In the future, we may issue preferred stock which could make it more difficult for a third party to acquire us and could depress our stock price.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our board of directors may issue one or more series of preferred stock that have more than one vote per share. This could permit our board of directors to issue preferred stock to investors who support our management and us and permit our management to retain control of our business. Additionally, issuance of preferred stock could block an acquisition resulting in both a drop in our stock price and a decline in interest of our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 20 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Since we intend to retain any earnings for development of our business for the foreseeable future, you will likely not receive any dividends for the foreseeable future.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have not and do not intend to pay any dividends in the foreseeable future, as we intend to retain any earnings for development and expansion of our business operations. As a result, you will not receive any dividends on your investment for an indefinite period of time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item1b"></span><b>ITEM 1B. UNRESOLVED STAFF COMMENTS.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="Item2"></span><b>ITEM 2. PROPERTIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Ghost maintains its headquarters in New York, NY. The headquarters are in an executive suite environment where services are provided on an as-needed basis. Our officers spend limited time in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="Item3"></span><b>ITEM 3. LEGAL PROCEEDINGS.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="Item4"></span><b>ITEM 4. MINE SAFETY DISCLOSURES.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <!-- Field: Page; Sequence: 21 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>PART II</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item5"></span><b>ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our common stock is not listed on any securities exchange, and is quoted on the OTC Pink Market under the symbol “GHST.” Because our common stock is not listed on a securities exchange and its quotations on OTC Pink are limited and sporadic, there is currently no established public trading market for our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following table reflects the high and low closing sales information for our common stock for each fiscal quarter during the fiscal years ended June 30, 2022 and 2021. This information was obtained from OTC Pink and reflects inter-dealer prices without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>COMMON STOCK <br /> MARKET PRICE</b></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>HIGH</b></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>LOW</b></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-decoration: underline">Fiscal Year Ended June 30, 2022:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 66%; text-align: left">First Quarter</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.14</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.26</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Second Quarter</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.735</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.1001</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Third Quarter</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.101</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Fourth Quarter</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.074</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>COMMON STOCK <br /> MARKET PRICE</b></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>HIGH</b></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>LOW</b></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-decoration: underline">Fiscal Year Ended June 30, 2021:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 66%; text-align: left">First Quarter</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.24</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Second Quarter</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Third Quarter</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.3</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Fourth Quarter</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>Holders</b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of September 22, 2022, there were approximately 615 shareholders of record of the Company's common stock. We believe that additional beneficial owners of our common stock hold shares in street name.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Shares Eligible for Future Sale </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the outstanding shares of common stock of the Company are restricted securities and cannot be sold under Rule 144 until at least six months have passed since payment, and the other requirements of Rule 144(i)(1)(ii) have been satisfied, including the Company being current in its SEC periodic reporting obligations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, Rule 144 provides that any non-affiliate of the Company, who has held restricted common stock for at least six-months, is entitled to sell their restricted stock freely, provided that the Company stays current in its SEC filings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An officer, director or other person in control of the Company may sell after six months with the following restrictions: (i) the Company is current in its SEC filings, (ii) certain manner of sale provisions, (iii) the filing of a Form 144, and (iv) volume limitations limiting the sale of shares within any three-month period to a number of shares that does not exceed 1% of the total number of outstanding shares. A person who has ceased to be an affiliate at least three months immediately preceding the applicable sale and who has owned such shares of common stock for at least one year may sell the shares under Rule 144 without regard to any of the limitations described above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 22 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such shares may be sold outside of the United States. Further, such shares may be sold to purchasers in the United States under Section 4(a)(1) of the Securities Act if paid for more than two years ago and if the seller is not an affiliate of the Company. However, some broker-dealers and transfer agents will not accept legal opinion relying on Section 4(a)(1).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equity Compensation Plan Information</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any securities authorized for issuance or outstanding under an equity compensation plan or equity compensation grants made outside of such a plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Dividend Policy</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have not paid cash dividends on our common stock and do not plan to pay such dividends in the foreseeable future. Our Board of Directors will determine our future dividend policy on the basis of many factors, including results of operations, capital requirements, and general business conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>Unregistered Sales of Equity Securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal year ended June 30, 2022, we have sold securities which are not registered under the Securities Act. These unregistered sales are set forth in the following table:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1pt solid; width: 19%; text-align: justify"><b>Name or Class</b></td> <td style="padding-bottom: 1pt; width: 1%; text-align: justify"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; text-align: justify"><b>Date Sold</b></td> <td style="padding-bottom: 1pt; width: 1%; text-align: justify"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; text-align: justify"><b>No. of Securities</b></td> <td style="padding-bottom: 1pt; width: 1%; text-align: justify"> </td> <td style="border-bottom: Black 1pt solid; width: 42%; text-align: justify"><b>Consideration</b></td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td style="text-align: justify">Common Stock (1)</td> <td style="text-align: justify"> </td> <td style="text-align: justify">December 27, 2021</td> <td style="text-align: justify"> </td> <td style="text-align: justify">41,600 </td> <td style="text-align: justify"> </td> <td style="text-align: justify">Issuances of shares in exchange for $8,000 in subscription payments</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Common Stock (1)</td> <td style="text-align: justify"> </td> <td style="text-align: justify">January 15, 2022</td> <td style="text-align: justify"> </td> <td style="text-align: justify">23,333</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Issuances of shares in exchange for $3,500 in subscription payments</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td style="text-align: justify">Common Stock (1)</td> <td style="text-align: justify"> </td> <td style="text-align: justify">February 18, 2022</td> <td style="text-align: justify"> </td> <td style="text-align: justify">15,333</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Issuances of shares in exchange for $2,300 in subscription payments</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Common Stock (1)</td> <td style="text-align: justify"> </td> <td style="text-align: justify">April 13, 2022</td> <td style="text-align: justify"> </td> <td style="text-align: justify">163,015</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Issuances of shares in exchange for $21,192 in subscription payments</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td style="text-align: justify">Common Stock (1)</td> <td style="text-align: justify"> </td> <td style="text-align: justify">May 31, 2022</td> <td style="text-align: justify"> </td> <td style="text-align: justify">107,938</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Issuances of shares in exchange for $14,032.01 in subscription payments</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Common Stock (1)</td> <td style="text-align: justify"> </td> <td style="text-align: justify">June 14, 2022</td> <td style="text-align: justify"> </td> <td style="text-align: justify">119,972</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Issuances of shares in exchange for $15,596.47 in subscription payments</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1)       The transaction was exempt under Regulation S of the Securities Act. These securities were issued in offshore transactions to persons who are not U.S. Persons as defined by Regulation S under the Securities Act and there were no directed selling efforts made in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p> <!-- Field: Page; Sequence: 23 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="Item6and7"></span>ITEM 6. [Reserved]</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.75in"><b>ITEM 7.</b></td><td style="text-align: justify"><span><b>MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain statements in “Management’s Discussion and Analysis and Plan of Financial Condition and Results of Operations” are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. You should read the following discussion in conjunction with our financial statements, which are included elsewhere in this Report. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements. Our actual results could differ materially from those discussed in the forward-looking statements. See “Cautionary Note Regarding Forward Looking Statements” and “Summary of Risk Factors” contained in the forepart of this Report for more information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Overview</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are a company which is seeking to exploit a patent and obtain and exploit future patents for the Smart Shin Guard. We have not generated any revenue and need substantial additional financing to market our services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Plan of Operation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 30, 2020 we obtained the intellectual property rights to the Smart Shin Guard and began efforts to implement our new business model of developing and marketing advanced wearable sports tracking and analysis devices, with an initial focus on soccer. On June 30, 2020, we were issued the U.S. patent for our product and have patents pending in other jurisdictions. While we believe we have sufficient capital to fund our initial operations, we anticipate we will need additional funding to expand our operations and market and sell our product, including for the following expenses:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Symbol">·</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify">Develop, test, and improve upon our Smart Shin Guard;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Compensating out management and key personnel;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Obtain the raw materials needed for our manufacturing of our products, including pursuant to contracts with third party suppliers we may enter into to procure the same;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Arrange for the production of Smart Shin Guards and factory and warehouse space for the such production (which we may be required to outsource to a third party or parties);</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Develop relationships with soccer leagues, teams and players in order to both locate potential customers and establish business relationships to assist with advertising to the general public;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Develop, maintain and protect our intellectual property rights including patent(s) in applicable jurisdictions;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%"><span style="font-family: Symbol">·</span></td> <td style="width: 94%; text-align: justify">Communicate with and advocate for our product to FIFA and other soccer leagues and regulators to allow for widespread in-game use of our product in professional settings.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6pc; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are currently in the process of developing our product, including by miniaturizing our product and developing software for the artificial intelligence component of the product’s data collection and transmission capabilities. We expect development to be completed before the end of the year, however we may need to allocate further resources to developing our product depending on the results of the current development process and further testing we may undertake. Additionally, the professional kit version of our product is expected to take a longer time to develop than the consumer kit due to the increased complexity of its functionality.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 24 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following our product development efforts (and assuming successful completion of the same), we intend to then turn our attention during the next 12 months towards manufacturing the product and establishing a market for selling our product. Because our product focuses on soccer, or “football,” we plan to focus these efforts on countries located in Europe, where the sport is most popular and well-funded, and teams and players may be more likely to subscribe to our offerings. We expect that our ability to have success during this stage will depend on a number of factors which may be beyond our control, including our ability to have patents issued in target jurisdictions, our ability to complete product development and manufacturing efforts on schedule, and our ability to obtain strategic partnerships from professional teams or athletes to assist us in our marketing efforts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Marketing Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our goal is to develop and expand a market for our Smart Shin Guard both to professional and casual soccer players and teams. With the right people on our side, we intend and hope for the market for our product to grow to a global scale. Subject to our ability to successfully raise the necessary capital and complete the development process of the Smart Shin Guard, our tentative aspirations for the Company’s entry into the advanced sports technology industry envision progress and growth occurring in two phases (measured from June 30, 2022):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Headquarters</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are currently headquartered in New York, NY; however our directors and officers are located in Italy and other European countries. We believe our presence in these locations will be useful in initiating our marketing strategy, in which we plan to focus our efforts on European countries and access the U.S. capital markets to fund our operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Need for League Approval</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in “Risk Factors,” the Smart Shin Guard’s value, particularly with respect to professional teams and players, will in large part be determined by our ability to obtain approval for in-game use of the product from FIFA, UEFA Champions League, Serie A (Italy), Ligue 1 (France), and the English Premier League, as well as other prominent international and national soccer leagues that attract a significant number of viewers. Management believes that due to our product’s small size and design to be used as a wearable shin guard, which equipment is already used in games, we should be able to obtain such approval, but any difficulties or delays in obtaining this consent from target leagues could result in limitations to the prospective market for our product and/or require us to allocate capital and time towards obtaining such approval.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Critical Accounting Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The methods, estimates, and judgments that we use in applying our accounting policies have a significant impact on the results that we report in our financial statements. Some of our accounting policies require us to make difficult and subjective judgments, often as a result of the need to make estimates regarding matters that are inherently uncertain. These estimates, which are discussed below, involve certain assumptions that if incorrect could create a material adverse impact on Ghost’s results of operations and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Results of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following discussion should be read in conjunction with the financial statements and notes thereto included elsewhere in this report. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Fiscal Year Ended June 30, 2022 Compared to the Fiscal Year Ended June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We had no revenues in the years ended June 30, 2022 and 2021, and we sustained net losses of $151,885 and $151,336, respectively, in those periods. Our expenses consisted of general and administrative costs. We do not expect to generate material revenue unless and until we can implement our business plan and begin marketing and selling our product(s) in sufficient quantities, which has been delayed due to COVID-19 impacts on our development efforts and on league play which adversely affects our marketing capabilities. In order to become profitable, we will need to establish a sufficient market for our product, including internationally, to offset our development, manufacturing and advertising costs, and our ability to do so will be subject to a number of factors, many of which will be beyond our control.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <!-- Field: Page; Sequence: 25 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Liquidity and Capital Resources</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Net Cash used by Operating Activities</span>:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year ended June 30, 2022, the Company used net cash of approximately $163,028 in operating activities as compared to approximately $143,930 for the fiscal year ended June 30, 2021. The increase in cash used in operations was primarily due to fees for financial and legal services, as well as and contracts and other costs in developing our product and business plan. We expect expenses for professional services to remain higher than in prior periods due to our continuing reporting obligations with the SEC as a result of the Form 10 becoming effective on May 8, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Cash Used in Investing Activities</span>:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the years ended June 30, 2022 and 2021, the Company used $0 and $7,395 in investing activities. Our investing activities during these periods consisted of obtaining our patent and related patent applications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Cash Flows from Financing Activities</span>:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash flows from financing activities for the fiscal year ended June 30, 2022 were $155,884 compared to $158,383 for the fiscal year ended June 30, 2021.  On August 20, 2021, we issued 55,750 shares of common stock to certain of our investors in exchange for $16,725 of previously paid subscriptions. In addition, during the fiscal year ended June 30, 2022, $225,259 of debt was converted to 118,663,761 shares of common stock and we received $81,345 from the sale of 526,941 shares of our common stock as follows: (i) in August 2021 we issued 55,750 shares of common stock to two investors in exchange for a total of $16,725; (ii) in December 2021 we issued 48,767,465 shares of common stock to various investors in exchange for $86,520 of debt; (iii) in December 2021 we issued 33,000 shares of common stock to an investor in exchange for $5,792 of debt; (iv) in December 2021 we issued 41,600 shares of common stock to two investors in exchange for a total of $8,000; (v) in January 2022 we issued 23,333 shares of common stock to an investor in exchange for a total of $3,500; (vi) in February 2022 we issued 15,333 shares of common stock to an investor in exchange for a total of $2,300; (vii) in February 2022 we issued 69,863,296 shares of common stock to various investors in exchange for $129,247 of debt; (viii) in April 2022 we issued 163,015 shares of common stock to two investors in exchange for a total of $21,192; (ix) in May 2022 we issued 107,938 shares of common stock to three investors in exchange for a total of $14,032; and (x) in June 2022 we issued 119,972 shares of common stock to two investor in exchange for $15,596.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have approximately $25,000,000 in available cash as of September 22, 2022, and for the past two years we have been relying on loans and stock purchases from our current investors and related parties to fund our operations. As reflected in the Financial Statements contained elsewhere in this Report, management has expressed substantial doubt about our ability to continue as a going concern during the fiscal year ended June 30, 2022 unless we can raise the required capital or generate material revenue to fund our operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We do not have sufficient capital to support our operations for the next 12 months and will dependent upon on the proceeds from a financing, which may consist of sales of our common stock, the issuance of debt securities and/or issuance of securities convertible into shares of our common stock, any of which could have a dilutive effect on our existing shareholders. We intend to continue to raise capital from existing investors and/or to obtain funding from the sale of a minority interest in our subsidiaries if and to the extent possible. We estimate that we will need to raise at least $1,000,000 in order to meet our working capital needs for the next 12 months. As described elsewhere in this Report, we plan to phase in our expenses and grow our business as working capital is available.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-size: 4pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>COVID-19</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our product development and marketing efforts were hindered during the second half of the fiscal year ended June 30, 2022 as a result of the COVID-19 pandemic, due in part to temporary suspension of league play, decreased demand caused by economic hardship and uncertainty, and operational challenges caused by supply shortages and the lockdowns. While COVID-19 seems to no longer pose the threat it did, we cannot predict what future impact it may have in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 26 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Significant Accounting Policies and Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Please see the notes to our Financial Statements for information about our Significant Accounting Policies and Recent Accounting Pronouncements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="Item7a"></span>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Not applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item8"></span><b>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements and the other information required by this Item can be found beginning on page F-1.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item9"></span><b>ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Not applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item9a"></span><span style="background-color: white"><b>ITEM 9A. CONTROLS AND PROCEDURES.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Evaluation of Disclosure Controls and Procedures</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officers, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officers have concluded that our disclosure controls and procedures as of June 30, 2022 were not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms because of a material weakness in the Company’s internal control over financial reporting. Specifically, the Company did not maintain effective controls to identify and maintain segregation of duties to support the identification, authorization, approval, accounting for, and the disclosure of related-party transactions and non-routine transactions. One individual, the Chief Executive Officer, initiates related-party transactions and non-routine transactions and also reviews, evaluates and approves these same transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Changes in Internal Control Over Financial Reporting</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Item9b"></span><b>ITEM 9B. OTHER INFORMATION.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="item9c"></span>ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <!-- Field: Page; Sequence: 27 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>PART III</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><span id="Item10"></span><b>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a list of our directors and executive officers. All directors serve one-year terms or until each of their successors are duly qualified and elected. The officers are elected by the board of directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 45%; text-align: justify"><b>Name</b></td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><b>Age</b></td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 41%; text-align: justify"><b>Position(s)</b></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify">Edoardo Berti Riboli</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">45</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">Chief Executive Officer</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify">Paolo Sangiovanni</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">66</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">Chief Financial Officer</td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify">Marcello Appella</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">67</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">Chief Financial Officer</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify">Massimiliano Stella</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">53</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">Chief Information Officer</td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify">Esterino Castellazzi</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">72</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">President and Chairman of the Board of Directors</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify">Giovanni Lavati</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">57</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">Secretary, Treasurer and Director</td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: justify">Pierangelo Negri</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">84</td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: justify">Director</td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Edoardo Berti Riboli </b>has been the Company’s Chief Executive Officer since 2017. Mr. Riboli is a lawyer practicing in Rimond Group since 2017 located in Milan and Rome, Italy. From 2010 to 2016, Mr. Riboli practiced in Studio Legale Pettinello law firm.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Paolo Sangiovanni</b> has been the Company’s Chief Financial Officer since 2017. Mr. Sangiovanni is the Chief Executive Officer and Chairman of the Board of Alchemy Business Management Ltd. Since September 2009, he has been the Managing Director of Management Asset Planning Ltd. Since 2014, he has been the Chairman of the Board of Mapbiz Holdings SA. From September 2013 to January 2017, he was the Managing Director of Ozone Int. Ltd. Since September 2012 he has been the Managing Director of Mapleton Films Ltd. On May 2016, he was the Chairman of the Board of Acorn Global Partners Ltd.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Marcello Appella</b> has been the Company’s Chief Financial Officer since March 19, 2019. Since 1996, Mr. Appella is the Chief Executive Officer and owner of ADI Sarl.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Massimiliano Stella</b> has been the Company’s Chief Information Officer since February 2021. Since July 2020, he has provided services to businesses as a management and software consultant. From July 2016 to May 2020, he served as President of E-Win S.r.l., a software company focused on enterprise resource planning (ERP) applications. From January 2005 until May 2020, he served as Chief Executive Officer at GoodWorks S.r.l., a software development and distribution company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Esterino Castellazzi </b>is President and Chairman of the Board of Directors of the Company. Formerly, Mr. Castellazzi served as the Company’s Vice President from July 28, 2008 to 2017. Mr. Castellazzi is the President and Chairman of the Board of Directors since 2017. Since 2016, Mr. Castellazzi has been the liquidator for Contractor Spa. From 2006 to 2016, Mr. Castellazzi served as the Chief Executive Officer of the advertising company Ghost Technology Spa of the European Union. From 2004 to 2016, he was the Chief Executive Officer of Gaved Srl. a publishing company. Mr. Castellazzi was also an officer and part owner of the DVD recording company In Service Media Video, Srl from 2002 to 2016, and was the Chief Executive Officer of the multimedia company M.C. Video Srl from 1997 to 2015. Mr. Castellazzi was appointed a director because of his knowledge of the Company and its business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Giovanni Lavati</b> has been a director of the Company since May 13, 2016. Since 2016, Mr. Lavati is the Project Manager for Expertise SRL. Mr. Lavati was appointed a director because of his experience and skill in managing businesses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Pierangelo Negri </b>has been a director of Ghost since 2017. Since 2000, Mr. Negri has been the Chief Executive Officer and owner of FAPI Service Ltd. Mr. Negri was appointed a director because of his experience and expertise in capital markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 28 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Family Relationships</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are no family relationships among our directors or officers. However, Roberto Castellazzi, the Company’s Operations Manager and Chief Executive Officer and Chairman of the Board of Directors of GHST Sport Inc., is the son of Esterino Castellazzi, the Company’s President and Chairman of the Board of Directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Director Independence</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Board has determined that each of our directors with the exception of Mr. Castellazzi are independent under the Nasdaq Stock Market listing rules.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Committees of the Board of Directors</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We presently do not have an audit committee, compensation committee, or other committee or committees performing similar functions, as our board of directors and management believe that until recently it has been premature at the early stage of our Company’s business development to form an audit, compensation or other committees. Each member of our Board considers candidates for directorship and executive officer and director compensation. We intend to establish an audit committee in connection with our SEC reporting obligations which began on May 8, 2021 if and when we can identify and compensate a viable candidate or candidates as the Board may determine. Members of the audit committee and/or other committees that the Board may form may consist of current Board members, new directors, or a combination of both.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>Delinquent Section 16(a) Reports</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Section 16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10% of our common stock to file initial reports of ownership and changes in ownership of our common stock and other equity securities with the SEC. These individuals are required by the regulations of the SEC to furnish us with copies of all Section 16(a) forms they file. Based solely on a review of the copies of the forms furnished to us, and written representations from reporting persons, we believe that all filing requirements applicable to our officers, directors and 10% beneficial owners were complied with for the fiscal year ended June 30, 2022, except that one Form 4 for Mr. Castellazzi and one Form 4 for Mr. Lavati reporting each a grant of shares in exchange for debt and a gift was not timely filed due to an administrative error.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b><br /> Code of Ethics</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our Board has adopted a Code of Ethics that applies to all of our employees, including our Chief Executive Officer and Chief Financial Officers. Although not required, the Code of Ethics also applies to our directors. The Code of Ethics provides written standards that we believe are reasonably designed to deter wrongdoing and promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, full, fair, accurate, timely and understandable disclosure and compliance with laws, rules and regulations, including insider trading, corporate opportunities and whistleblowing or the prompt reporting of illegal or unethical behavior. We will provide a copy, without charge, to anyone that requests a copy of our code of ethics in writing by contacting GHST World Inc., 667 Madison Avenue 5th Floor New York, NY, 10065, Attention: Corporate Secretary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Shareholder Communications</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although we do not have a formal policy regarding communications with the Board, shareholders may communicate with the Board by writing to us at GHST World, Inc., 667 Madison Avenue, 5th Floor, New York, NY 10065. Shareholders who would like their submission directed to a member of the Board may so specify, and the communication will be forwarded, as appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="Item11"></span>ITEM 11. EXECUTIVE COMPENSATION.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Summary Compensation Table</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The officers of the Company have not received any compensation paid, distributed nor accrued from the Company for the last two fiscal years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Director Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The directors of the Company have not received any compensation paid, distributed nor accrued from the Company for the last two fiscal years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p> <!-- Field: Page; Sequence: 29 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="Item12"></span>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the number of shares of Ghost’s voting stock beneficially owned as of September 27, 2022 by (i) those persons known by Ghost to be owners of more than 5% of Ghost’s common stock, (ii) each director of Ghost, (iii) all Named Executive Officers (as defined in Item 6), and (iv) all executive officers and directors of Ghost as a group:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><b>Title of Class</b></td> <td style="width: 3%"> </td> <td style="border-bottom: black 1pt solid; width: 39%; text-align: center"><b>Name and Address of Beneficial Owner</b></td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 16%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Amount and</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Nature of Beneficial<br /> Owner(1)</b></p></td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 15%; text-align: center"><b>Percent of <br /> Voting Power (1)</b></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top"><b>Directors and Executive Officers:</b></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"> </td></tr> <tr> <td style="vertical-align: top">Common Stock and Preferred Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Esterino Castellazzi(2)(3)(4)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">124,939,535</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">55.67%</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Edoardo Berti Riboli(3)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">0</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">*</td></tr> <tr> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Paolo Sangiovanni(3)(5)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">100,000</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">*</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Giovanni Lavati(2)(3)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">17,085,762</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">13.73%</td></tr> <tr> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Marcello Appella(3)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">0</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">*</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Pierangelo Negri(2)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">     1,000</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">*</td></tr> <tr> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Massimiliano Stella(3)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">0</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">*</td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">All directors and executive officers as a group (6 persons)</td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom; text-align: center">142,126,297</td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom; text-align: center">63.3% </td></tr> <tr> <td style="vertical-align: top"><b>5% Shareholders:</b></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"> </td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> Alessandro Cristiano(6)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">9,461,388</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">7.6%</td></tr> <tr> <td style="vertical-align: top">Common Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Cesarino Ferrario(7)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">7,078,378</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">5.689 </td></tr> <tr style="background-color: rgb(204,255,204)"> <td style="vertical-align: top">Common Stock and Preferred Stock</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top">Gianfranco Gracchi(8)</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">1,820</td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center">26.56% </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">———————</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">*   Less than 1%</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%">(1)</td> <td style="width: 97%; text-align: justify">Represents voting power. Applicable percentages are based on 124,430,534 shares of common stock and 6,000 shares of Series A Preferred Stock (the “Series A”) with 150,000,000 votes outstanding, adjusted as required by rules of the SEC beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants and convertible notes currently exercisable or convertible, or exercisable or convertible within 60 days are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any other person. It does not include options held by our management, which are subject to performance standards. Unless otherwise indicated in the footnotes to this table, Ghost believes that each of the shareholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned by them.</td></tr> <tr style="vertical-align: top"> <td>(2)</td> <td style="text-align: justify">A director.</td></tr> <tr style="vertical-align: top"> <td>(3)</td> <td style="text-align: justify">An executive officer.</td></tr> <tr style="vertical-align: top"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(4)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(5)</p></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Includes 4,000 shares of Series A. Each share of Series A is entitled to 25,000 votes per share. Does not include 2,000 shares of Series B Preferred Stock which has a liquidation preference of $27.50 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Represents 100,000 shares of common stock held by Palmetum Business SL, an entity owned and controlled by Mr. Sangiovanni.</p></td></tr> <tr style="vertical-align: top"> <td>(6)</td> <td style="text-align: justify">Address is Via Righi 10, Novara (NO) 28010, Italy.</td></tr> <tr style="vertical-align: top"> <td>(7)</td> <td style="text-align: justify">Address is Via B Cellini 6, Busto Arsizio (VA) 21052, Italy.</td></tr> <tr style="vertical-align: top"> <td>(8)</td> <td style="text-align: justify">Includes 1,800 shares of Series A. Each share of Series A is entitled to 25,000 votes per share. Does not include 200 shares of Series B Preferred Stock which has a liquidation preference of $27.50 per share. Address is Loc. Bagnol 3, Pastrengo (VR) 37010, Italy.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <!-- Field: Page; Sequence: 30 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><span id="Item13"></span><b>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From May 7, 2021 to September 20, 2021, the Company borrowed a total of $8,199.26 from Esterino Castellazzi, the Company’s President and Chairman of the Board of Directors. Prior to that, beginning in 2016 through June 30, 2020 the Company borrowed a total of $60,013.14 from Mr. Castellazzi. As of February 23, 2022, the Company issued Mr. Castellazzi 32,495,535 shares of common stock in satisfaction of this indebtedness.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Beginning in 2016 through June 30, 2020 the Company borrowed a total of $32,538 including $9,975 on July 7, 2019 from Giovanni Lavati, the Company’s director. As of February 23, 2022, the Company issued Mr. Lavati 17,579,562 shares of common stock in satisfaction of this indebtedness.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b><span id="Item14"></span>ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the services provided and fees charged by Ciro E. Adams, CPA, LLC (the “Auditor”) our principal accountant, were approved by our Board. The following table shows the fees paid to the Auditor for the fiscal years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Year Ended June 30,</b></span></td> <td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>2022</b></span></td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>2021</b></span></td> <td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 68%">Audit Fees (1)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 13%; text-align: right">35,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 13%; text-align: right">35,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td>Audit Related Fees</td> <td> </td> <td> </td> <td style="text-align: right">—  </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">—  </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td>Tax Fees</td> <td> </td> <td> </td> <td style="text-align: right">—  </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">—  </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td>All Other Fees</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—  </td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—  </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-bottom: 2.5pt">     Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">35,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">35,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">———————</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%">(1)</td> <td style="width: 96%; text-align: justify">Audit fees – these fees relate to the annual audits and quarterly reviews of our financial statements and registration statements as well as services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings or engagements.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p> <!-- Field: Page; Sequence: 31 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>PART IV</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b><span id="Exhibits"></span>ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Incorporated by Reference</b></span></td> <td style="text-align: center"> </td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Filed or</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Furnished</b></p></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; width: 9%; text-align: center"><span style="font-size: 8pt"><b>Exhibit #</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; width: 49%; text-align: center"><span style="font-size: 8pt"><b>Exhibit Description</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; width: 9%; text-align: center"><span style="font-size: 8pt"><b>Form</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; width: 9%; text-align: center"><span style="font-size: 8pt"><b>Date</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; width: 9%; text-align: center"><span style="font-size: 8pt"><b>Number</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-size: 8pt"><b>Herewith</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>2.1</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000135448810000486/gost_ex31.htm">Certificate of Merger</a></td> <td> </td> <td style="text-align: center">10-K</td> <td style="text-align: center"> </td> <td style="text-align: center">2/18/2010</td> <td style="text-align: center"> </td> <td style="text-align: center">3.2</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td>3.1</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000155335021000175/ghst_ex3z1.htm">Amended and Restated Certificate of Incorporation</a></td> <td> </td> <td style="text-align: center">10-12G</td> <td> </td> <td style="text-align: center">3/9/2021</td> <td> </td> <td style="text-align: center">3.1</td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>3.1(a)</td> <td> </td> <td><span style="color: blue"><span style="text-decoration: underline">Certificate of Amendment to Certificate of Incorporation (Reverse Stock Split)</span></span></td> <td> </td> <td style="text-align: center">10-Q</td> <td> </td> <td style="text-align: center">11/15/2021</td> <td> </td> <td style="text-align: center">3.2</td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td>3.1(b)</td> <td> </td> <td><span style="color: blue"><span style="text-decoration: underline">Certificate of Amendment to Certificate of Incorporation (Decrease in Authorized Capital)</span></span></td> <td> </td> <td style="text-align: center">10-Q</td> <td> </td> <td style="text-align: center">11/15/2021</td> <td style="text-align: justify"> </td> <td style="text-align: center">3.3</td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>3.1(c)</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000135448810000486/gost_ex33.htm">Certificate of Designation</a></td> <td> </td> <td style="text-align: center">10-K</td> <td> </td> <td style="text-align: center">2/18/2010</td> <td> </td> <td style="text-align: center">3.3</td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td>3.3</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000155335021000175/ghst_ex3z3.htm">Amended and Restated Bylaws</a></td> <td> </td> <td style="text-align: center">10-12G</td> <td> </td> <td style="text-align: center">3/9/2021</td> <td> </td> <td style="text-align: center">3.3</td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>10.1</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000155335021000175/ghst_ex10z1.htm">Securities Exchange Agreement dated June 29, 2019+</a></td> <td> </td> <td style="text-align: center">10-12G</td> <td style="text-align: center"> </td> <td style="text-align: center">3/9/2021</td> <td style="text-align: center"> </td> <td style="text-align: center">10.1</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td>10.2</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000155335021000318/ghst_ex10z2.htm">Development Agreement between the Company and Hemar AG dated January 4, 2021**</a></td> <td> </td> <td style="text-align: center">10-12G/A</td> <td style="text-align: center"> </td> <td style="text-align: center">4/21/2021</td> <td style="text-align: center"> </td> <td style="text-align: center">10.2</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>10.3</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000155335021000318/ghst_ex10z3.htm">Development Agreement between the Company and Applica srl dated February 2, 2021**</a></td> <td> </td> <td style="text-align: center">10-12G/A</td> <td style="text-align: center"> </td> <td style="text-align: center">4/21/2021</td> <td style="text-align: center"> </td> <td style="text-align: center">10.3</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td>21.1</td> <td> </td> <td><a href="http://www.sec.gov/Archives/edgar/data/1121795/000155335021000175/ghst_ex21z1.htm">List of Subsidiaries</a></td> <td> </td> <td style="text-align: center">10-12G</td> <td style="text-align: center"> </td> <td style="text-align: center">3/9/2021</td> <td style="text-align: center"> </td> <td style="text-align: center">21.1</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>31.1</td> <td> </td> <td><a href="ghst_ex31z1.htm">Certification of Principal Executive Officer (302)</a></td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top"> <td>31.2(a)</td> <td> </td> <td><a href="ghst_ex31z2a.htm">Certification of Principal Financial Officer (302)</a></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>31.2(b)</td> <td> </td> <td><a href="ghst_ex31z2b.htm">Certification of Principal Financial Officer (302)</a></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top"> <td>32.1</td> <td> </td> <td><a href="ghst_ex32z1.htm">Certification of Principal Executive and Principal Financial Officers (906)</a></td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Furnished*</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>101.INS</td> <td> </td> <td>Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top"> <td>101.SCH</td> <td> </td> <td>Inline XBRL Taxonomy Extension Schema Document</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>101.CAL</td> <td> </td> <td>Inline XBRL Taxonomy Extension Calculation Linkbase Document</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top"> <td>101.DEF</td> <td> </td> <td>Inline XBRL Taxonomy Extension Definition Linkbase Document</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>101.LAB</td> <td> </td> <td>Inline XBRL Taxonomy Extension Label Linkbase Document</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top"> <td>101.PRE</td> <td> </td> <td>Inline XBRL Taxonomy Extension Presentation Linkbase Document</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">Filed</td></tr> <tr style="vertical-align: top; background-color: rgb(204,255,204)"> <td>104</td> <td> </td> <td>Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>  </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">*This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">** Portions of this exhibit have been omitted as permitted by the rules of the SEC. The information excluded is both (i) treated by the Company as private or confidential and (ii) not material. The Company undertakes to submit a marked copy of this exhibit for review by the SEC staff, to the extent it has not been previously provided, and provide supplemental materials to the SEC staff promptly upon request.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <!-- Field: Page; Sequence: 32 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">+ Certain schedules, appendices and exhibits to this agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the Securities and Exchange Commission staff upon request.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Copies of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to GHST World Inc., 667 Madison Avenue, 5th Floor, New York, NY 10065.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span id="Item16"></span><b>ITEM 16. FORM 10-K SUMMARY.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Not applicable.</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 33 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td> </td> <td> </td> <td colspan="2"><b>GHST World Inc.</b></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td colspan="2"> </td></tr> <tr style="vertical-align: top"> <td style="width: 6%">Dated: </td> <td style="width: 43%"> September 28, 2022</td> <td style="width: 3%">By:</td> <td style="border-bottom: Black 1pt solid; width: 48%">/s/ Edoardo Berti Riboli</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td>Edoardo Berti Riboli,Chief Executive Officer</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify">(Principal Executive Officer)</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Dated: </td> <td> September 28, 2022</td> <td>By:</td> <td style="border-bottom: black 1pt solid"><i>/s/ </i>Marcello Appella</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td>Marcello Appella, Chief Financial Officer</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(Principal Financial Officer)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p></td></tr> <tr style="vertical-align: top"> <td>Dated: </td> <td> September 28, 2022</td> <td>By:</td> <td style="border-bottom: black 1pt solid; text-align: justify">/s/ Paolo Sangiovanni</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify">Paolo Sangiovanni, Chief Financial Officer</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify">(Principal Financial Officer)</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Dated: </td> <td> September 28, 2022</td> <td>By:</td> <td style="border-bottom: Black 1pt solid; text-align: justify">/s/ Giovanni Lavati</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0">Giovanni Lavati, Chief Accounting Officer</p> <p style="margin-top: 0; margin-bottom: 0">(Principal Accounting Officer), Director</p></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Dated: </td> <td> September 28, 2022</td> <td>By:</td> <td style="border-bottom: black 1pt solid; text-align: justify">/s/ Esterino Castellazzi</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify">Esterino Castellazzi, Director</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Dated: </td> <td> September 28, 2022</td> <td>By:</td> <td style="border-bottom: black 1pt solid; text-align: justify">/s/ Pierangelo Negri</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify">Pierangelo Negri, Director</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 34 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>GHST WORLD, INC.</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>FOR THE YEARS ENDED </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>JUNE 30, 2022 AND 2021</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">  </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>CONTENTS</b></span> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><span style="font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: top; text-align: left"> <td style="padding-bottom: 1pt; width: 90%"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; width: 10%; vertical-align: bottom"><b>Page(s)</b></td></tr> <tr style="vertical-align: top; text-align: left"> <td> </td> <td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: top; text-align: left; background-color: rgb(204,255,204)"> <td>Report of Independent Registered Public Accounting Firm (<span id="xdx_90D_edei--AuditorName_c20210701__20220630_zxF5H4aBgIGk"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AuditorName">Ciro E. Adams, CPA, LLC</ix:nonNumeric></span>, <span id="xdx_902_edei--AuditorLocation_c20210701__20220630_zF8MzXnYfJvg"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AuditorLocation">Wilmington, DE</ix:nonNumeric></span>, PCAOB ID# <span id="xdx_906_edei--AuditorFirmId_c20210701__20220630_zpUpQW6omc6h"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AuditorFirmId">5938</ix:nonNumeric></span>)</td> <td style="text-align: center; vertical-align: bottom">F-2</td></tr> <tr style="vertical-align: top; text-align: left; background-color: White"> <td>Consolidated Balance Sheets – As of June 30, 2022 and 2021</td> <td style="text-align: center; vertical-align: bottom">F-4</td></tr> <tr style="vertical-align: top; text-align: left; background-color: rgb(204,255,204)"> <td>Consolidated Statements of Operations – For the Years Ended June 30, 2022 and 2021</td> <td style="text-align: center; vertical-align: bottom">F-5</td></tr> <tr style="vertical-align: top; text-align: left; background-color: White"> <td>Consolidated Statements of Stockholders’ Equity (Deficit) – For the Years Ended June 30, 2022 and 2021</td> <td style="text-align: center; vertical-align: bottom">F-6</td></tr> <tr style="vertical-align: top; text-align: left; background-color: rgb(204,255,204)"> <td>Consolidated Statements of Cash Flows – For the Years Ended June 30, 2022 and 2021 </td> <td style="text-align: center; vertical-align: bottom">F-7</td></tr> <tr style="vertical-align: top; text-align: left; background-color: White"> <td>Notes to Consolidated Financial Statements 	</td> <td style="text-align: center; vertical-align: bottom">F-8 - F-11</td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><span style="font-size: 10pt"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <!-- Field: Page; Sequence: 35; Options: NewSection --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"> </p> <p style="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0"><img src="image_004.jpg" alt="" style="height: 59px; width: 331px" /></p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0.5pc; text-align: left"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">To the Board of Directors and<br /> Stockholders of GHST World Inc.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">New York, NY 10065-8029</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pc 0 0; text-align: left"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0.5pc"><b>Opinion on the Financial Statements</b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We have audited the accompanying balance sheets of GHST World, Inc., (the Company), as of June 30, 2022 and 2021, and the related statements of operations, stockholders’ equity, and cash flows for each of the years in the two-year period ended June 30, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the two-year period ended June 30, 2022, in conformity with accounting principles generally accepted in the United States of America.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Going Concern</b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 2, the Company has a significant working capital deficiency, has incurred significant losses, and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Basis for Opinion</b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.5pt solid; font-size: 1pt"> </div></div><!-- Field: /Rule-Page --> <p style="font: 11pt Perpetua,serif; margin: 0; text-align: center; color: #2F5496">56 Rockford Road, Wilmington, DE 19806-1004 | Phone: 302-652-4783</p> <p style="font: 11pt Perpetua,serif; margin: 0; text-align: center; color: #2F5496"><b>ciroadamscpa.com</b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0.5pc"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 36 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Critical Audit Matters</b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><img src="image_005.jpg" alt="" style="height: 40px; width: 271px" /></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Wilmington, DE 19806-1004</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">September 28, 2022</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We have served as the Company’s auditor since 2021.</p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.5pt solid; font-size: 1pt"> </div></div><!-- Field: /Rule-Page --> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Perpetua,serif; font-size: 11pt; color: #2F5496"><b><img src="image_006.jpg" alt="" style="height: 33px; width: 184px" /></b></span></p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 16.95pc"> </p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 16.95pc"> </p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 37 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST World Inc.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Consolidated Balance Sheets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_304_111_zjJuUCePFYqc" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20220630" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20210630" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, <br /> 2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, <br /> 2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--AssetsAbstract_iB_zjHs08R6zxwb" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-decoration: underline; font-weight: bold; text-align: center">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AssetsCurrentAbstract_i01B_ziuRL6Yj3SMa" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: justify">Current Assets</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--Cash_i02I_maCzDKd_za5rLlr3pM3i" style="vertical-align: bottom"> <td style="width: 74%; text-align: justify; padding-bottom: 1pt">Cash</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,350</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AssetsCurrent_i01TI_mtCzDKd_maCzisc_z1jXLz6pMfEe" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1pt">Total Current Assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,350</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherAssetsNoncurrent_i01I_maCzisc_zH2FeWUxJc7d" style="vertical-align: bottom"> <td style="text-align: justify">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,000</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_i01I_maCzisc_z5BodrpSiC94" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify; padding-bottom: 1pt">Patent costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedPatentsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,181</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedPatentsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,181</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Assets_iTI_mtCzisc_z7hTCPIgNXhb" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,387</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,531</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zUqGJn8igJ8b" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-decoration: underline; font-weight: bold; text-align: center">Liabilities and Stockholders’ Deficit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesCurrentAbstract_i01B_zqppciXOfDvk" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: justify">Current Liabilities</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maCzkrj_z4WM5Cz845q7" style="vertical-align: bottom"> <td style="text-align: justify">Accounts payable and accrued expenses</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,685</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,528</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DueToRelatedPartiesCurrent_i02I_maCzkrj_zRNjCRkKUzY9" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify">Advances from related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,446</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,241</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--CommonStockPayable_i02I_maCzkrj_zXBsG5oNJtKd" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt">Common stock payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="GHST:CommonStockPayable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,559</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="GHST:CommonStockPayable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,784</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i01TI_mtCzkrj_maCzXRB_z3aOatRmw26i" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1pt">Total Current Liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">86,690</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,553</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--StockholdersEquityAbstract_iB_z0HBeFTGJHA4" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: justify">Stockholders’ Deficit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Preferred stock, $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220630_pdd" title="Preferred stock, par value"><span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20210630_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_c20220630_pdd" title="Preferred stock, shares authorized"><span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_c20210630_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized;</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify">     Series A, <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PreferredStockValue_pp0p0_maCzajs_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zT0PK66BFEhi" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PreferredStockValue_pp0p0_maCzajs_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zyeIwvHJxqN7" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">     Series B, <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,200</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--PreferredStockValue_pp0p0_maCzajs_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zhiC6q38otFg" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PreferredStockValue_pp0p0_maCzajs_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zKj42Z9MH4K8" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CommonStockValue_iI_maCzajs_zSDLJC9kdubc" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify">Common stock, $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630_pdd" title="Par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_c20210630_pdd" title="Par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_c20220630_pdd" title="Common Stock, Shares Authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20210630_pdd" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20220630_pdd" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">124,430,534</ix:nonFraction></span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20210630_pdd" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,239,832</ix:nonFraction></span> shares issued at June 30 2022 and 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,431</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,240</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_iI_maCzajs_zhx0cbWlHAz7" style="vertical-align: bottom"> <td style="text-align: justify">Additional paid-in-capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,362,205</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,174,792</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maCzajs_zFojAwmFKN3l" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,418,947</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,267,062</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--StockholdersEquity_iTI_mtCzajs_maCzXRB_zQy6o7fkVn0j" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1pt">Total Stockholders’ Deficit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,697</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,022</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzXRB_zmVY9OlqhQWe" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total Liabilities and Stockholders' Deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,387</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,531</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px">The accompanying notes are an integral part of these consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <!-- Field: Page; Sequence: 38 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST World Inc.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Consolidated Statements of Operations</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px"></span></p> <table cellpadding="0" cellspacing="0" id="xdx_307_113_zBBmiHnAo2Qk" summary="xdx: Statement - Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20210701__20220630_zQbEDpjjxAEd" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20200701__20210630_z6KNQPzodn0f" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">For the Years Ended <br /> June 30,</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_maCzA0l_zqQr79UGT0Qf" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left">Revenues</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0149">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0150">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_z8EvLc7gTZc" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzykU_zKlVOF7SDGIa" style="vertical-align: bottom"> <td style="width: 74%; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,702</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,366</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingExpenses_i01T_mtCzykU_msCzA0l_zZKXtUY1o7e3" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,702</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,366</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zXbkxYaCbT6k" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left">Other Income(expense):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--UnrealizedGainOnForeignCurrencyDerivativesBeforeTax_i01_maCzGEu_z5yCSewIEwJl" style="vertical-align: bottom"> <td style="text-align: left">Foreign exchange gain</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">667</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0165">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InterestExpense_i01N_di_msCzGEu_zGrrW3BOnz6e" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0168">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_i01_maCzGEu_zryU35ZBZc7l" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt">Loss on change in fair value of debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,700</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0171">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzGEu_maCzA0l_zGRMdQiPILD6" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Other Income(expense)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,183</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0174">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLoss_i01T_mtCzA0l_zmZ3wqPfHA6e" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,885</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--EarningsPerShareAbstract_i01B_zkXRtFeTGvy1" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td><b>Net loss per common share</b></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--EarningsPerShareBasic_i01_zRHfbFIND0m" style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"> - basic </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.03</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_zfizomMYDqKb" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"> - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.03</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--WeightedAverageNumberOfCommonSharesOutstandingAbstract_iB_zdarHDtububj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td><b>Weighted average number of common shares outstanding</b></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_z5uNc45CSgT9" style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"> - basic </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">54,032,711</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,760,534</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_zP8fXASGR4pb" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">- diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">54,032,711</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,760,534</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px">The accompanying notes are an integral part of these consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <!-- Field: Page; Sequence: 39 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST World Inc.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Statement of Changes in Stockholders' Deficit</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the Years Ended June 30, 2022 and 2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" id="xdx_30A_114_zKTm80ROdrqb" summary="xdx: Statement - Consolidated Statement of Changes in Stockholders' Deficit" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_custom--PreferredStockSeriesAMember_z4uELcxt3Bvl" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--PreferredStockSeriesBMember_zpoMm5HPMhBh" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_znZdE4aMcE44" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zVVUAt7Q6mMa" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zrDwblLKm4qf" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B2_zYAdrui1HDC7" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 7pt; text-align: right"> </td><td style="font-size: 7pt; font-weight: bold"> </td> <td colspan="6" style="font-size: 7pt; font-weight: bold; text-align: center">Preferred Stock</td><td style="font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold"> </td> <td colspan="6" style="font-size: 7pt; font-weight: bold; text-align: center">Preferred Stock</td><td style="font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold"> </td> <td colspan="6" style="font-size: 7pt; font-weight: bold; text-align: center">Common Stock</td><td style="font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 7pt; font-weight: bold; text-align: center">Additional</td><td style="font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 7pt; font-weight: bold; text-align: center"> </td><td style="font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 7pt; font-weight: bold; text-align: center">Total</td><td style="font-size: 7pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 7pt; text-align: right"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Series A</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">$0.001 Par Value</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-size: 7pt; font-weight: bold; text-align: center">Paid in</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-size: 7pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-size: 7pt; font-weight: bold; text-align: center">Stockholders'</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 7pt; text-align: right"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center"> Capital</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td><td style="font-size: 7pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 7pt; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-size: 7pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr id="xdx_437_c20200701__20210630_eus-gaap--StockholdersEquity_iS_ziQZQO0b4DP5" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 37%">Balance June 30, 2020</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockSeriesAMember_zqN7sejAU8w4" title="Beginning balance, shares" style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_PreferredStockSeriesAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_PreferredStockSeriesAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockSeriesBMember_z6sRTiuNEIf6" title="Beginning balance, shares" style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_PreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,200</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_PreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLGjk3nm6xt4" title="Beginning balance, shares" style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,980,176</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,980</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,002,643</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 4%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,115,696</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 4%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">109,065</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_zNxO6RTlrjsa" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left">Issuance of common stock for cash, net of issuance costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesOther_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3DgiEpUTbq9" title="Issuance of common stock for cash, net of issuance costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,009,656</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,010</ix:nonFraction></td><td style="text-align: left"> </td><td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">147,468</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">148,478</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--IssuanceOfSharesInExchangeOfDebt_zVEUQ1s3DYI4" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Issuance of common stock in exchange for debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceOfSharesInExchangeOfDebtShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr6vRKE4vmT9" title="Issuance of common stock in exchange for debt, shares" style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebtShares" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250</ix:nonFraction></td><td style="text-align: left"> </td><td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,681</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,931</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-bottom: 1pt">Net loss for the year ended June 30, 2021</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0228">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0229">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0230">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0231">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,366</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,366</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_435_c20210701__20220630_eus-gaap--StockholdersEquity_iS_zsTuDnz4ILDi" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-bottom: 2.5pt">Balance June 30, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockSeriesAMember_z2Bhbgu6YzBf" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_PreferredStockSeriesAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_PreferredStockSeriesAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockSeriesBMember_z5QYsyMYgBwa" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_PreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,200</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_PreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9lxiA37z4Zd" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,239,832</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,240</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,174,792</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,267,062</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,022</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--IssuanceOfSharesInExchangeOfDebt_zRnewLqot0hi" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left">Issuance of common stock in exchange for debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--IssuanceOfSharesInExchangeOfDebtShares_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWdWVJeXEdya" title="Issuance of common stock in exchange for debt, shares" style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebtShares" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">118,663,761</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,664</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,595</ix:nonFraction></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,259</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_iP3us-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_zTXKab0v5lTe" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Issuance of common stock for cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_iP3us-gaap--StockIssuedDuringPeriodValueNewIssues_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVEf3IvPcaPd" title="Issuance of common stock for cash, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">526,941</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">527</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,818</ix:nonFraction></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,345</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zdK4ac0U6Nz8" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-bottom: 1pt">Net loss for the Year ended June 30, 2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0266">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0267">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0269">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,885</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,885</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_43C_c20210701__20220630_eus-gaap--StockholdersEquity_iE_zlSnIziGsD3j" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-bottom: 2.5pt">Balance June 30, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockSeriesAMember_zUxoM31PcjWd" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_PreferredStockSeriesAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_PreferredStockSeriesAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockSeriesBMember_zwdWfZI6HQmd" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_PreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,200</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_PreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdF7UnN2MJMe" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">124,430,534</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,431</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,362,205</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,418,947</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px">The accompanying notes are an integral part of these consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <!-- Field: Page; Sequence: 40 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST World Inc.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Statements of Cash Flows</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" id="xdx_30C_112_zyXcjABAHFLh" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210701_20220630" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20200701__20210630_zG4cOUzmzwP1" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">For the years ended <br /> June 30,</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zVPatVHJkHBe" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_i01_maCzG5V_zBpss6m6FM24" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 10pt; width: 74%; text-align: left">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,885</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,366</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zi6XBcI1z3pf" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_i01N_di_msCzG5V_zq18Ni14x0Mb" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 20pt; text-align: left">Loss on change in fair value of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,700</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zOLRWjqtECn1" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 10pt; text-align: left">Changes in operating assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_maCzG5V_zRAk12PxGpCe" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accounts payable and accrued expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,843</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,436</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtCzG5V_maCz5Mp_z7Jh7bnWjeY3" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net Cash Used In Operating Activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">163,028</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">143,930</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left">CASH FLOWS  FROM INVESTING ACTIVITIES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di0_msCz9Ev_z4T1CR7y4hJd" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Patent costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-01to2022-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">—</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,395</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtCz9Ev_maCz5Mp_z7Nzq28W8zHh" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net Cash Used In Investing Activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0313">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,395</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zK5n1El2fQVd" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maCzBwb_zwdoDNlIRiXa" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 10pt; text-align: left">Advances from related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,205</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,905</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ProceedsFromRepaymentOfLoansToPurchaseCommonStock_i01_maCzBwb_z2ZZnIq32qU1" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 10pt; text-align: left">Increase in common stock payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,334</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzBwb_zPWuHhBVguvc" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Issuance of common stock for cash</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,345</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">148,478</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtCzBwb_maCz5Mp_z4QtrKsHPx09" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net Cash Provided By Financing Activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">155,884</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,383</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCz5Mp_zo6mmUFxYXYb" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Net increase (decrease) in cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,144</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,058</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zzRDsm1s9mP8" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-bottom: 1pt">Cash - beginning of period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,350</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zZxfIxN1BZxj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-bottom: 2.5pt">Cash - end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,350</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--SupplementalCashFlowInformationAbstract_iB_znsPFpH9L1gg" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-decoration: underline; font-weight: bold; text-align: left">SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--CashPaidDuringYearperiodForAbstract_i01B_z9RDIFo1sSt6" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 10pt; text-align: left">Cash paid during the year/period for:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestPaidNet_i01_z8UWU9brpar5" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Interest</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxesPaidNet_i01_zB3fDZ0q7A06" style="vertical-align: bottom; background-color: transparent"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0349">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zHi37kzltUa9" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-decoration: underline; font-weight: bold; text-align: left">SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-weight: bold"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--IssuanceOfCommonStockInExchangeForDebt_zn1QwLUdTx88" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Issuance of common stock in exchange for debt</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="GHST:IssuanceOfCommonStockInExchangeForDebt" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,259</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="GHST:IssuanceOfCommonStockInExchangeForDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,931</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <!-- Field: Page; Sequence: 41 --> <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST WORLD, INC.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Notes to Consolidated Financial Statements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2022 and 2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zxGhKiIo8uYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1- <span id="xdx_827_zLZ9lgVQO2hl">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Background	</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GHST World Inc. (“the Company”), is a Delaware corporation that was incorporated on November 12, 1999.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a holding company for various technology and other activities. The Company has acquired and is developing several patents in the technology sector.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zIzOvYRvRMk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 – <span id="xdx_82B_zXuVV6K2AFib">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="GHST:LiquidityAndGoingConcernPolicyTextBlock"><p id="xdx_844_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z2FoL3yYz4eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zeHWc3LWuds8">Liquidity and Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had a net losses of <span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20210701__20220630_zmz8MSvXZmq5" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">151,885</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20200701__20210630_zZd1dIau7cM8" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">151,366</ix:nonFraction></span> for the years ended June 30, 2022 and 2021. The Company has an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zAVVM7emf5nl" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,418,947</ix:nonFraction></span> and a stockholders’ equity of $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_pp0p0_c20220630_zcc3vDg7HoE1" title="Stockholders' Deficit"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,697</ix:nonFraction></span> as of June 30, 2022 and used $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20220630_zAyQn2euDP3f" title="Cash Used In Operating Activities"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">163,028</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zqebNGRH7yd2" title="Cash Used In Operating Activities"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">143,930</ix:nonFraction></span> in cash flow from operating activities for the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders and from the possible sale of a minority interest in its subsidiaries. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zsgfZ1XuwvWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_869_zSz2CbUibQM4">Principles of Consolidation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the following wholly owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"></td><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Art World, Inc</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"></td><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Sport Inc.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"></td><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">IoTT world Inc.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z3HpBf7G8lca" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zWHfRkVzZct9">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSOnFowtP8li" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zNrK5RML5r6">Foreign Currency</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_847_eus-gaap--UseOfEstimates_ziCkLWZVNIOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_860_zg2FmSDz8Fq5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <ix:exclude><!-- Field: Page; Sequence: 42; Section: Notes; Options: NewSection; Value: 8 --> <div id="xdx_231_zWo9dIXZUmb3" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> </td></tr></table></div> <div id="xdx_23D_zT2x4U9IruQk" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_232_zGg4t6Tov68c" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST WORLD, INC.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Notes to Consolidated Financial Statements</b></p><p id="xdx_23E_zHtht4dwi0me" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2022 and 2021</b></p></td></tr></table></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_233_zWIBLXv5Vgzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such estimates and assumptions impact, among others, the following: the fair value of share-based payments and deferred taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b> </b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9ZXW0XWvqPl" style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b><span id="xdx_869_zni92yQAP89j">Cash</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt">Cash are amounts held at local banks. The Company had <span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zk9vQTJrYiz3" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20210630_z95bfoqoVx03" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash equivalents at June 30, 2022 or 2021.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:UnusualRisksAndUncertaintiesTextBlock"><p id="xdx_84E_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zAZigSwjiU4i" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_862_z5vkkg5EQuGi">Risks and Uncertainties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="GHST:FairValuePolicyTextBlock"><p id="xdx_84A_ecustom--FairValuePolicyTextBlock_zkk2cPE36D27" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_867_zrqvUP8ZogV2">Fair Value</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 0pt; text-align: justify">The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"></td><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"></td><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"></td><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has <span id="xdx_90D_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20210701__20220630_zbnBi5hDGppe" title="Fair value of assets and liabilities measured on recurring basis"><span id="xdx_903_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20200701__20210630_zhSRINs9lcq7" title="Fair value of assets and liabilities measured on recurring basis"><ix:nonFraction name="us-gaap:FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" contextRef="From2021-07-01to2022-06-30" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" contextRef="From2020-07-012021-06-30" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zayaPPSTDd21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zLQiEhUtGhwk">Impairment of Long-Lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets consist primarily of property, plant and equipment. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. As of June 30, 2022 and 2021, the Company did <span id="xdx_907_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210701__20220630_zYDiNY71uM76" title="Impairment losses"><span id="xdx_909_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20200701__20210630_zYD4jAjFrATd" title="Impairment losses"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2021-07-01to2022-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2020-07-012021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span>t recognize any impairment losses.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zzhzy2Ls5vE3" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_864_ztyHlZLJpcV3">Intangible Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. The Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over ten years, which represents the estimated useful lives of the patents. The ten-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. For the years ended June 30, 2022 and 2021 the Company has capitalized $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20210701__20220630_zStcLwqFZZag" title="Patent costs"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>, and $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20200701__20210630_zDNvihKasFv2" title="Patent costs"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,395</ix:nonFraction></span> of patent costs. As of June 30, 2022 and 2021, patent cost totaled $<span id="xdx_903_eus-gaap--FiniteLivedPatentsGross_c20220630_pp0p0" title="Total Patent costs"><span id="xdx_900_eus-gaap--FiniteLivedPatentsGross_c20210630_pp0p0" title="Total Patent costs"><ix:nonFraction name="us-gaap:FiniteLivedPatentsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedPatentsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,181</ix:nonFraction></ix:nonFraction></span></span>.</p> <ix:exclude><!-- Field: Page; Sequence: 43 --> <div id="xdx_231_z1dL0lKekmn5" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> </td></tr></table></div> <div id="xdx_231_zA5XTMrHlUwe" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST WORLD, INC.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Notes to Consolidated Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2022 and 2021</b></p></td></tr></table></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23E_zFESsr5DbTp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zAnGSnDqIfh1" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_863_zP885dFnuvBc">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company’s tax returns are subject to examination by federal and state taxing authorities for the years ended June 30, 2018 through 2021. However, the Company's federal net operating losses for tax years ending June 30, 2021 and 2022 will remain subject to examination until the losses are utilized or expire. Under the Tax Cuts and Jobs Act (“TCJA”), which was enacted on December 22, 2017, Net Operating Losses (“NOLs”) incurred for tax years beginning before January 1, 2018, will be able to be carried forward for 20 years. For NOLs incurred in tax years beginning after December 31, 2017, these NOLs will be subject to the new limitations imposed by TCJA. Under the new law, an NOL can offset only 80% of taxable income in any given tax year. Furthermore, NOLs can no longer be carried back, they must be carried forward. The 20-year carryforward period has been replaced with an indefinite carryforward period for NOLs incurred for tax years beginning after December 31, 2017. The NOL carryforwards for the periods ended June 30, 2022 and 2021 are approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220630_zsmgMB36oBg1" title="Net loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">152,000</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,000</ix:nonFraction></span>, respectively and the total NOL carryforward to the year ended June 30, 2022 is approximately $2.8 million. At June 30, 2022, a valuation allowance fully offsets any tax benefit from these NOLs carryforard.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAQGU9opKyE8" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86C_zNwMskVMNdi8">Stock Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company applies the fair value method of ASC 718, Share Based Payment, formerly Statement of Financial Accounting Standards ("SFAS") No. l23R "Accounting for Stock Based Compensation", in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z4dMRpgH54Vh" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86A_zrO4Ao76rwYc">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt">There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.</p> </ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zMEpLJXr0ftg" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 3 – <span id="xdx_820_zFENBecNv2de">PATENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company obtained a patent dated June 30, 2020, which is a protection device used in sporting activity with the capability to monitor data from the device. The Company has capitalized the patent costs totaling $<span id="xdx_90C_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20220630_z8Ul69jBpI72" title="Patent costs"><span id="xdx_905_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20210630_z7ML6ojRBu07" title="Patent costs"><ix:nonFraction name="us-gaap:FiniteLivedPatentsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedPatentsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,181</ix:nonFraction></ix:nonFraction></span></span>, at June 30, 2022 and 2021. The Company will amortize the patent over the useful life of the patent once it is placed in service. <span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20210701__20220630_zQ5NpmtuW7q7" title="Amortization of intangible assets"><span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20200701__20210630_zQynfPKUoZOk" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-01to2022-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></span></span> amortization was recorded for the years ended June 30, 2022 and 2021.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="GHST:CommonStockPayableTextBlock"><p id="xdx_804_ecustom--CommonStockPayableTextBlock_z27XqMHEyjXl" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 4 – <span id="xdx_825_zKSroEyrARZ6">COMMON STOCK PAYABLE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company has an agreement with certain investors to convert their investment into common stock of the Company at a price equal to the average value of the stock over the previous six months. The conversion is contingent on the Company effectuating a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20210902__20210930_zdhArBQDIgfe" title="Reverse stock split"><ix:nonNumeric contextRef="From2021-09-022021-09-30" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-100 reverse stock split</ix:nonNumeric></span> which was effected on September 30, 2021. As of June 30, 2022, and June 30, 2021, the Company has a total of $<span id="xdx_90C_ecustom--CommonStockReceived_iI_pp0p0_c20220630_z5uQoDW6Thvg" title="Common stock received"><ix:nonFraction name="GHST:CommonStockReceived" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,559</ix:nonFraction></span> and $<span id="xdx_90F_ecustom--CommonStockReceived_iI_pp0p0_c20210630_z1yRkZB18Jjb" title="Common stock received"><ix:nonFraction name="GHST:CommonStockReceived" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,784</ix:nonFraction></span> that has not been converted to common stock. During the year ended June 30, 2022 certain investors agreed to accept a total of <span id="xdx_909_ecustom--IssuanceOfSharesInExchangeOfDebtShares_c20210701__20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_z0wIrHhuSANd" title="Issuance of shares in exchange of debt, shares"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebtShares" contextRef="From2021-07-012022-06-30_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">118,663,761</ix:nonFraction></span> shares at an average price of approximately $<span id="xdx_90C_eus-gaap--SharePrice_iI_c20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_zkStJ8U8Pkb6" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-06-30_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0019</ix:nonFraction></span> in exchange for $<span id="xdx_908_ecustom--IssuanceOfSharesInExchangeOfDebt_pp0p0_c20210701__20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_zdLy4vnQA0Y1" title="Issuance of shares in exchange of debt"><ix:nonFraction name="GHST:IssuanceOfSharesInExchangeOfDebt" contextRef="From2021-07-012022-06-30_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">225,259</ix:nonFraction></span> of debt.</p> <ix:exclude><p id="xdx_23A_zr9YTvsFhwo6" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify"> </p></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 44 --> <div id="xdx_238_zmNp6C3xeK14" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> </td></tr></table></div> <div id="xdx_237_z0kAsMzjNgz7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_z7mThxECS9D2" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>GHST WORLD, INC.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Notes to Consolidated Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2022 and 2021</b></p></td></tr></table></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_231_znS8VsdpMux2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company recorded a common stock payable in 2018 for an agreement in which the Company agreed to issue <span id="xdx_906_ecustom--CommonStockPayableShares_iI_c20180630_zz3fF0qVCYE" title="Common stock payable, number of shares to be issued in exchange for patent"><ix:nonFraction name="GHST:CommonStockPayableShares" contextRef="AsOf2018-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of post-split stock in exchange for the patent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company recorded this at $<span id="xdx_909_ecustom--CommonStockPayablePerShareValue_iI_c20180630_zvmJbeT4R3i6" title="Common stock payable per share value"><ix:nonFraction name="GHST:CommonStockPayablePerShareValue" contextRef="AsOf2018-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> or $<span id="xdx_906_ecustom--CommonStockPayableValue_iI_pp0p0_c20180630_zi6KI24oiin8" title="Common stock payable"><ix:nonFraction name="GHST:CommonStockPayableValue" contextRef="AsOf2018-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,000</ix:nonFraction></span>. The Company valued the stock at the six-month average which was $<span id="xdx_902_ecustom--CommonStockPayablePerShareValue_iI_c20220630_zbYw66QoTrtl" title="Common stockpayable per share value"><ix:nonFraction name="GHST:CommonStockPayablePerShareValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00185</ix:nonFraction></span> per share or $<span id="xdx_909_ecustom--CommonStockPayableValue_iI_pp0p0_c20220630_zA0Mym1U5A1i" title="Common stock payable"><ix:nonFraction name="GHST:CommonStockPayableValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,700</ix:nonFraction></span>. As a result the Company recognized a market value adjustment on the accompanying Income Statement of $<span id="xdx_905_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_iN_pp0p0_di_c20210701__20220630_zxjiFafoaL1k" title="Fair Value, Option, Changes in Fair Value, Gain (Loss)"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,700</ix:nonFraction></span> for year ended June 30, 2022.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztGax7FCfFxj" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify"><b>NOTE 5 – <span id="xdx_82F_zkHK3OOLTPL3">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">At June 30, 2022 and 2021, the Company owed related parties a total of $<span id="xdx_909_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20220630_pp0p0" title="Advances from related parties"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,446</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20210630_pp0p0" title="Advances from related parties"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,241</ix:nonFraction></span>. These shareholder loans are unsecured, non-interest bearing and are due on demand. See Note 4 as these amounts that will be converted to common stock..</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">As shown in Note 4, the Company has committed to converting certain debts to equity. Included in the debts is $<span id="xdx_906_ecustom--CommonStockPayableRelatedParties_c20220630_pp0p0" title="Common stock payable - related parties"><ix:nonFraction name="GHST:CommonStockPayableRelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,558</ix:nonFraction></span> as of June 30, 2022 of amounts due to related parties that will also be converted as described in Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">These transactions were in the normal course of operations and were measured at a value that represents the amount of consideration established and agreed to by the related parties.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zh3dtgW7G0w2" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 6 – <span id="xdx_827_z7YtYdJo3r8h">STOCKHOLDERS’ EQUITY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210807_zrSAfoGlG2aj" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-08-07" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">310,000,000</ix:nonFraction></span> of which <span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20210807_pdd" title="Common stock reserve"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2021-08-07" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></span> are reserved for common stock and <span id="xdx_90A_eus-gaap--PreferredStockCapitalSharesReservedForFutureIssuance_c20210807_pdd" title="Preferred stock reserve"><ix:nonFraction name="us-gaap:PreferredStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2021-08-07" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span> for preferred stock. The amendment was effective on September 9, 2021. Effective on September 30, 2021, the Company effectuated a <span id="xdx_906_eus-gaap--StockholdersEquityNoteStockSplit_c20210701__20220630" title="Revese stock split"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="us-gaap:StockholdersEquityNoteStockSplit">100-1 reverse stock split</ix:nonNumeric></span>. All per share amounts have been retroactively restated to reflect the split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>Common Stock Issuances</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt; text-align: justify">During the year ended June 30, 2022 the Company issued a total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210701__20220630_pdd" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">118,663,761</ix:nonFraction></span> shares at an average price of approximately $<span id="xdx_909_eus-gaap--SharePrice_c20220630_pdd" title="Price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0019</ix:nonFraction></span> in exchange for $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210701__20220630_pp0p0" title="Exchange of debt"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">225,259</ix:nonFraction></span> (See Note 4) and sold <span id="xdx_904_ecustom--SaleOfStockNumberOfShareIssuedInTransaction_c20210701__20220630_pdd" title="Sale of stock"><ix:nonFraction name="GHST:SaleOfStockNumberOfShareIssuedInTransaction" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">526,941</ix:nonFraction></span> shares in exchange for $<span id="xdx_907_ecustom--SharesToExchangeValue_c20210701__20220630_pp0p0" title="Exchange value"><ix:nonFraction name="GHST:SharesToExchangeValue" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,345</ix:nonFraction></span> at an average price of $<span id="xdx_903_eus-gaap--SharePrice_iI_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhVkaR40pSG6" title="Price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.15</ix:nonFraction></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zOB4G23Rw0Q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 7 – <span id="xdx_825_zGUyd1IPfZf6">INCOME TAXES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company has accumulated losses of approximately <span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_z8BaLvXfoDYj" title="Accumulated losses" style="display: none"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,418,947</ix:nonFraction></span> 9.4 million since its inception. For income tax purposes, <span id="xdx_90E_ecustom--OperatingLossDescription_c20210701__20220630_zevn5qHsGrbb" title="Operating loss Description"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="GHST:OperatingLossDescription">the Company has operating loss carryforwards of approximately $<span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_dm_c20220630_zn0fmYHIHCLb" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">2.8</ix:nonFraction></span> million from tax years beginning before January 1, 2021, that begin to expire in 2027. These operating losses are subject to the limitations which were enacted in the Tax Cuts and Jobs Act (“TCJA”).</ix:nonNumeric></span> These operating losses can offset only 80% of taxable income in any given tax year. The carryover period for these operating losses is indefinite. No federal or state tax asset has been reported in the financial statements, because the Company believes there is a 50% or greater chance that the carryforwards will expire unused. Accordingly, the potential tax benefits of the loss carryforwards (approximately $<span id="xdx_903_eus-gaap--OperatingLossCarryforwardsValuationAllowance_c20220630_pp0p0" title="Operating loss carryforwards valuation allowance"><ix:nonFraction name="us-gaap:OperatingLossCarryforwardsValuationAllowance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,000</ix:nonFraction></span>) have been offset by a valuation allowance of the same amount.</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z7c1jybkHcyg" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 8 – <span id="xdx_823_zb02XiHuYWP5">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">On August 18, 2022, the Company sold <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220801__20220818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziCtLCNld9cf" title="Stock Issued During Period, Shares, New Issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-08-012022-08-18_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">296,640</ix:nonFraction></span> shares of common stock for cash proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20220801__20220818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrRDGRcJ8ZE2" title="Proceeds from Issuance or Sale of Equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-08-012022-08-18_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,664</ix:nonFraction></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: center">*****</p> </ix:nonNumeric><p id="xdx_815_zKcGVGczKPL9" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"> </p> <p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 11.5pt; margin-right: 0; margin-left: 0"></p> </body> </html> <!-- Field: Set; Name: xdx; ID: xdx_08B_extensions --> <!-- 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 --> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>2 <FILENAME>ghst_ex31z1.htm <DESCRIPTION>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.1 </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B> </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Edoardo Riboli, certify that:</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">1. I have reviewed this annual report on Form 10-K of GHST World Inc.;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"><A NAME="a_Aci_Pg1"></A> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: September 28, 2022</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 30%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Edoardo Riboli</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Edoardo Riboli</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.15pt">Chief Executive Officer</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Executive Officer)</P></TD></TR> </TABLE> <P STYLE="margin: 0"> </P> <P STYLE="margin: 0"> </P> <P STYLE="margin: 0"> </P> <P STYLE="margin: 0"> </P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.1A <SEQUENCE>3 <FILENAME>ghst_ex31z2a.htm <DESCRIPTION>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.2(a)</B></P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</B></P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I, Marcello Appella, certify that:</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">1. I have reviewed this annual report on Form 10-K of GHST World Inc.;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: September 28, 2022</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 30%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Marcello Appella</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Marcello Appella</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer)</P></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"> </P> <P STYLE="margin: 0"> </P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.1B <SEQUENCE>4 <FILENAME>ghst_ex31z2b.htm <DESCRIPTION>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.2(b)</B></P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</B></P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I, Paolo Sangiovanni, certify that:</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">1. I have reviewed this annual report on Form 10-K of GHST World Inc.;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 6pc">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: September 28, 2022</P> <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 30%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Paolo Sangiovanni</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Paolo Sangiovanni</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer)</P></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-right: 0; margin-bottom: 0; margin-left: 0"> </P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-32.1 <SEQUENCE>5 <FILENAME>ghst_ex32z1.htm <DESCRIPTION>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-right: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 32.1</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-bottom: 0; margin-left: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P> <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the annual report of GHST World Inc. (the “Company”) on Form 10-K for the fiscal year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, Edoardo Riboli, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"> <TD STYLE="width: 3pc"></TD><TD STYLE="width: 3pc"><A NAME="a_Aci_An1_312E"></A><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and</FONT></TD></TR></TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"> <TD STYLE="width: 3pc"></TD><TD STYLE="width: 3pc"><A NAME="a_Aci_An2_322E"></A><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR></TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6pc; text-align: justify"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 35%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Edoardo Riboli</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Edoardo Riboli</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">Chief Executive Officer</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(Principal Executive Officer)</P></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dated: September 28, 2022</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the annual report of GHST World, Inc. (the “Company”) on Form 10-K for the fiscal year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, Marcello Appella, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"> <TD STYLE="width: 3pc"></TD><TD STYLE="width: 3pc"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and</FONT></TD></TR></TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"> <TD STYLE="width: 3pc"></TD><TD STYLE="width: 3pc"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR></TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 35%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Marcello Appella</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Marcello Appella</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.15pt">Chief Financial Officer</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer)</P></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dated: September 28, 2022</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the annual report of GHST World, Inc. (the “Company”) on Form 10-K for the fiscal year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, Paolo Sangiovanni, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"> <TD STYLE="width: 3pc"></TD><TD STYLE="width: 3pc"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and</FONT></TD></TR></TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"> <TD STYLE="width: 3pc"></TD><TD STYLE="width: 3pc"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR></TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 35%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Paolo Sangiovanni</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Paolo Sangiovanni</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.15pt">Chief Financial Officer</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer)</P></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dated: September 28, 2022</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"> </P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_004.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 image_004.jpg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͹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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>image_005.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 image_005.jpg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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>image_006.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 image_006.jpg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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>9 <FILENAME>ghst-20220630.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" ?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <!-- Field: Doc-Info; Name: Misc; Value: +qsps7xRiXgOn8uMY3pMOaiLibP9z5V92YkhsWt8bUnKTyso8KMo/CnqNIymAb0N --> <schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:GHST="http://ghstworld.com/20220630" elementFormDefault="qualified" targetNamespace="http://ghstworld.com/20220630"> <annotation> <appinfo> <link:roleType roleURI="http://ghstworld.com/role/Cover" id="Cover"> <link:definition>00000001 - Document - Cover</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/BalanceSheets" id="BalanceSheets"> <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical"> <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/StatementsOfOperations" id="StatementsOfOperations"> <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" id="StatementOfChangesInStockholdersDeficit"> <link:definition>00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows"> <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" id="OrganizationAndDescriptionOfBusiness"> <link:definition>00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies"> <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/Patents" id="Patents"> <link:definition>00000009 - Disclosure - PATENTS</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/CommonStockPayable" id="CommonStockPayable"> <link:definition>00000010 - Disclosure - COMMON STOCK PAYABLE</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions"> <link:definition>00000011 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/StockholdersEquity" id="StockholdersEquity"> <link:definition>00000012 - Disclosure - STOCKHOLDERS’ EQUITY</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/IncomeTaxes" id="IncomeTaxes"> <link:definition>00000013 - Disclosure - INCOME TAXES</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/SubsequentEvents" id="SubsequentEvents"> <link:definition>00000014 - Disclosure - SUBSEQUENT EVENTS</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies"> <link:definition>00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative"> <link:definition>00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/PatentsDetailsNarrative" id="PatentsDetailsNarrative"> <link:definition>00000017 - Disclosure - PATENTS (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" id="CommonStockPayableDetailsNarrative"> <link:definition>00000018 - Disclosure - COMMON STOCK PAYABLE (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative"> <link:definition>00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative"> <link:definition>00000020 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative"> <link:definition>00000021 - Disclosure - INCOME TAXES (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative"> <link:definition>00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:linkbaseRef xlink:type="simple" xlink:href="ghst-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" /> <link:linkbaseRef xlink:type="simple" xlink:href="ghst-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" /> <link:linkbaseRef xlink:type="simple" xlink:href="ghst-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" /> <link:linkbaseRef xlink:type="simple" xlink:href="ghst-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" /> </appinfo> </annotation> <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" /> <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" /> <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" /> <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" /> <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" /> <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" /> <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" /> <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" /> <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" /> <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" /> <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" /> <element id="GHST_PreferredStockSeriesAMember" name="PreferredStockSeriesAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="GHST_PreferredStockSeriesBMember" name="PreferredStockSeriesBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockPayable" name="CommonStockPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract" name="WeightedAverageNumberOfCommonSharesOutstandingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" /> <element id="GHST_IssuanceOfSharesInExchangeOfDebt" name="IssuanceOfSharesInExchangeOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_IssuanceOfSharesInExchangeOfDebtShares" name="IssuanceOfSharesInExchangeOfDebtShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CashPaidDuringYearperiodForAbstract" name="CashPaidDuringYearperiodForAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" /> <element id="GHST_IssuanceOfCommonStockInExchangeForDebt" name="IssuanceOfCommonStockInExchangeForDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_DisclosureCommonStockPayableAbstract" name="DisclosureCommonStockPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockPayableTextBlock" name="CommonStockPayableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="GHST_LiquidityAndGoingConcernPolicyTextBlock" name="LiquidityAndGoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="GHST_FairValuePolicyTextBlock" name="FairValuePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockReceived" name="CommonStockReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockPayableShares" name="CommonStockPayableShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockPayablePerShareValue" name="CommonStockPayablePerShareValue" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockPayableValue" name="CommonStockPayableValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_CommonStockPayableRelatedParties" name="CommonStockPayableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_SaleOfStockNumberOfShareIssuedInTransaction" name="SaleOfStockNumberOfShareIssuedInTransaction" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="GHST_SharesToExchangeValue" name="SharesToExchangeValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="GHST_OperatingLossDescription" name="OperatingLossDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" /> </schema> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.CAL <SEQUENCE>10 <FILENAME>ghst-20220630_cal.xml <DESCRIPTION>XBRL CALCULATION FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://ghstworld.com/role/Cover" xlink:href="ghst-20220630.xsd#Cover" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/BalanceSheets" xlink:href="ghst-20220630.xsd#BalanceSheets" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/BalanceSheetsParenthetical" xlink:href="ghst-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementsOfOperations" xlink:href="ghst-20220630.xsd#StatementsOfOperations" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" xlink:href="ghst-20220630.xsd#StatementOfChangesInStockholdersDeficit" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementsOfCashFlows" xlink:href="ghst-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="ghst-20220630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/Patents" xlink:href="ghst-20220630.xsd#Patents" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/CommonStockPayable" xlink:href="ghst-20220630.xsd#CommonStockPayable" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/RelatedPartyTransactions" xlink:href="ghst-20220630.xsd#RelatedPartyTransactions" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StockholdersEquity" xlink:href="ghst-20220630.xsd#StockholdersEquity" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/IncomeTaxes" xlink:href="ghst-20220630.xsd#IncomeTaxes" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SubsequentEvents" xlink:href="ghst-20220630.xsd#SubsequentEvents" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/PatentsDetailsNarrative" xlink:href="ghst-20220630.xsd#PatentsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" xlink:href="ghst-20220630.xsd#CommonStockPayableDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ghst-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" xlink:href="ghst-20220630.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" xlink:href="ghst-20220630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" xlink:href="ghst-20220630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/Cover" xlink:title="00000001 - Document - Cover" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedPatentsGross" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayable" xlink:label="loc_GHSTCommonStockPayable" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_GHSTCommonStockPayable" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" /> <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" xlink:label="loc_us-gaapUnrealizedGainOnForeignCurrencyDerivativesBeforeTax" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainOnForeignCurrencyDerivativesBeforeTax" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock" xlink:label="loc_us-gaapProceedsFromRepaymentOfLoansToPurchaseCommonStock" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentOfLoansToPurchaseCommonStock" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/Patents" xlink:title="00000009 - Disclosure - PATENTS" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/CommonStockPayable" xlink:title="00000010 - Disclosure - COMMON STOCK PAYABLE" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - RELATED PARTY TRANSACTIONS" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StockholdersEquity" xlink:title="00000012 - Disclosure - STOCKHOLDERS’ EQUITY" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/IncomeTaxes" xlink:title="00000013 - Disclosure - INCOME TAXES" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SubsequentEvents" xlink:title="00000014 - Disclosure - SUBSEQUENT EVENTS" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/PatentsDetailsNarrative" xlink:title="00000017 - Disclosure - PATENTS (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" xlink:title="00000018 - Disclosure - COMMON STOCK PAYABLE (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000020 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000021 - Disclosure - INCOME TAXES (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" /> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>11 <FILENAME>ghst-20220630_def.xml <DESCRIPTION>XBRL DEFINITION FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://ghstworld.com/role/Cover" xlink:href="ghst-20220630.xsd#Cover" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/BalanceSheets" xlink:href="ghst-20220630.xsd#BalanceSheets" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/BalanceSheetsParenthetical" xlink:href="ghst-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementsOfOperations" xlink:href="ghst-20220630.xsd#StatementsOfOperations" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" xlink:href="ghst-20220630.xsd#StatementOfChangesInStockholdersDeficit" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementsOfCashFlows" xlink:href="ghst-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="ghst-20220630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/Patents" xlink:href="ghst-20220630.xsd#Patents" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/CommonStockPayable" xlink:href="ghst-20220630.xsd#CommonStockPayable" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/RelatedPartyTransactions" xlink:href="ghst-20220630.xsd#RelatedPartyTransactions" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StockholdersEquity" xlink:href="ghst-20220630.xsd#StockholdersEquity" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/IncomeTaxes" xlink:href="ghst-20220630.xsd#IncomeTaxes" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SubsequentEvents" xlink:href="ghst-20220630.xsd#SubsequentEvents" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/PatentsDetailsNarrative" xlink:href="ghst-20220630.xsd#PatentsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" xlink:href="ghst-20220630.xsd#CommonStockPayableDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ghst-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" xlink:href="ghst-20220630.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" xlink:href="ghst-20220630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" xlink:href="ghst-20220630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/Cover" xlink:title="00000001 - Document - Cover" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_40" xlink:type="arc" order="41" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCash_70" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOtherAssetsNoncurrent_70" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapFiniteLivedPatentsGross_70" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_70" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_70" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayable" xlink:label="loc_GHSTCommonStockPayable_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_GHSTCommonStockPayable_70" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="12" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="13" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="14" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="15" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="16" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="17" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="18" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="19" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_40" xlink:type="arc" order="41" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="6" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_PreferredStockSeriesAMember" xlink:label="loc_GHSTPreferredStockSeriesAMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GHSTPreferredStockSeriesAMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_PreferredStockSeriesBMember" xlink:label="loc_GHSTPreferredStockSeriesBMember_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_GHSTPreferredStockSeriesBMember_10" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_70" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebt" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebt_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebt_70" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares_70" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="10" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/Patents" xlink:title="00000009 - Disclosure - PATENTS" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/CommonStockPayable" xlink:title="00000010 - Disclosure - COMMON STOCK PAYABLE" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - RELATED PARTY TRANSACTIONS" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StockholdersEquity" xlink:title="00000012 - Disclosure - STOCKHOLDERS’ EQUITY" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/IncomeTaxes" xlink:title="00000013 - Disclosure - INCOME TAXES" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SubsequentEvents" xlink:title="00000014 - Disclosure - SUBSEQUENT EVENTS" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/PatentsDetailsNarrative" xlink:title="00000017 - Disclosure - PATENTS (Details Narrative)" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" xlink:title="00000018 - Disclosure - COMMON STOCK PAYABLE (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_us-gaapInvestorMember_30" xlink:type="arc" order="31" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_80" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockReceived" xlink:label="loc_GHSTCommonStockReceived_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockReceived_80" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares_80" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharePrice_80" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebt" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebt_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebt_80" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableShares" xlink:label="loc_GHSTCommonStockPayableShares_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockPayableShares_80" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayablePerShareValue" xlink:label="loc_GHSTCommonStockPayablePerShareValue_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockPayablePerShareValue_80" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableValue" xlink:label="loc_GHSTCommonStockPayableValue_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockPayableValue_80" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1_80" xlink:type="arc" order="8" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000020 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_30" xlink:type="arc" order="31" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_50" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapPreferredStockCapitalSharesReservedForFutureIssuance_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockCapitalSharesReservedForFutureIssuance_50" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplit_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplit_50" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_50" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_SaleOfStockNumberOfShareIssuedInTransaction" xlink:label="loc_GHSTSaleOfStockNumberOfShareIssuedInTransaction_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GHSTSaleOfStockNumberOfShareIssuedInTransaction_50" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_SharesToExchangeValue" xlink:label="loc_GHSTSharesToExchangeValue_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GHSTSharesToExchangeValue_50" xlink:type="arc" order="8" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000021 - Disclosure - INCOME TAXES (Details Narrative)" /> <link:definitionLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_20" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_20" xlink:type="arc" order="1" /> </link:definitionLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>12 <FILENAME>ghst-20220630_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" /> <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_PreferredStockSeriesAMember" xlink:label="GHST_PreferredStockSeriesAMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_PreferredStockSeriesAMember" xlink:to="GHST_PreferredStockSeriesAMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_PreferredStockSeriesAMember_lbl" xml:lang="en-US">Preferred Stock Series A [Member]</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_PreferredStockSeriesBMember" xlink:label="GHST_PreferredStockSeriesBMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_PreferredStockSeriesBMember" xlink:to="GHST_PreferredStockSeriesBMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_PreferredStockSeriesBMember_lbl" xml:lang="en-US">Preferred Stock Series B [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="us-gaap_FiniteLivedPatentsGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedPatentsGross" xlink:to="us-gaap_FiniteLivedPatentsGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedPatentsGross_lbl" xml:lang="en-US">Patent costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders’ Deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Advances from related parties</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayable" xlink:label="GHST_CommonStockPayable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayable" xlink:to="GHST_CommonStockPayable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockPayable_lbl" xml:lang="en-US">Common stock payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders’ Deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value, 300,000,000 shares authorized; 124,430,534 and 5,239,832 shares issued at June 30 2022 and 2021</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders’ Deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders' Deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Par value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income(expense):</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" xlink:label="us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" xlink:to="us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax_lbl" xml:lang="en-US">Foreign exchange gain</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xml:lang="en-US">Loss on change in fair value of debts</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Other Income(expense)</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net loss per common share</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">- basic</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">- diluted</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:label="GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:to="GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of common shares outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">- basic</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">- diluted</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of common stock for cash, net of issuance costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of common stock for cash, net of issuance costs, shares</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebt" xlink:label="GHST_IssuanceOfSharesInExchangeOfDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_IssuanceOfSharesInExchangeOfDebt" xlink:to="GHST_IssuanceOfSharesInExchangeOfDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_IssuanceOfSharesInExchangeOfDebt_lbl" xml:lang="en-US">Issuance of common stock in exchange for debt</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:label="GHST_IssuanceOfSharesInExchangeOfDebtShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:to="GHST_IssuanceOfSharesInExchangeOfDebtShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_IssuanceOfSharesInExchangeOfDebtShares_lbl" xml:lang="en-US">Issuance of common stock in exchange for debt, shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock for cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock for cash, shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_2_lbl" xml:lang="en-US">Loss on change in fair value of debt</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash Used In Operating Activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS  FROM INVESTING ACTIVITIES</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Patent costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net Cash Used In Investing Activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Advances from related parties</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock" xlink:label="us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock" xlink:to="us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock_lbl" xml:lang="en-US">Increase in common stock payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of common stock for cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash Provided By Financing Activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash - beginning of period</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash - end of period</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CashPaidDuringYearperiodForAbstract" xlink:label="GHST_CashPaidDuringYearperiodForAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CashPaidDuringYearperiodForAbstract" xlink:to="GHST_CashPaidDuringYearperiodForAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CashPaidDuringYearperiodForAbstract_lbl" xml:lang="en-US">Cash paid during the year/period for:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Taxes</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfCommonStockInExchangeForDebt" xlink:label="GHST_IssuanceOfCommonStockInExchangeForDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_IssuanceOfCommonStockInExchangeForDebt" xlink:to="GHST_IssuanceOfCommonStockInExchangeForDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GHST_IssuanceOfCommonStockInExchangeForDebt_lbl" xml:lang="en-US">Issuance of common stock in exchange for debt</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND DESCRIPTION OF BUSINESS</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">PATENTS</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_DisclosureCommonStockPayableAbstract" xlink:label="GHST_DisclosureCommonStockPayableAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_DisclosureCommonStockPayableAbstract" xlink:to="GHST_DisclosureCommonStockPayableAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_DisclosureCommonStockPayableAbstract_lbl" xml:lang="en-US">Common Stock Payable</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableTextBlock" xlink:label="GHST_CommonStockPayableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayableTextBlock" xlink:to="GHST_CommonStockPayableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockPayableTextBlock_lbl" xml:lang="en-US">COMMON STOCK PAYABLE</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS’ EQUITY</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_LiquidityAndGoingConcernPolicyTextBlock" xlink:label="GHST_LiquidityAndGoingConcernPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_LiquidityAndGoingConcernPolicyTextBlock" xlink:to="GHST_LiquidityAndGoingConcernPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_LiquidityAndGoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Liquidity and Going Concern</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:to="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" xml:lang="en-US">Risks and Uncertainties</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_FairValuePolicyTextBlock" xlink:label="GHST_FairValuePolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_FairValuePolicyTextBlock" xlink:to="GHST_FairValuePolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_FairValuePolicyTextBlock_lbl" xml:lang="en-US">Fair Value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock Based Compensation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net loss</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Deficit</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash Used In Operating Activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" xlink:label="us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" xlink:to="us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_lbl" xml:lang="en-US">Fair value of assets and liabilities measured on recurring basis</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Impairment losses</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Patent costs</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedPatentsGross" xlink:to="us-gaap_FiniteLivedPatentsGross_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedPatentsGross_2_lbl" xml:lang="en-US">Total Patent costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net loss carryforwards</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockReceived" xlink:label="GHST_CommonStockReceived" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockReceived" xlink:to="GHST_CommonStockReceived_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockReceived_lbl" xml:lang="en-US">Common stock received</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:to="GHST_IssuanceOfSharesInExchangeOfDebtShares_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GHST_IssuanceOfSharesInExchangeOfDebtShares_2_lbl" xml:lang="en-US">Issuance of shares in exchange of debt, shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_IssuanceOfSharesInExchangeOfDebt" xlink:to="GHST_IssuanceOfSharesInExchangeOfDebt_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GHST_IssuanceOfSharesInExchangeOfDebt_2_lbl" xml:lang="en-US">Issuance of shares in exchange of debt</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableShares" xlink:label="GHST_CommonStockPayableShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayableShares" xlink:to="GHST_CommonStockPayableShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockPayableShares_lbl" xml:lang="en-US">Common stock payable, number of shares to be issued in exchange for patent</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayablePerShareValue" xlink:label="GHST_CommonStockPayablePerShareValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayablePerShareValue" xlink:to="GHST_CommonStockPayablePerShareValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockPayablePerShareValue_lbl" xml:lang="en-US">Common stockpayable per share value</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableValue" xlink:label="GHST_CommonStockPayableValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayableValue" xlink:to="GHST_CommonStockPayableValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GHST_CommonStockPayableValue_lbl" xml:lang="en-US">Common stock payable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_3_lbl" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Advances from related parties</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableRelatedParties" xlink:label="GHST_CommonStockPayableRelatedParties" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayableRelatedParties" xlink:to="GHST_CommonStockPayableRelatedParties_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockPayableRelatedParties_lbl" xml:lang="en-US">Common stock payable - related parties</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock reserve</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Preferred stock reserve</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="us-gaap_StockholdersEquityNoteStockSplit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplit" xlink:to="us-gaap_StockholdersEquityNoteStockSplit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplit_lbl" xml:lang="en-US">Revese stock split</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Issuance of shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Price per share</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Exchange of debt</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_SaleOfStockNumberOfShareIssuedInTransaction" xlink:label="GHST_SaleOfStockNumberOfShareIssuedInTransaction" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_SaleOfStockNumberOfShareIssuedInTransaction" xlink:to="GHST_SaleOfStockNumberOfShareIssuedInTransaction_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_SaleOfStockNumberOfShareIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_SharesToExchangeValue" xlink:label="GHST_SharesToExchangeValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_SharesToExchangeValue" xlink:to="GHST_SharesToExchangeValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_SharesToExchangeValue_lbl" xml:lang="en-US">Exchange value</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_3_lbl" xml:lang="en-US">Accumulated losses</link:label> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_OperatingLossDescription" xlink:label="GHST_OperatingLossDescription" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_OperatingLossDescription" xlink:to="GHST_OperatingLossDescription_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_OperatingLossDescription_lbl" xml:lang="en-US">Operating loss Description</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance_lbl" xml:lang="en-US">Operating loss carryforwards valuation allowance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_3_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Proceeds from Related Party Debt</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_IssuanceOfCommonStockInExchangeForDebt" xlink:to="GHST_IssuanceOfCommonStockInExchangeForDebt_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_IssuanceOfCommonStockInExchangeForDebt_2_lbl" xml:lang="en-US">IssuanceOfCommonStockInExchangeForDebt</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GHST_CommonStockPayableValue" xlink:to="GHST_CommonStockPayableValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GHST_CommonStockPayableValue_2_lbl" xml:lang="en-US">CommonStockPayableValue</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Due to Related Parties</link:label> </link:labelLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>13 <FILENAME>ghst-20220630_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://ghstworld.com/role/Cover" xlink:href="ghst-20220630.xsd#Cover" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/BalanceSheets" xlink:href="ghst-20220630.xsd#BalanceSheets" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/BalanceSheetsParenthetical" xlink:href="ghst-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementsOfOperations" xlink:href="ghst-20220630.xsd#StatementsOfOperations" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" xlink:href="ghst-20220630.xsd#StatementOfChangesInStockholdersDeficit" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StatementsOfCashFlows" xlink:href="ghst-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="ghst-20220630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/Patents" xlink:href="ghst-20220630.xsd#Patents" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/CommonStockPayable" xlink:href="ghst-20220630.xsd#CommonStockPayable" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/RelatedPartyTransactions" xlink:href="ghst-20220630.xsd#RelatedPartyTransactions" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StockholdersEquity" xlink:href="ghst-20220630.xsd#StockholdersEquity" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/IncomeTaxes" xlink:href="ghst-20220630.xsd#IncomeTaxes" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SubsequentEvents" xlink:href="ghst-20220630.xsd#SubsequentEvents" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ghst-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/PatentsDetailsNarrative" xlink:href="ghst-20220630.xsd#PatentsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" xlink:href="ghst-20220630.xsd#CommonStockPayableDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ghst-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" xlink:href="ghst-20220630.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" xlink:href="ghst-20220630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" xlink:href="ghst-20220630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" /> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/Cover" xlink:title="00000001 - Document - Cover"> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" /> <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" /> <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" /> <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" /> <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" /> <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" /> <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" /> <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" /> <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" /> <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" /> <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" /> <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" /> <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" /> <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" /> <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" /> <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" /> <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" /> <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" /> <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" /> <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" /> <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" /> <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" /> <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" /> <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" /> <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" /> <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" /> <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" /> <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" /> <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" /> <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" /> <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" /> <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" /> <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" /> <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" /> <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" /> <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" /> <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" /> <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" /> <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" /> <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" /> <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" /> <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedPatentsGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayable" xlink:label="loc_GHSTCommonStockPayable" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_GHSTCommonStockPayable" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax" xlink:label="loc_us-gaapUnrealizedGainOnForeignCurrencyDerivativesBeforeTax" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapUnrealizedGainOnForeignCurrencyDerivativesBeforeTax" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:label="loc_GHSTWeightedAverageNumberOfCommonSharesOutstandingAbstract" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_GHSTWeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GHSTWeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GHSTWeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_PreferredStockSeriesAMember" xlink:label="loc_GHSTPreferredStockSeriesAMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_GHSTPreferredStockSeriesAMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_PreferredStockSeriesBMember" xlink:label="loc_GHSTPreferredStockSeriesBMember" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_GHSTPreferredStockSeriesBMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebt" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebt" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock" xlink:label="loc_us-gaapProceedsFromRepaymentOfLoansToPurchaseCommonStock" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentOfLoansToPurchaseCommonStock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CashPaidDuringYearperiodForAbstract" xlink:label="loc_GHSTCashPaidDuringYearperiodForAbstract" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_GHSTCashPaidDuringYearperiodForAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" /> <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" /> <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" /> <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfCommonStockInExchangeForDebt" xlink:label="loc_GHSTIssuanceOfCommonStockInExchangeForDebt" /> <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_GHSTIssuanceOfCommonStockInExchangeForDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/Patents" xlink:title="00000009 - Disclosure - PATENTS"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/CommonStockPayable" xlink:title="00000010 - Disclosure - COMMON STOCK PAYABLE"> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_DisclosureCommonStockPayableAbstract" xlink:label="loc_GHSTDisclosureCommonStockPayableAbstract" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableTextBlock" xlink:label="loc_GHSTCommonStockPayableTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GHSTDisclosureCommonStockPayableAbstract" xlink:to="loc_GHSTCommonStockPayableTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - RELATED PARTY TRANSACTIONS"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StockholdersEquity" xlink:title="00000012 - Disclosure - STOCKHOLDERS’ EQUITY"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/IncomeTaxes" xlink:title="00000013 - Disclosure - INCOME TAXES"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SubsequentEvents" xlink:title="00000014 - Disclosure - SUBSEQUENT EVENTS"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_LiquidityAndGoingConcernPolicyTextBlock" xlink:label="loc_GHSTLiquidityAndGoingConcernPolicyTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GHSTLiquidityAndGoingConcernPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:label="loc_us-gaapUnusualRisksAndUncertaintiesTextBlock" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUnusualRisksAndUncertaintiesTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_FairValuePolicyTextBlock" xlink:label="loc_GHSTFairValuePolicyTextBlock" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_GHSTFairValuePolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" xlink:label="loc_us-gaapFairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFiniteLivedPatentsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/PatentsDetailsNarrative" xlink:title="00000017 - Disclosure - PATENTS (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedPatentsGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/CommonStockPayableDetailsNarrative" xlink:title="00000018 - Disclosure - COMMON STOCK PAYABLE (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_DisclosureCommonStockPayableAbstract" xlink:label="loc_GHSTDisclosureCommonStockPayableAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GHSTDisclosureCommonStockPayableAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockReceived" xlink:label="loc_GHSTCommonStockReceived" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockReceived" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebtShares" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebtShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_IssuanceOfSharesInExchangeOfDebt" xlink:label="loc_GHSTIssuanceOfSharesInExchangeOfDebt" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTIssuanceOfSharesInExchangeOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableShares" xlink:label="loc_GHSTCommonStockPayableShares" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockPayableShares" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayablePerShareValue" xlink:label="loc_GHSTCommonStockPayablePerShareValue" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockPayablePerShareValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableValue" xlink:label="loc_GHSTCommonStockPayableValue" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_GHSTCommonStockPayableValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_CommonStockPayableRelatedParties" xlink:label="loc_GHSTCommonStockPayableRelatedParties" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_GHSTCommonStockPayableRelatedParties" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000020 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapPreferredStockCapitalSharesReservedForFutureIssuance" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplit" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_SaleOfStockNumberOfShareIssuedInTransaction" xlink:label="loc_GHSTSaleOfStockNumberOfShareIssuedInTransaction" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GHSTSaleOfStockNumberOfShareIssuedInTransaction" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_SharesToExchangeValue" xlink:label="loc_GHSTSharesToExchangeValue" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_GHSTSharesToExchangeValue" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000021 - Disclosure - INCOME TAXES (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" /> <link:loc xlink:type="locator" xlink:href="ghst-20220630.xsd#GHST_OperatingLossDescription" xlink:label="loc_GHSTOperatingLossDescription" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_GHSTOperatingLossDescription" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaapOperatingLossCarryforwardsValuationAllowance" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsValuationAllowance" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://ghstworld.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" /> </link:presentationLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525436304"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Sep. 22, 2022</div></th> <th class="th"><div>Dec. 31, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td> <td class="text">10-K<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td> <td class="text">Jun. 30, 2022<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td> <td class="text">FY<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td> <td class="text">2022<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td> <td class="text">--06-30<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td> <td class="text">000-31705<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td> <td class="text">GHST World Inc.<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td> <td class="text">0001121795<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td> <td class="text">91-2007477<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td> <td class="text">DE<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td> <td class="text">667 Madison Avenue<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td> <td class="text">5th Floor<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td> <td class="text">New York<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td> <td class="text">NY<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td> <td class="text">10065<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td> <td class="text">212<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td> <td class="text">634-6860<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td> <td class="text">No<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td> <td class="text">No<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td> <td class="text">Yes<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td> <td class="text">Yes<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td> <td class="text">Non-accelerated Filer<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 911,327<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td> <td class="text"> <span></span> </td> <td class="nump">124,430,534<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td> <td class="text">Ciro E. Adams, CPA, LLC<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td> <td class="text">Wilmington, DE<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td> <td class="text">5938<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_AmendmentFlag</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_AuditorFirmId</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:nonemptySequenceNumberItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_AuditorLocation</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:internationalNameItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_AuditorName</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:internationalNameItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CityAreaCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CoverAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:gMonthDayItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentAnnualReport</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:fiscalPeriodItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:gYearItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:dateItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentTransitionReport</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentType</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:submissionTypeItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:stateOrProvinceItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCentralIndexKey</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:centralIndexKeyItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityFileNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:fileNumberItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityFilerCategory</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:filerCategoryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:edgarStateCountryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityPublicFloat</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityRegistrantName</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityShellCompany</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntitySmallBusiness</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:employerIdItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LocalPhoneNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525230976"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td> <td class="nump">$ 206<span></span> </td> <td class="nump">$ 7,350<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td> <td class="nump">206<span></span> </td> <td class="nump">7,350<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td> <td class="nump">115,000<span></span> </td> <td class="nump">115,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedPatentsGross', window );">Patent costs</a></td> <td class="nump">39,181<span></span> </td> <td class="nump">39,181<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td> <td class="nump">154,387<span></span> </td> <td class="nump">161,531<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td> <td class="nump">1,685<span></span> </td> <td class="nump">14,528<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Advances from related parties</a></td> <td class="nump">75,446<span></span> </td> <td class="nump">16,241<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockPayable', window );">Common stock payable</a></td> <td class="nump">9,559<span></span> </td> <td class="nump">217,784<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td> <td class="nump">86,690<span></span> </td> <td class="nump">248,553<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders’ Deficit</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 300,000,000 shares authorized; 124,430,534 and 5,239,832 shares issued at June 30 2022 and 2021</a></td> <td class="nump">124,431<span></span> </td> <td class="nump">5,240<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td> <td class="nump">9,362,205<span></span> </td> <td class="nump">9,174,792<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td> <td class="num">(9,418,947)<span></span> </td> <td class="num">(9,267,062)<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders’ Deficit</a></td> <td class="nump">67,697<span></span> </td> <td class="num">(87,022)<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Deficit</a></td> <td class="nump">154,387<span></span> </td> <td class="nump">161,531<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders’ Deficit</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td> <td class="nump">6<span></span> </td> <td class="nump">6<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders’ Deficit</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td> <td class="nump">$ 2<span></span> </td> <td class="nump">$ 2<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Assets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AssetsCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Cash</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedPatentsGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FiniteLivedPatentsGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>16 <FILENAME>R3.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125524285760"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td> <td class="nump">$ 0.001<span></span> </td> <td class="nump">$ 0.001<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td> <td class="nump">10,000,000<span></span> </td> <td class="nump">10,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value</a></td> <td class="nump">$ 0.001<span></span> </td> <td class="nump">$ 0.001<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td> <td class="nump">300,000,000<span></span> </td> <td class="nump">300,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td> <td class="nump">124,430,534<span></span> </td> <td class="nump">5,239,832<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td> <td class="nump">6,000<span></span> </td> <td class="nump">6,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td> <td class="nump">6,000<span></span> </td> <td class="nump">6,000<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td> <td class="nump">2,200<span></span> </td> <td class="nump">2,200<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td> <td class="nump">2,200<span></span> </td> <td class="nump">2,200<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>17 <FILENAME>R4.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125524337520"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th> <th class="th" colspan="2">12 Months Ended</th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td> <td class="nump">150,702<span></span> </td> <td class="nump">151,366<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td> <td class="nump">150,702<span></span> </td> <td class="nump">151,366<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income(expense):</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax', window );">Foreign exchange gain</a></td> <td class="nump">667<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td> <td class="num">(150)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Loss on change in fair value of debts</a></td> <td class="num">(1,700)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income(expense)</a></td> <td class="num">(1,183)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="num">$ (151,885)<span></span> </td> <td class="num">$ (151,366)<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per common share</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">- basic</a></td> <td class="nump">$ (0.00)<span></span> </td> <td class="num">$ (0.03)<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">- diluted</a></td> <td class="nump">$ (0.00)<span></span> </td> <td class="num">$ (0.03)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract', window );"><strong>Weighted average number of common shares outstanding</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">- basic</a></td> <td class="nump">54,032,711<span></span> </td> <td class="nump">4,760,534<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">- diluted</a></td> <td class="nump">54,032,711<span></span> </td> <td class="nump">4,760,534<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingExpenses</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Revenues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain related to the increase in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>18 <FILENAME>R5.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125524160768"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Stockholders' Deficit - USD ($)<br></strong></div></th> <th class="th"><div>Preferred Stock Series A [Member]</div></th> <th class="th"><div>Preferred Stock Series B [Member]</div></th> <th class="th"><div>Common Stock [Member]</div></th> <th class="th"><div>Additional Paid-in Capital [Member]</div></th> <th class="th"><div>Retained Earnings [Member]</div></th> <th class="th"><div>Total</div></th> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2020</a></td> <td class="nump">$ 6<span></span> </td> <td class="nump">$ 2<span></span> </td> <td class="nump">$ 3,980<span></span> </td> <td class="nump">$ 9,002,643<span></span> </td> <td class="num">$ (9,115,696)<span></span> </td> <td class="num">$ (109,065)<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2020</a></td> <td class="nump">6,000<span></span> </td> <td class="nump">2,200<span></span> </td> <td class="nump">3,980,176<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock for cash, net of issuance costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 1,010<span></span> </td> <td class="nump">147,468<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">148,478<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock for cash, net of issuance costs, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,009,656<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebt', window );">Issuance of common stock in exchange for debt</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 250<span></span> </td> <td class="nump">24,681<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">24,931<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebtShares', window );">Issuance of common stock in exchange for debt, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">250,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">(151,366)<span></span> </td> <td class="num">(151,366)<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2021</a></td> <td class="nump">$ 6<span></span> </td> <td class="nump">$ 2<span></span> </td> <td class="nump">$ 5,240<span></span> </td> <td class="nump">9,174,792<span></span> </td> <td class="num">(9,267,062)<span></span> </td> <td class="num">$ (87,022)<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td> <td class="nump">6,000<span></span> </td> <td class="nump">2,200<span></span> </td> <td class="nump">5,239,832<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock for cash, net of issuance costs, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">118,663,761<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebt', window );">Issuance of common stock in exchange for debt</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 118,664<span></span> </td> <td class="nump">106,595<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 225,259<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebtShares', window );">Issuance of common stock in exchange for debt, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">118,663,761<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">(151,885)<span></span> </td> <td class="num">(151,885)<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for cash</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 527<span></span> </td> <td class="nump">80,818<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">81,345<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">526,941<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2022</a></td> <td class="nump">$ 6<span></span> </td> <td class="nump">$ 2<span></span> </td> <td class="nump">$ 124,431<span></span> </td> <td class="nump">$ 9,362,205<span></span> </td> <td class="num">$ (9,418,947)<span></span> </td> <td class="nump">$ 67,697<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2022</a></td> <td class="nump">6,000<span></span> </td> <td class="nump">2,200<span></span> </td> <td class="nump">124,430,534<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_IssuanceOfSharesInExchangeOfDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_IssuanceOfSharesInExchangeOfDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_IssuanceOfSharesInExchangeOfDebtShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_IssuanceOfSharesInExchangeOfDebtShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>19 <FILENAME>R6.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525326368"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th> <th class="th" colspan="2">12 Months Ended</th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="num">$ (151,885)<span></span> </td> <td class="num">$ (151,366)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Loss on change in fair value of debt</a></td> <td class="nump">1,700<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td> <td class="num">(12,843)<span></span> </td> <td class="nump">7,436<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used In Operating Activities</a></td> <td class="num">(163,028)<span></span> </td> <td class="num">(143,930)<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS  FROM INVESTING ACTIVITIES</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Patent costs</a></td> <td class="nump">0<span></span> </td> <td class="num">(7,395)<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used In Investing Activities</a></td> <td class="text"> <span></span> </td> <td class="num">(7,395)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Advances from related parties</a></td> <td class="nump">59,205<span></span> </td> <td class="nump">7,905<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock', window );">Increase in common stock payable</a></td> <td class="nump">15,334<span></span> </td> <td class="nump">2,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock for cash</a></td> <td class="nump">81,345<span></span> </td> <td class="nump">148,478<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided By Financing Activities</a></td> <td class="nump">155,884<span></span> </td> <td class="nump">158,383<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash</a></td> <td class="num">(7,144)<span></span> </td> <td class="nump">7,058<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash - beginning of period</a></td> <td class="nump">7,350<span></span> </td> <td class="nump">292<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash - end of period</a></td> <td class="nump">206<span></span> </td> <td class="nump">7,350<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CashPaidDuringYearperiodForAbstract', window );"><strong>Cash paid during the year/period for:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Taxes</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfCommonStockInExchangeForDebt', window );">Issuance of common stock in exchange for debt</a></td> <td class="nump">$ 225,259<span></span> </td> <td class="nump">$ 24,931<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CashPaidDuringYearperiodForAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CashPaidDuringYearperiodForAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_IssuanceOfCommonStockInExchangeForDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_IssuanceOfCommonStockInExchangeForDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestPaidNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash inflow from repayment of loans for purchasing common stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>20 <FILENAME>R7.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125527766784"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND DESCRIPTION OF BUSINESS<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND DESCRIPTION OF BUSINESS</a></td> <td class="text"><p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zxGhKiIo8uYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1- <span id="xdx_827_zLZ9lgVQO2hl">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Background </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GHST World Inc. (“the Company”), is a Delaware corporation that was incorporated on November 12, 1999.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a holding company for various technology and other activities. The Company has acquired and is developing several patents in the technology sector.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&trid=2197479<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>21 <FILENAME>R8.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125528205392"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td> <td class="text"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zIzOvYRvRMk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 – <span id="xdx_82B_zXuVV6K2AFib">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_844_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z2FoL3yYz4eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zeHWc3LWuds8">Liquidity and Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had a net losses of <span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20210701__20220630_zmz8MSvXZmq5" title="Net loss">151,885</span> and $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20200701__20210630_zZd1dIau7cM8" title="Net loss">151,366</span> for the years ended June 30, 2022 and 2021. The Company has an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zAVVM7emf5nl" title="Accumulated deficit">9,418,947</span> and a stockholders’ equity of $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_pp0p0_c20220630_zcc3vDg7HoE1" title="Stockholders' Deficit">67,697</span> as of June 30, 2022 and used $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20220630_zAyQn2euDP3f" title="Cash Used In Operating Activities">163,028</span> and $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zqebNGRH7yd2" title="Cash Used In Operating Activities">143,930</span> in cash flow from operating activities for the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders and from the possible sale of a minority interest in its subsidiaries. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zsgfZ1XuwvWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_869_zSz2CbUibQM4">Principles of Consolidation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the following wholly owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Art World, Inc</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Sport Inc.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">IoTT world Inc.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z3HpBf7G8lca" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zWHfRkVzZct9">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSOnFowtP8li" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zNrK5RML5r6">Foreign Currency</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p id="xdx_847_eus-gaap--UseOfEstimates_ziCkLWZVNIOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_860_zg2FmSDz8Fq5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such estimates and assumptions impact, among others, the following: the fair value of share-based payments and deferred taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b> </b></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9ZXW0XWvqPl" style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b><span id="xdx_869_zni92yQAP89j">Cash</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt">Cash are amounts held at local banks. The Company had <span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zk9vQTJrYiz3" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20210630_z95bfoqoVx03" title="Cash equivalents">no</span></span> cash equivalents at June 30, 2022 or 2021.</p> <p id="xdx_84E_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zAZigSwjiU4i" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_862_z5vkkg5EQuGi">Risks and Uncertainties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.</p> <p id="xdx_84A_ecustom--FairValuePolicyTextBlock_zkk2cPE36D27" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_867_zrqvUP8ZogV2">Fair Value</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 0pt; text-align: justify">The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has <span id="xdx_90D_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20210701__20220630_zbnBi5hDGppe" title="Fair value of assets and liabilities measured on recurring basis"><span id="xdx_903_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20200701__20210630_zhSRINs9lcq7" title="Fair value of assets and liabilities measured on recurring basis">no</span></span> assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zayaPPSTDd21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zLQiEhUtGhwk">Impairment of Long-Lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets consist primarily of property, plant and equipment. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. As of June 30, 2022 and 2021, the Company did <span id="xdx_907_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210701__20220630_zYDiNY71uM76" title="Impairment losses"><span id="xdx_909_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20200701__20210630_zYD4jAjFrATd" title="Impairment losses">no</span></span>t recognize any impairment losses.</p> <p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zzhzy2Ls5vE3" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_864_ztyHlZLJpcV3">Intangible Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. The Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over ten years, which represents the estimated useful lives of the patents. The ten-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. For the years ended June 30, 2022 and 2021 the Company has capitalized $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20210701__20220630_zStcLwqFZZag" title="Patent costs">0</span>, and $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20200701__20210630_zDNvihKasFv2" title="Patent costs">7,395</span> of patent costs. As of June 30, 2022 and 2021, patent cost totaled $<span id="xdx_903_eus-gaap--FiniteLivedPatentsGross_c20220630_pp0p0" title="Total Patent costs"><span id="xdx_900_eus-gaap--FiniteLivedPatentsGross_c20210630_pp0p0" title="Total Patent costs">39,181</span></span>.</p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zAnGSnDqIfh1" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_863_zP885dFnuvBc">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company’s tax returns are subject to examination by federal and state taxing authorities for the years ended June 30, 2018 through 2021. However, the Company's federal net operating losses for tax years ending June 30, 2021 and 2022 will remain subject to examination until the losses are utilized or expire. Under the Tax Cuts and Jobs Act (“TCJA”), which was enacted on December 22, 2017, Net Operating Losses (“NOLs”) incurred for tax years beginning before January 1, 2018, will be able to be carried forward for 20 years. For NOLs incurred in tax years beginning after December 31, 2017, these NOLs will be subject to the new limitations imposed by TCJA. Under the new law, an NOL can offset only 80% of taxable income in any given tax year. Furthermore, NOLs can no longer be carried back, they must be carried forward. The 20-year carryforward period has been replaced with an indefinite carryforward period for NOLs incurred for tax years beginning after December 31, 2017. The NOL carryforwards for the periods ended June 30, 2022 and 2021 are approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220630_zsmgMB36oBg1" title="Net loss carryforwards">152,000</span> and $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net loss carryforwards">151,000</span>, respectively and the total NOL carryforward to the year ended June 30, 2022 is approximately $2.8 million. At June 30, 2022, a valuation allowance fully offsets any tax benefit from these NOLs carryforard.</p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAQGU9opKyE8" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86C_zNwMskVMNdi8">Stock Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company applies the fair value method of ASC 718, Share Based Payment, formerly Statement of Financial Accounting Standards ("SFAS") No. l23R "Accounting for Stock Based Compensation", in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.</p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z4dMRpgH54Vh" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86A_zrO4Ao76rwYc">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt">There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&trid=2122369<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>22 <FILENAME>R9.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125527797152"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PATENTS<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">PATENTS</a></td> <td class="text"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zMEpLJXr0ftg" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 3 – <span id="xdx_820_zFENBecNv2de">PATENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company obtained a patent dated June 30, 2020, which is a protection device used in sporting activity with the capability to monitor data from the device. The Company has capitalized the patent costs totaling $<span id="xdx_90C_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20220630_z8Ul69jBpI72" title="Patent costs"><span id="xdx_905_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20210630_z7ML6ojRBu07" title="Patent costs">39,181</span></span>, at June 30, 2022 and 2021. The Company will amortize the patent over the useful life of the patent once it is placed in service. <span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20210701__20220630_zQ5NpmtuW7q7" title="Amortization of intangible assets"><span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20200701__20210630_zQynfPKUoZOk" title="Amortization of intangible assets">No</span></span> amortization was recorded for the years ended June 30, 2022 and 2021.</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&trid=2144471<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>23 <FILENAME>R10.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125527797152"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK PAYABLE<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_DisclosureCommonStockPayableAbstract', window );"><strong>Common Stock Payable</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockPayableTextBlock', window );">COMMON STOCK PAYABLE</a></td> <td class="text"><p id="xdx_804_ecustom--CommonStockPayableTextBlock_z27XqMHEyjXl" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 4 – <span id="xdx_825_zKSroEyrARZ6">COMMON STOCK PAYABLE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company has an agreement with certain investors to convert their investment into common stock of the Company at a price equal to the average value of the stock over the previous six months. The conversion is contingent on the Company effectuating a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20210902__20210930_zdhArBQDIgfe" title="Reverse stock split">1-for-100 reverse stock split</span> which was effected on September 30, 2021. As of June 30, 2022, and June 30, 2021, the Company has a total of $<span id="xdx_90C_ecustom--CommonStockReceived_iI_pp0p0_c20220630_z5uQoDW6Thvg" title="Common stock received">9,559</span> and $<span id="xdx_90F_ecustom--CommonStockReceived_iI_pp0p0_c20210630_z1yRkZB18Jjb" title="Common stock received">217,784</span> that has not been converted to common stock. During the year ended June 30, 2022 certain investors agreed to accept a total of <span id="xdx_909_ecustom--IssuanceOfSharesInExchangeOfDebtShares_c20210701__20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_z0wIrHhuSANd" title="Issuance of shares in exchange of debt, shares">118,663,761</span> shares at an average price of approximately $<span id="xdx_90C_eus-gaap--SharePrice_iI_c20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_zkStJ8U8Pkb6" title="Share price">0.0019</span> in exchange for $<span id="xdx_908_ecustom--IssuanceOfSharesInExchangeOfDebt_pp0p0_c20210701__20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_zdLy4vnQA0Y1" title="Issuance of shares in exchange of debt">225,259</span> of debt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company recorded a common stock payable in 2018 for an agreement in which the Company agreed to issue <span id="xdx_906_ecustom--CommonStockPayableShares_iI_c20180630_zz3fF0qVCYE" title="Common stock payable, number of shares to be issued in exchange for patent">2,000,000</span> shares of post-split stock in exchange for the patent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company recorded this at $<span id="xdx_909_ecustom--CommonStockPayablePerShareValue_iI_c20180630_zvmJbeT4R3i6" title="Common stock payable per share value">0.001</span> or $<span id="xdx_906_ecustom--CommonStockPayableValue_iI_pp0p0_c20180630_zi6KI24oiin8" title="Common stock payable">2,000</span>. The Company valued the stock at the six-month average which was $<span id="xdx_902_ecustom--CommonStockPayablePerShareValue_iI_c20220630_zbYw66QoTrtl" title="Common stockpayable per share value">0.00185</span> per share or $<span id="xdx_909_ecustom--CommonStockPayableValue_iI_pp0p0_c20220630_zA0Mym1U5A1i" title="Common stock payable">3,700</span>. As a result the Company recognized a market value adjustment on the accompanying Income Statement of $<span id="xdx_905_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_iN_pp0p0_di_c20210701__20220630_zxjiFafoaL1k" title="Fair Value, Option, Changes in Fair Value, Gain (Loss)">1,700</span> for year ended June 30, 2022.</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockPayableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockPayableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_DisclosureCommonStockPayableAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_DisclosureCommonStockPayableAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>24 <FILENAME>R11.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525401968"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td> <td class="text"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztGax7FCfFxj" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify"><b>NOTE 5 – <span id="xdx_82F_zkHK3OOLTPL3">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">At June 30, 2022 and 2021, the Company owed related parties a total of $<span id="xdx_909_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20220630_pp0p0" title="Advances from related parties">75,446</span> and $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20210630_pp0p0" title="Advances from related parties">16,241</span>. These shareholder loans are unsecured, non-interest bearing and are due on demand. See Note 4 as these amounts that will be converted to common stock..</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">As shown in Note 4, the Company has committed to converting certain debts to equity. Included in the debts is $<span id="xdx_906_ecustom--CommonStockPayableRelatedParties_c20220630_pp0p0" title="Common stock payable - related parties">9,558</span> as of June 30, 2022 of amounts due to related parties that will also be converted as described in Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">These transactions were in the normal course of operations and were measured at a value that represents the amount of consideration established and agreed to by the related parties.</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>25 <FILENAME>R12.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125524068208"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS’ EQUITY<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS’ EQUITY</a></td> <td class="text"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zh3dtgW7G0w2" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 6 – <span id="xdx_827_z7YtYdJo3r8h">STOCKHOLDERS’ EQUITY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210807_zrSAfoGlG2aj" title="Common Stock, Shares Authorized">310,000,000</span> of which <span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20210807_pdd" title="Common stock reserve">300,000,000</span> are reserved for common stock and <span id="xdx_90A_eus-gaap--PreferredStockCapitalSharesReservedForFutureIssuance_c20210807_pdd" title="Preferred stock reserve">10,000,000</span> for preferred stock. The amendment was effective on September 9, 2021. Effective on September 30, 2021, the Company effectuated a <span id="xdx_906_eus-gaap--StockholdersEquityNoteStockSplit_c20210701__20220630" title="Revese stock split">100-1 reverse stock split</span>. All per share amounts have been retroactively restated to reflect the split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>Common Stock Issuances</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt; text-align: justify">During the year ended June 30, 2022 the Company issued a total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210701__20220630_pdd" title="Issuance of shares">118,663,761</span> shares at an average price of approximately $<span id="xdx_909_eus-gaap--SharePrice_c20220630_pdd" title="Price per share">0.0019</span> in exchange for $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210701__20220630_pp0p0" title="Exchange of debt">225,259</span> (See Note 4) and sold <span id="xdx_904_ecustom--SaleOfStockNumberOfShareIssuedInTransaction_c20210701__20220630_pdd" title="Sale of stock">526,941</span> shares in exchange for $<span id="xdx_907_ecustom--SharesToExchangeValue_c20210701__20220630_pp0p0" title="Exchange value">81,345</span> at an average price of $<span id="xdx_903_eus-gaap--SharePrice_iI_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhVkaR40pSG6" title="Price per share">0.15</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EquityAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>26 <FILENAME>R13.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125529134048"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td> <td class="text"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zOB4G23Rw0Q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 7 – <span id="xdx_825_zGUyd1IPfZf6">INCOME TAXES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company has accumulated losses of approximately <span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_z8BaLvXfoDYj" style="display: none" title="Accumulated losses">9,418,947</span> 9.4 million since its inception. For income tax purposes, <span id="xdx_90E_ecustom--OperatingLossDescription_c20210701__20220630_zevn5qHsGrbb" title="Operating loss Description">the Company has operating loss carryforwards of approximately $<span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_dm_c20220630_zn0fmYHIHCLb" title="Operating loss carryforwards">2.8</span> million from tax years beginning before January 1, 2021, that begin to expire in 2027. These operating losses are subject to the limitations which were enacted in the Tax Cuts and Jobs Act (“TCJA”).</span> These operating losses can offset only 80% of taxable income in any given tax year. The carryover period for these operating losses is indefinite. No federal or state tax asset has been reported in the financial statements, because the Company believes there is a 50% or greater chance that the carryforwards will expire unused. Accordingly, the potential tax benefits of the loss carryforwards (approximately $<span id="xdx_903_eus-gaap--OperatingLossCarryforwardsValuationAllowance_c20220630_pp0p0" title="Operating loss carryforwards valuation allowance">700,000</span>) have been offset by a valuation allowance of the same amount.</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>27 <FILENAME>R14.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125523986704"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td> <td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z7c1jybkHcyg" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 8 – <span id="xdx_823_zb02XiHuYWP5">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">On August 18, 2022, the Company sold <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220801__20220818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziCtLCNld9cf" title="Stock Issued During Period, Shares, New Issues">296,640</span> shares of common stock for cash proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20220801__20220818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrRDGRcJ8ZE2" title="Proceeds from Issuance or Sale of Equity">29,664</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: center">*****</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>28 <FILENAME>R15.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525572528"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr><th class="th"><div>Jun. 30, 2022</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_LiquidityAndGoingConcernPolicyTextBlock', window );">Liquidity and Going Concern</a></td> <td class="text"><p id="xdx_844_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z2FoL3yYz4eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zeHWc3LWuds8">Liquidity and Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had a net losses of <span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20210701__20220630_zmz8MSvXZmq5" title="Net loss">151,885</span> and $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20200701__20210630_zZd1dIau7cM8" title="Net loss">151,366</span> for the years ended June 30, 2022 and 2021. The Company has an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zAVVM7emf5nl" title="Accumulated deficit">9,418,947</span> and a stockholders’ equity of $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_pp0p0_c20220630_zcc3vDg7HoE1" title="Stockholders' Deficit">67,697</span> as of June 30, 2022 and used $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20220630_zAyQn2euDP3f" title="Cash Used In Operating Activities">163,028</span> and $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zqebNGRH7yd2" title="Cash Used In Operating Activities">143,930</span> in cash flow from operating activities for the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders and from the possible sale of a minority interest in its subsidiaries. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td> <td class="text"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zsgfZ1XuwvWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_869_zSz2CbUibQM4">Principles of Consolidation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the following wholly owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Art World, Inc</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Sport Inc.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">IoTT world Inc.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td> <td class="text"><p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z3HpBf7G8lca" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zWHfRkVzZct9">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td> <td class="text"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSOnFowtP8li" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zNrK5RML5r6">Foreign Currency</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td> <td class="text"><p id="xdx_847_eus-gaap--UseOfEstimates_ziCkLWZVNIOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_860_zg2FmSDz8Fq5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such estimates and assumptions impact, among others, the following: the fair value of share-based payments and deferred taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b> </b></p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash</a></td> <td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9ZXW0XWvqPl" style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b><span id="xdx_869_zni92yQAP89j">Cash</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt">Cash are amounts held at local banks. The Company had <span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zk9vQTJrYiz3" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20210630_z95bfoqoVx03" title="Cash equivalents">no</span></span> cash equivalents at June 30, 2022 or 2021.</p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualRisksAndUncertaintiesTextBlock', window );">Risks and Uncertainties</a></td> <td class="text"><p id="xdx_84E_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zAZigSwjiU4i" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_862_z5vkkg5EQuGi">Risks and Uncertainties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.</p> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_FairValuePolicyTextBlock', window );">Fair Value</a></td> <td class="text"><p id="xdx_84A_ecustom--FairValuePolicyTextBlock_zkk2cPE36D27" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_867_zrqvUP8ZogV2">Fair Value</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 0pt; text-align: justify">The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has <span id="xdx_90D_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20210701__20220630_zbnBi5hDGppe" title="Fair value of assets and liabilities measured on recurring basis"><span id="xdx_903_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20200701__20210630_zhSRINs9lcq7" title="Fair value of assets and liabilities measured on recurring basis">no</span></span> assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td> <td class="text"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zayaPPSTDd21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zLQiEhUtGhwk">Impairment of Long-Lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets consist primarily of property, plant and equipment. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. As of June 30, 2022 and 2021, the Company did <span id="xdx_907_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210701__20220630_zYDiNY71uM76" title="Impairment losses"><span id="xdx_909_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20200701__20210630_zYD4jAjFrATd" title="Impairment losses">no</span></span>t recognize any impairment losses.</p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td> <td class="text"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zzhzy2Ls5vE3" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_864_ztyHlZLJpcV3">Intangible Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. The Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over ten years, which represents the estimated useful lives of the patents. The ten-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. For the years ended June 30, 2022 and 2021 the Company has capitalized $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20210701__20220630_zStcLwqFZZag" title="Patent costs">0</span>, and $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20200701__20210630_zDNvihKasFv2" title="Patent costs">7,395</span> of patent costs. As of June 30, 2022 and 2021, patent cost totaled $<span id="xdx_903_eus-gaap--FiniteLivedPatentsGross_c20220630_pp0p0" title="Total Patent costs"><span id="xdx_900_eus-gaap--FiniteLivedPatentsGross_c20210630_pp0p0" title="Total Patent costs">39,181</span></span>.</p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td> <td class="text"><p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zAnGSnDqIfh1" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_863_zP885dFnuvBc">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company’s tax returns are subject to examination by federal and state taxing authorities for the years ended June 30, 2018 through 2021. However, the Company's federal net operating losses for tax years ending June 30, 2021 and 2022 will remain subject to examination until the losses are utilized or expire. Under the Tax Cuts and Jobs Act (“TCJA”), which was enacted on December 22, 2017, Net Operating Losses (“NOLs”) incurred for tax years beginning before January 1, 2018, will be able to be carried forward for 20 years. For NOLs incurred in tax years beginning after December 31, 2017, these NOLs will be subject to the new limitations imposed by TCJA. Under the new law, an NOL can offset only 80% of taxable income in any given tax year. Furthermore, NOLs can no longer be carried back, they must be carried forward. The 20-year carryforward period has been replaced with an indefinite carryforward period for NOLs incurred for tax years beginning after December 31, 2017. The NOL carryforwards for the periods ended June 30, 2022 and 2021 are approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220630_zsmgMB36oBg1" title="Net loss carryforwards">152,000</span> and $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net loss carryforwards">151,000</span>, respectively and the total NOL carryforward to the year ended June 30, 2022 is approximately $2.8 million. At June 30, 2022, a valuation allowance fully offsets any tax benefit from these NOLs carryforard.</p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td> <td class="text"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAQGU9opKyE8" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86C_zNwMskVMNdi8">Stock Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company applies the fair value method of ASC 718, Share Based Payment, formerly Statement of Financial Accounting Standards ("SFAS") No. l23R "Accounting for Stock Based Compensation", in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.</p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td> <td class="text"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z4dMRpgH54Vh" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86A_zrO4Ao76rwYc">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt">There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.</p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_FairValuePolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_FairValuePolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_LiquidityAndGoingConcernPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_LiquidityAndGoingConcernPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&trid=2175825<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRisksAndUncertaintiesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of the unusual risk or uncertainty, if estimable, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_UnusualRisksAndUncertaintiesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_UseOfEstimates</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>29 <FILENAME>R16.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525525456"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="2">12 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> <th class="th"><div>Jun. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="nump">$ 151,885<span></span> </td> <td class="nump">$ 151,366<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td> <td class="nump">9,418,947<span></span> </td> <td class="nump">9,267,062<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Deficit</a></td> <td class="nump">67,697<span></span> </td> <td class="num">(87,022)<span></span> </td> <td class="num">$ (109,065)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash Used In Operating Activities</a></td> <td class="nump">163,028<span></span> </td> <td class="nump">143,930<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss', window );">Fair value of assets and liabilities measured on recurring basis</a></td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment losses</a></td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Patent costs</a></td> <td class="nump">(0)<span></span> </td> <td class="nump">7,395<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedPatentsGross', window );">Total Patent costs</a></td> <td class="nump">39,181<span></span> </td> <td class="nump">39,181<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net loss carryforwards</a></td> <td class="nump">$ 152,000<span></span> </td> <td class="nump">$ 151,000<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from asset (liability) measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedPatentsGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FiniteLivedPatentsGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>30 <FILENAME>R17.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125522523664"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PATENTS (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="2">12 Months Ended</th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedPatentsGross', window );">Patent costs</a></td> <td class="nump">$ 39,181<span></span> </td> <td class="nump">$ 39,181<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td> <td class="nump">$ 0<span></span> </td> <td class="nump">$ 0<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedPatentsGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FiniteLivedPatentsGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>31 <FILENAME>R18.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525247776"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK PAYABLE (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="1">1 Months Ended</th> <th class="th" colspan="2">12 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> <th class="th"><div>Jun. 30, 2018</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td> <td class="text">1-for-100 reverse stock split<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockReceived', window );">Common stock received</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 9,559<span></span> </td> <td class="nump">$ 217,784<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 0.0019<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebt', window );">Issuance of shares in exchange of debt</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 225,259<span></span> </td> <td class="nump">24,931<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockPayableShares', window );">Common stock payable, number of shares to be issued in exchange for patent</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">2,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockPayablePerShareValue', window );">Common stockpayable per share value</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 0.00185<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 0.001<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockPayableValue', window );">Common stock payable</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 3,700<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 2,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Fair Value, Option, Changes in Fair Value, Gain (Loss)</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 1,700<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebtShares', window );">Issuance of shares in exchange of debt, shares</a></td> <td class="text"> <span></span> </td> <td class="nump">118,663,761<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 0.0019<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_IssuanceOfSharesInExchangeOfDebt', window );">Issuance of shares in exchange of debt</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 225,259<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockPayablePerShareValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockPayablePerShareValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockPayableShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockPayableShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockPayableValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockPayableValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockReceived"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockReceived</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_IssuanceOfSharesInExchangeOfDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_IssuanceOfSharesInExchangeOfDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_IssuanceOfSharesInExchangeOfDebtShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_IssuanceOfSharesInExchangeOfDebtShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=us-gaap_InvestorMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_CounterpartyNameAxis=us-gaap_InvestorMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>32 <FILENAME>R19.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125525571408"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Advances from related parties</a></td> <td class="nump">$ 75,446<span></span> </td> <td class="nump">$ 16,241<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_CommonStockPayableRelatedParties', window );">Common stock payable - related parties</a></td> <td class="nump">$ 9,558<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_CommonStockPayableRelatedParties"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_CommonStockPayableRelatedParties</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>33 <FILENAME>R20.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125519001952"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="2">12 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> <th class="th"><div>Aug. 07, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td> <td class="nump">300,000,000<span></span> </td> <td class="nump">300,000,000<span></span> </td> <td class="nump">310,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserve</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">300,000,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance', window );">Preferred stock reserve</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">10,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplit', window );">Revese stock split</a></td> <td class="text">100-1 reverse stock split<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of shares</a></td> <td class="nump">118,663,761<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Price per share</a></td> <td class="nump">$ 0.0019<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Exchange of debt</a></td> <td class="nump">$ 225,259<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_SaleOfStockNumberOfShareIssuedInTransaction', window );">Sale of stock</a></td> <td class="nump">526,941<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_SharesToExchangeValue', window );">Exchange value</a></td> <td class="nump">$ 81,345<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of shares</a></td> <td class="text"> <span></span> </td> <td class="nump">1,009,656<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Price per share</a></td> <td class="nump">$ 0.15<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_SaleOfStockNumberOfShareIssuedInTransaction"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_SaleOfStockNumberOfShareIssuedInTransaction</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_SharesToExchangeValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_SharesToExchangeValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of nonredeemable preferred shares reserved for future issuance.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>34 <FILENAME>R21.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125519000896"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="1">12 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Jun. 30, 2022</div></th> <th class="th"><div>Jun. 30, 2021</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td> <td class="nump">$ 9,418,947<span></span> </td> <td class="nump">$ 9,267,062<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_GHST_OperatingLossDescription', window );">Operating loss Description</a></td> <td class="text">the Company has operating loss carryforwards of approximately $2.8 million from tax years beginning before January 1, 2021, that begin to expire in 2027. These operating losses are subject to the limitations which were enacted in the Tax Cuts and Jobs Act (“TCJA”).<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Operating loss carryforwards</a></td> <td class="nump">$ 2,800,000<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating loss carryforwards valuation allowance</a></td> <td class="nump">$ 700,000<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GHST_OperatingLossDescription"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">GHST_OperatingLossDescription</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>GHST_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>35 <FILENAME>R22.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140125528072752"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]<br></strong></div></th> <th class="th" colspan="1">1 Months Ended</th> </tr> <tr><th class="th"> <div>Aug. 18, 2022 </div> <div>USD ($) </div> <div>shares</div> </th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td> <td class="nump">296,640<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity | $</a></td> <td class="nump">$ 29,664<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>36 <FILENAME>ghst_10k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version="1.0" encoding="utf-8"?> <xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:GHST="http://ghstworld.com/20220630" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <link:schemaRef xlink:href="ghst-20220630.xsd" xlink:type="simple"/> <context id="From2021-07-01to2022-06-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="AsOf2021-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2022-09-22"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2022-09-22</instant> </period> </context> <context id="AsOf2022-06-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2021-06-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="From2020-07-012021-06-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="AsOf2020-06-30_custom_PreferredStockSeriesAMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="AsOf2020-06-30_custom_PreferredStockSeriesBMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="AsOf2020-06-30_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="AsOf2020-06-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="AsOf2021-06-30_custom_PreferredStockSeriesAMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="AsOf2021-06-30_custom_PreferredStockSeriesBMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="AsOf2021-06-30_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="From2020-07-012021-06-30_custom_PreferredStockSeriesAMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="From2020-07-012021-06-30_custom_PreferredStockSeriesBMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="From2021-07-012022-06-30_custom_PreferredStockSeriesAMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="From2021-07-012022-06-30_custom_PreferredStockSeriesBMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="From2021-07-012022-06-30_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="AsOf2022-06-30_custom_PreferredStockSeriesAMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesAMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2022-06-30_custom_PreferredStockSeriesBMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">GHST:PreferredStockSeriesBMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2022-06-30_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="From2021-09-022021-09-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <startDate>2021-09-02</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="From2021-07-012022-06-30_us-gaap_InvestorMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">us-gaap:InvestorMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2022-06-30</endDate> </period> </context> <context id="AsOf2022-06-30_us-gaap_InvestorMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">us-gaap:InvestorMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-06-30</instant> </period> </context> <context id="AsOf2018-06-30"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2018-06-30</instant> </period> </context> <context id="AsOf2021-08-07"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> </entity> <period> <instant>2021-08-07</instant> </period> </context> <context id="From2022-08-012022-08-18_us-gaap_SubsequentEventMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001121795</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-08-01</startDate> <endDate>2022-08-18</endDate> </period> </context> <unit id="USD"> <measure>iso4217:USD</measure> </unit> <unit id="Shares"> <measure>shares</measure> </unit> <unit id="USDPShares"> <divide> <unitNumerator> <measure>iso4217:USD</measure> </unitNumerator> <unitDenominator> <measure>shares</measure> </unitDenominator> </divide> </unit> <unit id="Pure"> <measure>pure</measure> </unit> <dei:EntityCentralIndexKey contextRef="From2021-07-01to2022-06-30">0001121795</dei:EntityCentralIndexKey> <dei:AmendmentFlag contextRef="From2021-07-01to2022-06-30">false</dei:AmendmentFlag> <dei:DocumentFiscalYearFocus contextRef="From2021-07-01to2022-06-30">2022</dei:DocumentFiscalYearFocus> <dei:DocumentFiscalPeriodFocus contextRef="From2021-07-01to2022-06-30">FY</dei:DocumentFiscalPeriodFocus> <us-gaap:Revenues contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0149" unitRef="USD" xsi:nil="true"/> <us-gaap:Revenues contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0150" unitRef="USD" xsi:nil="true"/> <us-gaap:UnrealizedGainOnForeignCurrencyDerivativesBeforeTax contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0165" unitRef="USD" xsi:nil="true"/> <us-gaap:InterestExpense contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0168" unitRef="USD" xsi:nil="true"/> <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0171" unitRef="USD" xsi:nil="true"/> <us-gaap:NonoperatingIncomeExpense contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0174" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30_custom_PreferredStockSeriesAMember" id="xdx2ixbrl0228" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30_custom_PreferredStockSeriesBMember" id="xdx2ixbrl0229" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0230" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0231" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2021-07-012022-06-30_custom_PreferredStockSeriesAMember" id="xdx2ixbrl0266" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2021-07-012022-06-30_custom_PreferredStockSeriesBMember" id="xdx2ixbrl0267" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0268" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0269" unitRef="USD" xsi:nil="true"/> <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0296" unitRef="USD" xsi:nil="true"/> <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0313" unitRef="USD" xsi:nil="true"/> <us-gaap:InterestPaidNet contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0346" unitRef="USD" xsi:nil="true"/> <us-gaap:InterestPaidNet contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0347" unitRef="USD" xsi:nil="true"/> <us-gaap:IncomeTaxesPaidNet contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0349" unitRef="USD" xsi:nil="true"/> <us-gaap:IncomeTaxesPaidNet contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0350" unitRef="USD" xsi:nil="true"/> <dei:DocumentType contextRef="From2021-07-01to2022-06-30">10-K</dei:DocumentType> <dei:DocumentAnnualReport contextRef="From2021-07-01to2022-06-30">true</dei:DocumentAnnualReport> <dei:DocumentPeriodEndDate contextRef="From2021-07-01to2022-06-30">2022-06-30</dei:DocumentPeriodEndDate> <dei:CurrentFiscalYearEndDate contextRef="From2021-07-01to2022-06-30">--06-30</dei:CurrentFiscalYearEndDate> <dei:DocumentTransitionReport contextRef="From2021-07-01to2022-06-30">false</dei:DocumentTransitionReport> <dei:EntityFileNumber contextRef="From2021-07-01to2022-06-30">000-31705</dei:EntityFileNumber> <dei:EntityRegistrantName contextRef="From2021-07-01to2022-06-30">GHST World Inc.</dei:EntityRegistrantName> <dei:EntityIncorporationStateCountryCode contextRef="From2021-07-01to2022-06-30">DE</dei:EntityIncorporationStateCountryCode> <dei:EntityTaxIdentificationNumber contextRef="From2021-07-01to2022-06-30">91-2007477</dei:EntityTaxIdentificationNumber> <dei:EntityAddressAddressLine1 contextRef="From2021-07-01to2022-06-30">667 Madison Avenue</dei:EntityAddressAddressLine1> <dei:EntityAddressAddressLine2 contextRef="From2021-07-01to2022-06-30">5th Floor</dei:EntityAddressAddressLine2> <dei:EntityAddressCityOrTown contextRef="From2021-07-01to2022-06-30">New York</dei:EntityAddressCityOrTown> <dei:EntityAddressStateOrProvince contextRef="From2021-07-01to2022-06-30">NY</dei:EntityAddressStateOrProvince> <dei:EntityAddressPostalZipCode contextRef="From2021-07-01to2022-06-30">10065</dei:EntityAddressPostalZipCode> <dei:CityAreaCode contextRef="From2021-07-01to2022-06-30">212</dei:CityAreaCode> <dei:LocalPhoneNumber contextRef="From2021-07-01to2022-06-30">634-6860</dei:LocalPhoneNumber> <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-07-01to2022-06-30">No</dei:EntityWellKnownSeasonedIssuer> <dei:EntityVoluntaryFilers contextRef="From2021-07-01to2022-06-30">No</dei:EntityVoluntaryFilers> <dei:EntityCurrentReportingStatus contextRef="From2021-07-01to2022-06-30">Yes</dei:EntityCurrentReportingStatus> <dei:EntityInteractiveDataCurrent contextRef="From2021-07-01to2022-06-30">Yes</dei:EntityInteractiveDataCurrent> <dei:EntityFilerCategory contextRef="From2021-07-01to2022-06-30">Non-accelerated Filer</dei:EntityFilerCategory> <dei:EntitySmallBusiness contextRef="From2021-07-01to2022-06-30">true</dei:EntitySmallBusiness> <dei:EntityEmergingGrowthCompany contextRef="From2021-07-01to2022-06-30">true</dei:EntityEmergingGrowthCompany> <dei:EntityExTransitionPeriod contextRef="From2021-07-01to2022-06-30">true</dei:EntityExTransitionPeriod> <dei:EntityShellCompany contextRef="From2021-07-01to2022-06-30">false</dei:EntityShellCompany> <dei:EntityPublicFloat contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">911327</dei:EntityPublicFloat> <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-09-22" decimals="INF" unitRef="Shares">124430534</dei:EntityCommonStockSharesOutstanding> <dei:AuditorName contextRef="From2021-07-01to2022-06-30">Ciro E. Adams, CPA, LLC</dei:AuditorName> <dei:AuditorLocation contextRef="From2021-07-01to2022-06-30">Wilmington, DE</dei:AuditorLocation> <dei:AuditorFirmId contextRef="From2021-07-01to2022-06-30">5938</dei:AuditorFirmId> <us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">206</us-gaap:Cash> <us-gaap:Cash contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7350</us-gaap:Cash> <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">206</us-gaap:AssetsCurrent> <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7350</us-gaap:AssetsCurrent> <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">115000</us-gaap:OtherAssetsNoncurrent> <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">115000</us-gaap:OtherAssetsNoncurrent> <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">39181</us-gaap:FiniteLivedPatentsGross> <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">39181</us-gaap:FiniteLivedPatentsGross> <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">154387</us-gaap:Assets> <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">161531</us-gaap:Assets> <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1685</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent> <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">14528</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent> <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">75446</us-gaap:DueToRelatedPartiesCurrent> <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16241</us-gaap:DueToRelatedPartiesCurrent> <GHST:CommonStockPayable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">9559</GHST:CommonStockPayable> <GHST:CommonStockPayable contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">217784</GHST:CommonStockPayable> <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">86690</us-gaap:LiabilitiesCurrent> <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">248553</us-gaap:LiabilitiesCurrent> <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare> <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-06-30" decimals="INF" unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare> <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized> <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized> <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares">6000</us-gaap:PreferredStockSharesIssued> <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares">6000</us-gaap:PreferredStockSharesOutstanding> <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares">6000</us-gaap:PreferredStockSharesIssued> <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares">6000</us-gaap:PreferredStockSharesOutstanding> <us-gaap:PreferredStockValue contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="0" unitRef="USD">6</us-gaap:PreferredStockValue> <us-gaap:PreferredStockValue contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" decimals="0" unitRef="USD">6</us-gaap:PreferredStockValue> <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares">2200</us-gaap:PreferredStockSharesIssued> <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares">2200</us-gaap:PreferredStockSharesOutstanding> <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares">2200</us-gaap:PreferredStockSharesIssued> <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares">2200</us-gaap:PreferredStockSharesOutstanding> <us-gaap:PreferredStockValue contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="0" unitRef="USD">2</us-gaap:PreferredStockValue> <us-gaap:PreferredStockValue contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" decimals="0" unitRef="USD">2</us-gaap:PreferredStockValue> <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare> <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-06-30" decimals="INF" unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare> <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">124430534</us-gaap:CommonStockSharesIssued> <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">5239832</us-gaap:CommonStockSharesIssued> <us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">124431</us-gaap:CommonStockValue> <us-gaap:CommonStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5240</us-gaap:CommonStockValue> <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">9362205</us-gaap:AdditionalPaidInCapital> <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9174792</us-gaap:AdditionalPaidInCapital> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-9418947</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-9267062</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">67697</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-87022</us-gaap:StockholdersEquity> <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">154387</us-gaap:LiabilitiesAndStockholdersEquity> <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">161531</us-gaap:LiabilitiesAndStockholdersEquity> <us-gaap:GeneralAndAdministrativeExpense contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">150702</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">151366</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:OperatingExpenses contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">150702</us-gaap:OperatingExpenses> <us-gaap:OperatingExpenses contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">151366</us-gaap:OperatingExpenses> <us-gaap:UnrealizedGainOnForeignCurrencyDerivativesBeforeTax contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">667</us-gaap:UnrealizedGainOnForeignCurrencyDerivativesBeforeTax> <us-gaap:InterestExpense contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">150</us-gaap:InterestExpense> <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-1700</us-gaap:FairValueOptionChangesInFairValueGainLoss1> <us-gaap:NonoperatingIncomeExpense contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-1183</us-gaap:NonoperatingIncomeExpense> <us-gaap:NetIncomeLoss contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-151885</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-151366</us-gaap:NetIncomeLoss> <us-gaap:EarningsPerShareBasic contextRef="From2021-07-01to2022-06-30" decimals="INF" unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic> <us-gaap:EarningsPerShareBasic contextRef="From2020-07-012021-06-30" decimals="INF" unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareBasic> <us-gaap:EarningsPerShareDiluted contextRef="From2021-07-01to2022-06-30" decimals="INF" unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareDiluted> <us-gaap:EarningsPerShareDiluted contextRef="From2020-07-012021-06-30" decimals="INF" unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareDiluted> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2021-07-01to2022-06-30" decimals="INF" unitRef="Shares">54032711</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2020-07-012021-06-30" decimals="INF" unitRef="Shares">4760534</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2021-07-01to2022-06-30" decimals="INF" unitRef="Shares">54032711</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2020-07-012021-06-30" decimals="INF" unitRef="Shares">4760534</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2020-06-30_custom_PreferredStockSeriesAMember" decimals="INF" unitRef="Shares">6000</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_custom_PreferredStockSeriesAMember" decimals="0" unitRef="USD">6</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2020-06-30_custom_PreferredStockSeriesBMember" decimals="INF" unitRef="Shares">2200</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_custom_PreferredStockSeriesBMember" decimals="0" unitRef="USD">2</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">3980176</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">3980</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">9002643</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD">-9115696</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-109065</us-gaap:StockholdersEquity> <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">1009656</us-gaap:StockIssuedDuringPeriodSharesOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">1010</us-gaap:StockIssuedDuringPeriodValueOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">147468</us-gaap:StockIssuedDuringPeriodValueOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">148478</us-gaap:StockIssuedDuringPeriodValueOther> <GHST:IssuanceOfSharesInExchangeOfDebtShares contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">250000</GHST:IssuanceOfSharesInExchangeOfDebtShares> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">250</GHST:IssuanceOfSharesInExchangeOfDebt> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">24681</GHST:IssuanceOfSharesInExchangeOfDebt> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">24931</GHST:IssuanceOfSharesInExchangeOfDebt> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD">-151366</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-151366</us-gaap:NetIncomeLoss> <us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_custom_PreferredStockSeriesAMember" decimals="INF" unitRef="Shares">6000</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_custom_PreferredStockSeriesAMember" decimals="0" unitRef="USD">6</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_custom_PreferredStockSeriesBMember" decimals="INF" unitRef="Shares">2200</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_custom_PreferredStockSeriesBMember" decimals="0" unitRef="USD">2</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">5239832</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">5240</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">9174792</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD">-9267062</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-87022</us-gaap:StockholdersEquity> <GHST:IssuanceOfSharesInExchangeOfDebtShares contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">118663761</GHST:IssuanceOfSharesInExchangeOfDebtShares> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">118664</GHST:IssuanceOfSharesInExchangeOfDebt> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">106595</GHST:IssuanceOfSharesInExchangeOfDebt> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">225259</GHST:IssuanceOfSharesInExchangeOfDebt> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">526941</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">527</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">80818</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">81345</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:NetIncomeLoss contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD">-151885</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-151885</us-gaap:NetIncomeLoss> <us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_custom_PreferredStockSeriesAMember" decimals="INF" unitRef="Shares">6000</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_custom_PreferredStockSeriesAMember" decimals="0" unitRef="USD">6</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_custom_PreferredStockSeriesBMember" decimals="INF" unitRef="Shares">2200</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_custom_PreferredStockSeriesBMember" decimals="0" unitRef="USD">2</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">124430534</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD">124431</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD">9362205</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD">-9418947</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">67697</us-gaap:StockholdersEquity> <us-gaap:NetIncomeLoss contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-151885</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-151366</us-gaap:NetIncomeLoss> <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-1700</us-gaap:FairValueOptionChangesInFairValueGainLoss1> <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-12843</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">7436</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-163028</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-143930</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-0</us-gaap:PaymentsToAcquireIntangibleAssets> <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">7395</us-gaap:PaymentsToAcquireIntangibleAssets> <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-7395</us-gaap:NetCashProvidedByUsedInInvestingActivities> <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">59205</us-gaap:ProceedsFromRelatedPartyDebt> <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">7905</us-gaap:ProceedsFromRelatedPartyDebt> <us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">15334</us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock> <us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">2000</us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock> <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">81345</us-gaap:ProceedsFromIssuanceOfCommonStock> <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">148478</us-gaap:ProceedsFromIssuanceOfCommonStock> <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">155884</us-gaap:NetCashProvidedByUsedInFinancingActivities> <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">158383</us-gaap:NetCashProvidedByUsedInFinancingActivities> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-7144</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">7058</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7350</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">292</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">206</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7350</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <GHST:IssuanceOfCommonStockInExchangeForDebt contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">225259</GHST:IssuanceOfCommonStockInExchangeForDebt> <GHST:IssuanceOfCommonStockInExchangeForDebt contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">24931</GHST:IssuanceOfCommonStockInExchangeForDebt> <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zxGhKiIo8uYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1- <span id="xdx_827_zLZ9lgVQO2hl">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Background </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GHST World Inc. (“the Company”), is a Delaware corporation that was incorporated on November 12, 1999.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a holding company for various technology and other activities. The Company has acquired and is developing several patents in the technology sector.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock> <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zIzOvYRvRMk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 – <span id="xdx_82B_zXuVV6K2AFib">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_844_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z2FoL3yYz4eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zeHWc3LWuds8">Liquidity and Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had a net losses of <span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20210701__20220630_zmz8MSvXZmq5" title="Net loss">151,885</span> and $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20200701__20210630_zZd1dIau7cM8" title="Net loss">151,366</span> for the years ended June 30, 2022 and 2021. The Company has an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zAVVM7emf5nl" title="Accumulated deficit">9,418,947</span> and a stockholders’ equity of $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_pp0p0_c20220630_zcc3vDg7HoE1" title="Stockholders' Deficit">67,697</span> as of June 30, 2022 and used $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20220630_zAyQn2euDP3f" title="Cash Used In Operating Activities">163,028</span> and $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zqebNGRH7yd2" title="Cash Used In Operating Activities">143,930</span> in cash flow from operating activities for the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders and from the possible sale of a minority interest in its subsidiaries. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zsgfZ1XuwvWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_869_zSz2CbUibQM4">Principles of Consolidation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the following wholly owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Art World, Inc</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Sport Inc.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">IoTT world Inc.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z3HpBf7G8lca" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zWHfRkVzZct9">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSOnFowtP8li" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zNrK5RML5r6">Foreign Currency</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p id="xdx_847_eus-gaap--UseOfEstimates_ziCkLWZVNIOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_860_zg2FmSDz8Fq5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such estimates and assumptions impact, among others, the following: the fair value of share-based payments and deferred taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b> </b></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9ZXW0XWvqPl" style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b><span id="xdx_869_zni92yQAP89j">Cash</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt">Cash are amounts held at local banks. The Company had <span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zk9vQTJrYiz3" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20210630_z95bfoqoVx03" title="Cash equivalents">no</span></span> cash equivalents at June 30, 2022 or 2021.</p> <p id="xdx_84E_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zAZigSwjiU4i" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_862_z5vkkg5EQuGi">Risks and Uncertainties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.</p> <p id="xdx_84A_ecustom--FairValuePolicyTextBlock_zkk2cPE36D27" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_867_zrqvUP8ZogV2">Fair Value</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 0pt; text-align: justify">The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has <span id="xdx_90D_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20210701__20220630_zbnBi5hDGppe" title="Fair value of assets and liabilities measured on recurring basis"><span id="xdx_903_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20200701__20210630_zhSRINs9lcq7" title="Fair value of assets and liabilities measured on recurring basis">no</span></span> assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zayaPPSTDd21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zLQiEhUtGhwk">Impairment of Long-Lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets consist primarily of property, plant and equipment. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. As of June 30, 2022 and 2021, the Company did <span id="xdx_907_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210701__20220630_zYDiNY71uM76" title="Impairment losses"><span id="xdx_909_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20200701__20210630_zYD4jAjFrATd" title="Impairment losses">no</span></span>t recognize any impairment losses.</p> <p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zzhzy2Ls5vE3" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_864_ztyHlZLJpcV3">Intangible Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. The Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over ten years, which represents the estimated useful lives of the patents. The ten-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. For the years ended June 30, 2022 and 2021 the Company has capitalized $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20210701__20220630_zStcLwqFZZag" title="Patent costs">0</span>, and $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20200701__20210630_zDNvihKasFv2" title="Patent costs">7,395</span> of patent costs. As of June 30, 2022 and 2021, patent cost totaled $<span id="xdx_903_eus-gaap--FiniteLivedPatentsGross_c20220630_pp0p0" title="Total Patent costs"><span id="xdx_900_eus-gaap--FiniteLivedPatentsGross_c20210630_pp0p0" title="Total Patent costs">39,181</span></span>.</p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zAnGSnDqIfh1" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_863_zP885dFnuvBc">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company’s tax returns are subject to examination by federal and state taxing authorities for the years ended June 30, 2018 through 2021. However, the Company's federal net operating losses for tax years ending June 30, 2021 and 2022 will remain subject to examination until the losses are utilized or expire. Under the Tax Cuts and Jobs Act (“TCJA”), which was enacted on December 22, 2017, Net Operating Losses (“NOLs”) incurred for tax years beginning before January 1, 2018, will be able to be carried forward for 20 years. For NOLs incurred in tax years beginning after December 31, 2017, these NOLs will be subject to the new limitations imposed by TCJA. Under the new law, an NOL can offset only 80% of taxable income in any given tax year. Furthermore, NOLs can no longer be carried back, they must be carried forward. The 20-year carryforward period has been replaced with an indefinite carryforward period for NOLs incurred for tax years beginning after December 31, 2017. The NOL carryforwards for the periods ended June 30, 2022 and 2021 are approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220630_zsmgMB36oBg1" title="Net loss carryforwards">152,000</span> and $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net loss carryforwards">151,000</span>, respectively and the total NOL carryforward to the year ended June 30, 2022 is approximately $2.8 million. At June 30, 2022, a valuation allowance fully offsets any tax benefit from these NOLs carryforard.</p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAQGU9opKyE8" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86C_zNwMskVMNdi8">Stock Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company applies the fair value method of ASC 718, Share Based Payment, formerly Statement of Financial Accounting Standards ("SFAS") No. l23R "Accounting for Stock Based Compensation", in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.</p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z4dMRpgH54Vh" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86A_zrO4Ao76rwYc">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt">There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.</p> </us-gaap:SignificantAccountingPoliciesTextBlock> <GHST:LiquidityAndGoingConcernPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_844_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z2FoL3yYz4eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86D_zeHWc3LWuds8">Liquidity and Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had a net losses of <span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20210701__20220630_zmz8MSvXZmq5" title="Net loss">151,885</span> and $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20200701__20210630_zZd1dIau7cM8" title="Net loss">151,366</span> for the years ended June 30, 2022 and 2021. The Company has an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zAVVM7emf5nl" title="Accumulated deficit">9,418,947</span> and a stockholders’ equity of $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_pp0p0_c20220630_zcc3vDg7HoE1" title="Stockholders' Deficit">67,697</span> as of June 30, 2022 and used $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20220630_zAyQn2euDP3f" title="Cash Used In Operating Activities">163,028</span> and $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zqebNGRH7yd2" title="Cash Used In Operating Activities">143,930</span> in cash flow from operating activities for the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders and from the possible sale of a minority interest in its subsidiaries. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </GHST:LiquidityAndGoingConcernPolicyTextBlock> <us-gaap:NetIncomeLoss contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-151885</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-151366</us-gaap:NetIncomeLoss> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-9418947</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">67697</us-gaap:StockholdersEquity> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-163028</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">-143930</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zsgfZ1XuwvWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_869_zSz2CbUibQM4">Principles of Consolidation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the following wholly owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Art World, Inc</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">GHST Sport Inc.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-size: 10pt">IoTT world Inc.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </us-gaap:ConsolidationPolicyTextBlock> <us-gaap:ConcentrationRiskCreditRisk contextRef="From2021-07-01to2022-06-30"><p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z3HpBf7G8lca" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zWHfRkVzZct9">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> </us-gaap:ConcentrationRiskCreditRisk> <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSOnFowtP8li" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zNrK5RML5r6">Foreign Currency</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock> <us-gaap:UseOfEstimates contextRef="From2021-07-01to2022-06-30"><p id="xdx_847_eus-gaap--UseOfEstimates_ziCkLWZVNIOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_860_zg2FmSDz8Fq5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such estimates and assumptions impact, among others, the following: the fair value of share-based payments and deferred taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b> </b></p> </us-gaap:UseOfEstimates> <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9ZXW0XWvqPl" style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b><span id="xdx_869_zni92yQAP89j">Cash</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt">Cash are amounts held at local banks. The Company had <span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zk9vQTJrYiz3" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20210630_z95bfoqoVx03" title="Cash equivalents">no</span></span> cash equivalents at June 30, 2022 or 2021.</p> </us-gaap:CashAndCashEquivalentsPolicyTextBlock> <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue> <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue> <us-gaap:UnusualRisksAndUncertaintiesTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_84E_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zAZigSwjiU4i" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_862_z5vkkg5EQuGi">Risks and Uncertainties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.</p> </us-gaap:UnusualRisksAndUncertaintiesTextBlock> <GHST:FairValuePolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_84A_ecustom--FairValuePolicyTextBlock_zkk2cPE36D27" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_867_zrqvUP8ZogV2">Fair Value</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 0pt; text-align: justify">The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 1.5pc"/><td style="width: 1.5pc"><span style="font-family: Symbol; font-size: 10pt">·</span></td><td style="text-align: left"><span style="font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has <span id="xdx_90D_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20210701__20220630_zbnBi5hDGppe" title="Fair value of assets and liabilities measured on recurring basis"><span id="xdx_903_eus-gaap--FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_do_c20200701__20210630_zhSRINs9lcq7" title="Fair value of assets and liabilities measured on recurring basis">no</span></span> assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the years ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> </GHST:FairValuePolicyTextBlock> <us-gaap:FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">0</us-gaap:FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss> <us-gaap:FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">0</us-gaap:FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss> <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zayaPPSTDd21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zLQiEhUtGhwk">Impairment of Long-Lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets consist primarily of property, plant and equipment. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. As of June 30, 2022 and 2021, the Company did <span id="xdx_907_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210701__20220630_zYDiNY71uM76" title="Impairment losses"><span id="xdx_909_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20200701__20210630_zYD4jAjFrATd" title="Impairment losses">no</span></span>t recognize any impairment losses.</p> </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock> <us-gaap:GoodwillImpairmentLoss contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">0</us-gaap:GoodwillImpairmentLoss> <us-gaap:GoodwillImpairmentLoss contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">0</us-gaap:GoodwillImpairmentLoss> <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2021-07-01to2022-06-30"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zzhzy2Ls5vE3" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_864_ztyHlZLJpcV3">Intangible Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. The Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over ten years, which represents the estimated useful lives of the patents. The ten-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. For the years ended June 30, 2022 and 2021 the Company has capitalized $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20210701__20220630_zStcLwqFZZag" title="Patent costs">0</span>, and $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp0p0_c20200701__20210630_zDNvihKasFv2" title="Patent costs">7,395</span> of patent costs. As of June 30, 2022 and 2021, patent cost totaled $<span id="xdx_903_eus-gaap--FiniteLivedPatentsGross_c20220630_pp0p0" title="Total Patent costs"><span id="xdx_900_eus-gaap--FiniteLivedPatentsGross_c20210630_pp0p0" title="Total Patent costs">39,181</span></span>.</p> </us-gaap:IntangibleAssetsFiniteLivedPolicy> <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">0</us-gaap:PaymentsToAcquireIntangibleAssets> <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">7395</us-gaap:PaymentsToAcquireIntangibleAssets> <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">39181</us-gaap:FiniteLivedPatentsGross> <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">39181</us-gaap:FiniteLivedPatentsGross> <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zAnGSnDqIfh1" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_863_zP885dFnuvBc">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company measures and recognizes the tax implications of positions taken or expected to be taken in its tax returns on an ongoing basis. The Company’s tax returns are subject to examination by federal and state taxing authorities for the years ended June 30, 2018 through 2021. However, the Company's federal net operating losses for tax years ending June 30, 2021 and 2022 will remain subject to examination until the losses are utilized or expire. Under the Tax Cuts and Jobs Act (“TCJA”), which was enacted on December 22, 2017, Net Operating Losses (“NOLs”) incurred for tax years beginning before January 1, 2018, will be able to be carried forward for 20 years. For NOLs incurred in tax years beginning after December 31, 2017, these NOLs will be subject to the new limitations imposed by TCJA. Under the new law, an NOL can offset only 80% of taxable income in any given tax year. Furthermore, NOLs can no longer be carried back, they must be carried forward. The 20-year carryforward period has been replaced with an indefinite carryforward period for NOLs incurred for tax years beginning after December 31, 2017. The NOL carryforwards for the periods ended June 30, 2022 and 2021 are approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220630_zsmgMB36oBg1" title="Net loss carryforwards">152,000</span> and $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net loss carryforwards">151,000</span>, respectively and the total NOL carryforward to the year ended June 30, 2022 is approximately $2.8 million. At June 30, 2022, a valuation allowance fully offsets any tax benefit from these NOLs carryforard.</p> </us-gaap:IncomeTaxPolicyTextBlock> <us-gaap:OperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">152000</us-gaap:OperatingLossCarryforwards> <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">151000</us-gaap:OperatingLossCarryforwards> <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-07-01to2022-06-30"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zAQGU9opKyE8" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86C_zNwMskVMNdi8">Stock Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company applies the fair value method of ASC 718, Share Based Payment, formerly Statement of Financial Accounting Standards ("SFAS") No. l23R "Accounting for Stock Based Compensation", in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.</p> </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy> <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z4dMRpgH54Vh" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b><span id="xdx_86A_zrO4Ao76rwYc">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt">There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.</p> </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock> <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zMEpLJXr0ftg" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 3 – <span id="xdx_820_zFENBecNv2de">PATENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company obtained a patent dated June 30, 2020, which is a protection device used in sporting activity with the capability to monitor data from the device. The Company has capitalized the patent costs totaling $<span id="xdx_90C_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20220630_z8Ul69jBpI72" title="Patent costs"><span id="xdx_905_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20210630_z7ML6ojRBu07" title="Patent costs">39,181</span></span>, at June 30, 2022 and 2021. The Company will amortize the patent over the useful life of the patent once it is placed in service. <span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20210701__20220630_zQ5NpmtuW7q7" title="Amortization of intangible assets"><span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20200701__20210630_zQynfPKUoZOk" title="Amortization of intangible assets">No</span></span> amortization was recorded for the years ended June 30, 2022 and 2021.</p> </us-gaap:IntangibleAssetsDisclosureTextBlock> <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">39181</us-gaap:FiniteLivedPatentsGross> <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">39181</us-gaap:FiniteLivedPatentsGross> <us-gaap:AmortizationOfIntangibleAssets contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets> <us-gaap:AmortizationOfIntangibleAssets contextRef="From2020-07-012021-06-30" decimals="0" unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets> <GHST:CommonStockPayableTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_804_ecustom--CommonStockPayableTextBlock_z27XqMHEyjXl" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 4 – <span id="xdx_825_zKSroEyrARZ6">COMMON STOCK PAYABLE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company has an agreement with certain investors to convert their investment into common stock of the Company at a price equal to the average value of the stock over the previous six months. The conversion is contingent on the Company effectuating a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20210902__20210930_zdhArBQDIgfe" title="Reverse stock split">1-for-100 reverse stock split</span> which was effected on September 30, 2021. As of June 30, 2022, and June 30, 2021, the Company has a total of $<span id="xdx_90C_ecustom--CommonStockReceived_iI_pp0p0_c20220630_z5uQoDW6Thvg" title="Common stock received">9,559</span> and $<span id="xdx_90F_ecustom--CommonStockReceived_iI_pp0p0_c20210630_z1yRkZB18Jjb" title="Common stock received">217,784</span> that has not been converted to common stock. During the year ended June 30, 2022 certain investors agreed to accept a total of <span id="xdx_909_ecustom--IssuanceOfSharesInExchangeOfDebtShares_c20210701__20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_z0wIrHhuSANd" title="Issuance of shares in exchange of debt, shares">118,663,761</span> shares at an average price of approximately $<span id="xdx_90C_eus-gaap--SharePrice_iI_c20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_zkStJ8U8Pkb6" title="Share price">0.0019</span> in exchange for $<span id="xdx_908_ecustom--IssuanceOfSharesInExchangeOfDebt_pp0p0_c20210701__20220630__srt--CounterpartyNameAxis__us-gaap--InvestorMember_zdLy4vnQA0Y1" title="Issuance of shares in exchange of debt">225,259</span> of debt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company recorded a common stock payable in 2018 for an agreement in which the Company agreed to issue <span id="xdx_906_ecustom--CommonStockPayableShares_iI_c20180630_zz3fF0qVCYE" title="Common stock payable, number of shares to be issued in exchange for patent">2,000,000</span> shares of post-split stock in exchange for the patent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company recorded this at $<span id="xdx_909_ecustom--CommonStockPayablePerShareValue_iI_c20180630_zvmJbeT4R3i6" title="Common stock payable per share value">0.001</span> or $<span id="xdx_906_ecustom--CommonStockPayableValue_iI_pp0p0_c20180630_zi6KI24oiin8" title="Common stock payable">2,000</span>. The Company valued the stock at the six-month average which was $<span id="xdx_902_ecustom--CommonStockPayablePerShareValue_iI_c20220630_zbYw66QoTrtl" title="Common stockpayable per share value">0.00185</span> per share or $<span id="xdx_909_ecustom--CommonStockPayableValue_iI_pp0p0_c20220630_zA0Mym1U5A1i" title="Common stock payable">3,700</span>. As a result the Company recognized a market value adjustment on the accompanying Income Statement of $<span id="xdx_905_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_iN_pp0p0_di_c20210701__20220630_zxjiFafoaL1k" title="Fair Value, Option, Changes in Fair Value, Gain (Loss)">1,700</span> for year ended June 30, 2022.</p> </GHST:CommonStockPayableTextBlock> <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2021-09-022021-09-30">1-for-100 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit> <GHST:CommonStockReceived contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">9559</GHST:CommonStockReceived> <GHST:CommonStockReceived contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">217784</GHST:CommonStockReceived> <GHST:IssuanceOfSharesInExchangeOfDebtShares contextRef="From2021-07-012022-06-30_us-gaap_InvestorMember" decimals="INF" unitRef="Shares">118663761</GHST:IssuanceOfSharesInExchangeOfDebtShares> <us-gaap:SharePrice contextRef="AsOf2022-06-30_us-gaap_InvestorMember" decimals="INF" unitRef="USDPShares">0.0019</us-gaap:SharePrice> <GHST:IssuanceOfSharesInExchangeOfDebt contextRef="From2021-07-012022-06-30_us-gaap_InvestorMember" decimals="0" unitRef="USD">225259</GHST:IssuanceOfSharesInExchangeOfDebt> <GHST:CommonStockPayableShares contextRef="AsOf2018-06-30" decimals="INF" unitRef="Shares">2000000</GHST:CommonStockPayableShares> <GHST:CommonStockPayablePerShareValue contextRef="AsOf2018-06-30" decimals="INF" unitRef="USDPShares">0.001</GHST:CommonStockPayablePerShareValue> <GHST:CommonStockPayableValue contextRef="AsOf2018-06-30" decimals="0" unitRef="USD">2000</GHST:CommonStockPayableValue> <GHST:CommonStockPayablePerShareValue contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares">0.00185</GHST:CommonStockPayablePerShareValue> <GHST:CommonStockPayableValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3700</GHST:CommonStockPayableValue> <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">-1700</us-gaap:FairValueOptionChangesInFairValueGainLoss1> <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztGax7FCfFxj" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify"><b>NOTE 5 – <span id="xdx_82F_zkHK3OOLTPL3">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">At June 30, 2022 and 2021, the Company owed related parties a total of $<span id="xdx_909_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20220630_pp0p0" title="Advances from related parties">75,446</span> and $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20210630_pp0p0" title="Advances from related parties">16,241</span>. These shareholder loans are unsecured, non-interest bearing and are due on demand. See Note 4 as these amounts that will be converted to common stock..</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">As shown in Note 4, the Company has committed to converting certain debts to equity. Included in the debts is $<span id="xdx_906_ecustom--CommonStockPayableRelatedParties_c20220630_pp0p0" title="Common stock payable - related parties">9,558</span> as of June 30, 2022 of amounts due to related parties that will also be converted as described in Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">These transactions were in the normal course of operations and were measured at a value that represents the amount of consideration established and agreed to by the related parties.</p> </us-gaap:RelatedPartyTransactionsDisclosureTextBlock> <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">75446</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent> <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16241</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent> <GHST:CommonStockPayableRelatedParties contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">9558</GHST:CommonStockPayableRelatedParties> <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zh3dtgW7G0w2" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 6 – <span id="xdx_827_z7YtYdJo3r8h">STOCKHOLDERS’ EQUITY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210807_zrSAfoGlG2aj" title="Common Stock, Shares Authorized">310,000,000</span> of which <span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20210807_pdd" title="Common stock reserve">300,000,000</span> are reserved for common stock and <span id="xdx_90A_eus-gaap--PreferredStockCapitalSharesReservedForFutureIssuance_c20210807_pdd" title="Preferred stock reserve">10,000,000</span> for preferred stock. The amendment was effective on September 9, 2021. Effective on September 30, 2021, the Company effectuated a <span id="xdx_906_eus-gaap--StockholdersEquityNoteStockSplit_c20210701__20220630" title="Revese stock split">100-1 reverse stock split</span>. All per share amounts have been retroactively restated to reflect the split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>Common Stock Issuances</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0pt 1.4pt; text-align: justify">During the year ended June 30, 2022 the Company issued a total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210701__20220630_pdd" title="Issuance of shares">118,663,761</span> shares at an average price of approximately $<span id="xdx_909_eus-gaap--SharePrice_c20220630_pdd" title="Price per share">0.0019</span> in exchange for $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210701__20220630_pp0p0" title="Exchange of debt">225,259</span> (See Note 4) and sold <span id="xdx_904_ecustom--SaleOfStockNumberOfShareIssuedInTransaction_c20210701__20220630_pdd" title="Sale of stock">526,941</span> shares in exchange for $<span id="xdx_907_ecustom--SharesToExchangeValue_c20210701__20220630_pp0p0" title="Exchange value">81,345</span> at an average price of $<span id="xdx_903_eus-gaap--SharePrice_iI_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhVkaR40pSG6" title="Price per share">0.15</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> </us-gaap:StockholdersEquityNoteDisclosureTextBlock> <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-08-07" decimals="INF" unitRef="Shares">310000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2021-08-07" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance> <us-gaap:PreferredStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2021-08-07" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockCapitalSharesReservedForFutureIssuance> <us-gaap:StockholdersEquityNoteStockSplit contextRef="From2021-07-01to2022-06-30">100-1 reverse stock split</us-gaap:StockholdersEquityNoteStockSplit> <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2021-07-01to2022-06-30" decimals="INF" unitRef="Shares">118663761</us-gaap:StockIssuedDuringPeriodSharesOther> <us-gaap:SharePrice contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares">0.0019</us-gaap:SharePrice> <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">225259</us-gaap:DebtConversionConvertedInstrumentAmount1> <GHST:SaleOfStockNumberOfShareIssuedInTransaction contextRef="From2021-07-01to2022-06-30" decimals="INF" unitRef="Shares">526941</GHST:SaleOfStockNumberOfShareIssuedInTransaction> <GHST:SharesToExchangeValue contextRef="From2021-07-01to2022-06-30" decimals="0" unitRef="USD">81345</GHST:SharesToExchangeValue> <us-gaap:SharePrice contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares">0.15</us-gaap:SharePrice> <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zOB4G23Rw0Q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 7 – <span id="xdx_825_zGUyd1IPfZf6">INCOME TAXES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">The Company has accumulated losses of approximately <span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_z8BaLvXfoDYj" style="display: none" title="Accumulated losses">9,418,947</span> 9.4 million since its inception. For income tax purposes, <span id="xdx_90E_ecustom--OperatingLossDescription_c20210701__20220630_zevn5qHsGrbb" title="Operating loss Description">the Company has operating loss carryforwards of approximately $<span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_dm_c20220630_zn0fmYHIHCLb" title="Operating loss carryforwards">2.8</span> million from tax years beginning before January 1, 2021, that begin to expire in 2027. These operating losses are subject to the limitations which were enacted in the Tax Cuts and Jobs Act (“TCJA”).</span> These operating losses can offset only 80% of taxable income in any given tax year. The carryover period for these operating losses is indefinite. No federal or state tax asset has been reported in the financial statements, because the Company believes there is a 50% or greater chance that the carryforwards will expire unused. Accordingly, the potential tax benefits of the loss carryforwards (approximately $<span id="xdx_903_eus-gaap--OperatingLossCarryforwardsValuationAllowance_c20220630_pp0p0" title="Operating loss carryforwards valuation allowance">700,000</span>) have been offset by a valuation allowance of the same amount.</p> </us-gaap:IncomeTaxDisclosureTextBlock> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-9418947</us-gaap:RetainedEarningsAccumulatedDeficit> <GHST:OperatingLossDescription contextRef="From2021-07-01to2022-06-30">the Company has operating loss carryforwards of approximately $2.8 million from tax years beginning before January 1, 2021, that begin to expire in 2027. These operating losses are subject to the limitations which were enacted in the Tax Cuts and Jobs Act (“TCJA”).</GHST:OperatingLossDescription> <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards> <us-gaap:OperatingLossCarryforwardsValuationAllowance contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">700000</us-gaap:OperatingLossCarryforwardsValuationAllowance> <us-gaap:SubsequentEventsTextBlock contextRef="From2021-07-01to2022-06-30"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z7c1jybkHcyg" style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt"><b>NOTE 8 – <span id="xdx_823_zb02XiHuYWP5">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: justify">On August 18, 2022, the Company sold <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220801__20220818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziCtLCNld9cf" title="Stock Issued During Period, Shares, New Issues">296,640</span> shares of common stock for cash proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20220801__20220818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrRDGRcJ8ZE2" title="Proceeds from Issuance or Sale of Equity">29,664</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 11.5pt 0 1.4pt; text-align: center">*****</p> </us-gaap:SubsequentEventsTextBlock> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-08-012022-08-18_us-gaap_SubsequentEventMember" decimals="INF" unitRef="Shares">296640</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2022-08-012022-08-18_us-gaap_SubsequentEventMember" decimals="0" unitRef="USD">29664</us-gaap:ProceedsFromIssuanceOrSaleOfEquity> </xbrl> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>37 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> begin 644 Financial_Report.xlsx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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>38 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>39 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>40 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version='1.0' encoding='utf-8'?> <FilingSummary> <Version>3.22.2.2</Version> <ProcessingTime/> <ReportFormat>html</ReportFormat> <ContextCount>42</ContextCount> <ElementCount>132</ElementCount> <EntityCount>1</EntityCount> <FootnotesReported>false</FootnotesReported> <SegmentCount>9</SegmentCount> <ScenarioCount>0</ScenarioCount> <TuplesReported>false</TuplesReported> <UnitCount>4</UnitCount> <MyReports> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R1.htm</HtmlFileName> <LongName>00000001 - Document - Cover</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/Cover</Role> <ShortName>Cover</ShortName> <MenuCategory>Cover</MenuCategory> <Position>1</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R2.htm</HtmlFileName> <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/BalanceSheets</Role> <ShortName>Consolidated Balance Sheets</ShortName> <MenuCategory>Statements</MenuCategory> <Position>2</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R3.htm</HtmlFileName> <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/BalanceSheetsParenthetical</Role> <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName> <MenuCategory>Statements</MenuCategory> <Position>3</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R4.htm</HtmlFileName> <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/StatementsOfOperations</Role> <ShortName>Consolidated Statements of Operations</ShortName> <MenuCategory>Statements</MenuCategory> <Position>4</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R5.htm</HtmlFileName> <LongName>00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit</Role> <ShortName>Consolidated Statement of Changes in Stockholders' Deficit</ShortName> <MenuCategory>Statements</MenuCategory> <Position>5</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R6.htm</HtmlFileName> <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/StatementsOfCashFlows</Role> <ShortName>Consolidated Statements of Cash Flows</ShortName> <MenuCategory>Statements</MenuCategory> <Position>6</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R7.htm</HtmlFileName> <LongName>00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness</Role> <ShortName>ORGANIZATION AND DESCRIPTION OF BUSINESS</ShortName> <MenuCategory>Notes</MenuCategory> <Position>7</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R8.htm</HtmlFileName> <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies</Role> <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName> <MenuCategory>Notes</MenuCategory> <Position>8</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R9.htm</HtmlFileName> <LongName>00000009 - Disclosure - PATENTS</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/Patents</Role> <ShortName>PATENTS</ShortName> <MenuCategory>Notes</MenuCategory> <Position>9</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R10.htm</HtmlFileName> <LongName>00000010 - Disclosure - COMMON STOCK PAYABLE</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/CommonStockPayable</Role> <ShortName>COMMON STOCK PAYABLE</ShortName> <MenuCategory>Notes</MenuCategory> <Position>10</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R11.htm</HtmlFileName> <LongName>00000011 - Disclosure - RELATED PARTY TRANSACTIONS</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/RelatedPartyTransactions</Role> <ShortName>RELATED PARTY TRANSACTIONS</ShortName> <MenuCategory>Notes</MenuCategory> <Position>11</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R12.htm</HtmlFileName> <LongName>00000012 - Disclosure - STOCKHOLDERS??? EQUITY</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/StockholdersEquity</Role> <ShortName>STOCKHOLDERS??? EQUITY</ShortName> <MenuCategory>Notes</MenuCategory> <Position>12</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R13.htm</HtmlFileName> <LongName>00000013 - Disclosure - INCOME TAXES</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/IncomeTaxes</Role> <ShortName>INCOME TAXES</ShortName> <MenuCategory>Notes</MenuCategory> <Position>13</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R14.htm</HtmlFileName> <LongName>00000014 - Disclosure - SUBSEQUENT EVENTS</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/SubsequentEvents</Role> <ShortName>SUBSEQUENT EVENTS</ShortName> <MenuCategory>Notes</MenuCategory> <Position>14</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R15.htm</HtmlFileName> <LongName>00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role> <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName> <MenuCategory>Policies</MenuCategory> <Position>15</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R16.htm</HtmlFileName> <LongName>00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role> <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole> <Position>16</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R17.htm</HtmlFileName> <LongName>00000017 - Disclosure - PATENTS (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/PatentsDetailsNarrative</Role> <ShortName>PATENTS (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/Patents</ParentRole> <Position>17</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R18.htm</HtmlFileName> <LongName>00000018 - Disclosure - COMMON STOCK PAYABLE (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/CommonStockPayableDetailsNarrative</Role> <ShortName>COMMON STOCK PAYABLE (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/CommonStockPayable</ParentRole> <Position>18</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R19.htm</HtmlFileName> <LongName>00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative</Role> <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/RelatedPartyTransactions</ParentRole> <Position>19</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R20.htm</HtmlFileName> <LongName>00000020 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/StockholdersEquityDetailsNarrative</Role> <ShortName>STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/StockholdersEquity</ParentRole> <Position>20</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R21.htm</HtmlFileName> <LongName>00000021 - Disclosure - INCOME TAXES (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/IncomeTaxesDetailsNarrative</Role> <ShortName>INCOME TAXES (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/IncomeTaxes</ParentRole> <Position>21</Position> </Report> <Report instance="ghst_10k.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R22.htm</HtmlFileName> <LongName>00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://ghstworld.com/role/SubsequentEventsDetailsNarrative</Role> <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://ghstworld.com/role/SubsequentEvents</ParentRole> <Position>22</Position> </Report> <Report> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <LongName>All Reports</LongName> <ReportType>Book</ReportType> <ShortName>All Reports</ShortName> </Report> </MyReports> <InputFiles> <File doctype="10-K" original="ghst_10k.htm">ghst_10k.htm</File> <File>ghst-20220630.xsd</File> <File>ghst-20220630_cal.xml</File> <File>ghst-20220630_def.xml</File> <File>ghst-20220630_lab.xml</File> <File>ghst-20220630_pre.xml</File> <File>ghst_ex31z1.htm</File> <File>ghst_ex31z2a.htm</File> <File>ghst_ex31z2b.htm</File> <File>ghst_ex32z1.htm</File> </InputFiles> <SupplementalFiles> <File>image_004.jpg</File> <File>image_005.jpg</File> <File>image_006.jpg</File> </SupplementalFiles> <BaseTaxonomies> <BaseTaxonomy items="207">http://fasb.org/us-gaap/2022</BaseTaxonomy> <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2022</BaseTaxonomy> </BaseTaxonomies> <HasPresentationLinkbase>true</HasPresentationLinkbase> <HasCalculationLinkbase>true</HasCalculationLinkbase> </FilingSummary> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>42 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> { "instance": { "ghst_10k.htm": { "axisCustom": 0, "axisStandard": 4, "contextCount": 42, "dts": { "calculationLink": { "local": [ "ghst-20220630_cal.xml" ] }, "definitionLink": { "local": [ "ghst-20220630_def.xml" ] }, "inline": { "local": [ "ghst_10k.htm" ] }, "labelLink": { "local": [ "ghst-20220630_lab.xml" ] }, "presentationLink": { "local": [ "ghst-20220630_pre.xml" ] }, "schema": { "local": [ "ghst-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 215, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 20, "http://xbrl.sec.gov/dei/2022": 4, "total": 24 }, "keyCustom": 15, "keyStandard": 117, "memberCustom": 2, "memberStandard": 7, "nsprefix": "GHST", "nsuri": "http://ghstworld.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://ghstworld.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "GHST:CommonStockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - COMMON STOCK PAYABLE", "role": "http://ghstworld.com/role/CommonStockPayable", "shortName": "COMMON STOCK PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "GHST:CommonStockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://ghstworld.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://ghstworld.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INCOME TAXES", "role": "http://ghstworld.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - SUBSEQUENT EVENTS", "role": "http://ghstworld.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "GHST:LiquidityAndGoingConcernPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "GHST:LiquidityAndGoingConcernPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedPatentsGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - PATENTS (Details Narrative)", "role": "http://ghstworld.com/role/PatentsDetailsNarrative", "shortName": "PATENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "p", "GHST:CommonStockPayableTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-09-022021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityReverseStockSplit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - COMMON STOCK PAYABLE (Details Narrative)", "role": "http://ghstworld.com/role/CommonStockPayableDetailsNarrative", "shortName": "COMMON STOCK PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "GHST:CommonStockPayableTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-09-022021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityReverseStockSplit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://ghstworld.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "role": "http://ghstworld.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2021-08-07", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://ghstworld.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "lang": "en-US", "name": "GHST:OperatingLossDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2022-08-012022-08-18_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://ghstworld.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2022-08-012022-08-18_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://ghstworld.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://ghstworld.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2020-06-30_custom_PreferredStockSeriesAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit", "role": "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "shortName": "Consolidated Statement of Changes in Stockholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "AsOf2020-06-30_custom_PreferredStockSeriesAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "role": "http://ghstworld.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "role": "http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - PATENTS", "role": "http://ghstworld.com/role/Patents", "shortName": "PATENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ghst_10k.htm", "contextRef": "From2021-07-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 9, "tag": { "GHST_CashPaidDuringYearperiodForAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the year/period for:" } } }, "localname": "CashPaidDuringYearperiodForAbstract", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "GHST_CommonStockPayable": { "auth_ref": [], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock payable" } } }, "localname": "CommonStockPayable", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "GHST_CommonStockPayablePerShareValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stockpayable per share value" } } }, "localname": "CommonStockPayablePerShareValue", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "GHST_CommonStockPayableRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock payable - related parties" } } }, "localname": "CommonStockPayableRelatedParties", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GHST_CommonStockPayableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock payable, number of shares to be issued in exchange for patent" } } }, "localname": "CommonStockPayableShares", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GHST_CommonStockPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMON STOCK PAYABLE" } } }, "localname": "CommonStockPayableTextBlock", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayable" ], "xbrltype": "textBlockItemType" }, "GHST_CommonStockPayableValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "CommonStockPayableValue", "verboseLabel": "Common stock payable" } } }, "localname": "CommonStockPayableValue", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GHST_CommonStockReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock received" } } }, "localname": "CommonStockReceived", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GHST_DisclosureCommonStockPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Payable" } } }, "localname": "DisclosureCommonStockPayableAbstract", "nsuri": "http://ghstworld.com/20220630", "xbrltype": "stringItemType" }, "GHST_FairValuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value" } } }, "localname": "FairValuePolicyTextBlock", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GHST_IssuanceOfCommonStockInExchangeForDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "IssuanceOfCommonStockInExchangeForDebt", "verboseLabel": "Issuance of common stock in exchange for debt" } } }, "localname": "IssuanceOfCommonStockInExchangeForDebt", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GHST_IssuanceOfSharesInExchangeOfDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common stock in exchange for debt", "verboseLabel": "Issuance of shares in exchange of debt" } } }, "localname": "IssuanceOfSharesInExchangeOfDebt", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative", "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GHST_IssuanceOfSharesInExchangeOfDebtShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common stock in exchange for debt, shares", "verboseLabel": "Issuance of shares in exchange of debt, shares" } } }, "localname": "IssuanceOfSharesInExchangeOfDebtShares", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative", "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GHST_LiquidityAndGoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity and Going Concern" } } }, "localname": "LiquidityAndGoingConcernPolicyTextBlock", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GHST_OperatingLossDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating loss Description" } } }, "localname": "OperatingLossDescription", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "GHST_PreferredStockSeriesAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Series A [Member]" } } }, "localname": "PreferredStockSeriesAMember", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "GHST_PreferredStockSeriesBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Series B [Member]" } } }, "localname": "PreferredStockSeriesBMember", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "GHST_SaleOfStockNumberOfShareIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sale of stock" } } }, "localname": "SaleOfStockNumberOfShareIssuedInTransaction", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GHST_SharesToExchangeValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Exchange value" } } }, "localname": "SharesToExchangeValue", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GHST_WeightedAverageNumberOfCommonSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfCommonSharesOutstandingAbstract", "nsuri": "http://ghstworld.com/20220630", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r274", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r274", "r276", "r277" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r274", "r276", "r277" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r274", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ghstworld.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r25", "r27", "r65", "r66", "r147", "r151" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r26", "r27", "r65", "r66", "r147", "r151" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r31", "r32", "r214", "r215", "r216", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r12", "r233" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r68", "r69", "r70", "r174", "r175", "r176", "r207" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r49", "r127", "r130" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/PatentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r8", "r62", "r107", "r110", "r115", "r121", "r134", "r135", "r136", "r138", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r199", "r202", "r211", "r231", "r233", "r242", "r250" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r17", "r62", "r121", "r134", "r135", "r136", "r138", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r199", "r202", "r211", "r231", "r233" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r6", "r233", "r261", "r262" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r6", "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r45", "r51", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash - end of period", "periodStartLabel": "Cash - beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r45", "r213" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r9", "r10", "r11", "r60", "r62", "r83", "r84", "r85", "r87", "r89", "r93", "r94", "r95", "r121", "r134", "r139", "r140", "r141", "r145", "r146", "r149", "r150", "r153", "r157", "r163", "r211", "r279" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common stock reserve" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r68", "r69", "r207" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical", "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11", "r233" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 300,000,000 shares authorized; 124,430,534 and 5,239,832 shares issued at June 30 2022 and 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r98", "r249" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r58", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r54", "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Exchange of debt" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r188", "r189" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r18", "r64", "r137", "r139", "r140", "r144", "r145", "r146", "r228" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Advances from related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r64", "r137", "r139", "r140", "r144", "r145", "r146", "r228", "r244", "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "verboseLabel": "Advances from related parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per common share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r37", "r73", "r74", "r75", "r76", "r77", "r81", "r83", "r87", "r88", "r89", "r90", "r91", "r208", "r209", "r246", "r255" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "- basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r37", "r73", "r74", "r75", "r76", "r77", "r83", "r87", "r88", "r89", "r90", "r91", "r208", "r209", "r246", "r255" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "- diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r31", "r32", "r33", "r68", "r69", "r70", "r72", "r78", "r80", "r92", "r122", "r163", "r165", "r174", "r175", "r176", "r191", "r192", "r207", "r214", "r215", "r216", "r217", "r218", "r219", "r224", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss": { "auth_ref": [ "r210" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset (liability) measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair value of assets and liabilities measured on recurring basis" } } }, "localname": "FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOptionChangesInFairValueGainLoss1": { "auth_ref": [ "r212" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://ghstworld.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.", "label": "Loss on change in fair value of debts", "negatedLabel": "Loss on change in fair value of debt", "negatedTerseLabel": "Fair Value, Option, Changes in Fair Value, Gain (Loss)" } } }, "localname": "FairValueOptionChangesInFairValueGainLoss1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative", "http://ghstworld.com/role/StatementsOfCashFlows", "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r129" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Patent costs", "verboseLabel": "Total Patent costs" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/PatentsDetailsNarrative", "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r38" ], "calculation": { "http://ghstworld.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r49", "r123", "r124", "r125", "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Impairment losses" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r63", "r181", "r182", "r186", "r193", "r194", "r195", "r196", "r197" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r30", "r179", "r180", "r182", "r183", "r185", "r190" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r48" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "PATENTS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/Patents" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r59", "r128", "r237", "r238", "r239", "r241" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r34", "r106", "r222", "r223", "r247" ], "calculation": { "http://ghstworld.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r44", "r46", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r227", "r228" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r16", "r62", "r121", "r211", "r233", "r243", "r252" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r20", "r62", "r121", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r200", "r202", "r203", "r211", "r231", "r232", "r233" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r45" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided By Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r45" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used In Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS\u00a0\u00a0FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r45", "r47", "r50" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Cash Used In Operating Activities", "totalLabel": "Net Cash Used In Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows", "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r28", "r29", "r33", "r36", "r50", "r62", "r71", "r73", "r74", "r75", "r76", "r79", "r80", "r86", "r107", "r109", "r111", "r114", "r116", "r121", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r209", "r211", "r245", "r254" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ghstworld.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "negatedLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/StatementsOfCashFlows", "http://ghstworld.com/role/StatementsOfOperations", "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://ghstworld.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income(expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income(expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ghstworld.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r184" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating loss carryforwards valuation allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r204" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r7" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r40" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Patent costs", "verboseLabel": "Patent costs" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows", "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of nonredeemable preferred shares reserved for future issuance.", "label": "Preferred stock reserve" } } }, "localname": "PreferredStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10", "r149" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10", "r149" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10", "r233" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r41" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Issuance of common stock for cash" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r42" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "verboseLabel": "Advances from related parties" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentOfLoansToPurchaseCommonStock": { "auth_ref": [ "r43" ], "calculation": { "http://ghstworld.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash inflow from repayment of loans for purchasing common stock.", "label": "Increase in common stock payable" } } }, "localname": "ProceedsFromRepaymentOfLoansToPurchaseCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r225", "r226", "r228", "r229", "r230" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r165", "r233", "r251", "r259", "r260" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "negatedTerseLabel": "Accumulated losses" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/IncomeTaxesDetailsNarrative", "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r68", "r69", "r70", "r72", "r78", "r80", "r122", "r174", "r175", "r176", "r191", "r192", "r207", "r256", "r258" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r35", "r62", "r104", "r105", "r108", "r112", "r113", "r117", "r118", "r119", "r121", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r211", "r248" ], "calculation": { "http://ghstworld.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r9", "r10", "r163" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r9", "r10", "r163" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r168", "r169", "r170", "r171", "r172", "r173", "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price", "verboseLabel": "Price per share" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative", "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r57", "r67" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r9", "r10", "r11", "r60", "r62", "r83", "r84", "r85", "r87", "r89", "r93", "r94", "r95", "r121", "r134", "r139", "r140", "r141", "r145", "r146", "r149", "r150", "r153", "r157", "r163", "r211", "r279" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/BalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r24", "r31", "r32", "r33", "r68", "r69", "r70", "r72", "r78", "r80", "r92", "r122", "r163", "r165", "r174", "r175", "r176", "r191", "r192", "r207", "r214", "r215", "r216", "r217", "r218", "r219", "r224", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/BalanceSheetsParenthetical", "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r68", "r69", "r70", "r92", "r240" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/BalanceSheetsParenthetical", "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r23", "r148", "r163", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r10", "r11", "r163", "r165" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock for cash, shares", "verboseLabel": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of common stock for cash, net of issuance costs, shares", "verboseLabel": "Issuance of shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r10", "r11", "r163", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of common stock for cash" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of common stock for cash, net of issuance costs" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r14", "r15", "r62", "r120", "r121", "r211", "r233" ], "calculation": { "http://ghstworld.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Deficit", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u2019 Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets", "http://ghstworld.com/role/StatementOfChangesInStockholdersDeficit", "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r61", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r165", "r167", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplit": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.", "label": "Revese stock split" } } }, "localname": "StockholdersEquityNoteStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/CommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r220", "r235" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r220", "r235" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r220", "r235" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r220", "r235" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r234", "r236" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainOnForeignCurrencyDerivativesBeforeTax": { "auth_ref": [ "r205" ], "calculation": { "http://ghstworld.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain related to the increase in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.", "label": "Foreign exchange gain" } } }, "localname": "UnrealizedGainOnForeignCurrencyDerivativesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualRisksAndUncertaintiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of the unusual risk or uncertainty, if estimable, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Risks and Uncertainties" } } }, "localname": "UnusualRisksAndUncertaintiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r96", "r97", "r99", "r100", "r101", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r82", "r89" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "- diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r81", "r89" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "- basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ghstworld.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r236": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r263": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r264": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r265": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r266": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r267": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r268": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r269": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r270": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r271": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r272": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r273": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r274": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r275": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r276": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r277": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r278": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r279": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r280": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r281": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r282": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r283": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r67": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" } }, "version": "2.1" } </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>43 <FILENAME>0001553350-22-000798-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> begin 644 0001553350-22-000798-xbrl.zip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�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end </TEXT> </DOCUMENT> </SEC-DOCUMENT>